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Summary 
Their genetic repertoire allows bacteria to adapt to constantly changing environments and to 
survive inhospitable conditions. Such genetic modules are toxin-antitoxin (TA) systems, which 
increase the survival of a population by inducing dormancy or cell death of a subpopulation of 
cells. They encode intracellular toxins, which have the potential to kill the cell, and are therefore 
tightly regulated by cognate antitoxins that inhibit the toxic activity. 
Toxicity is exerted by interference with essential cellular processes including replication, 
translation and homeostasis. Correspondingly, the toxins of the zeta family were found to poison 
cell wall synthesis by phosphorylation of the peptidoglycan precursor UDP-N-acetylglucosamine 
(UNAG). Zeta toxins are counteracted by small, proteinaceous epsilon antitoxins. These 
epsilon/zeta TA systems were first discovered as plasmid maintenance modules on the plasmids of 
Gram-positive streptococci and have long been thought to be confined to Gram-positive bacteria. 
This thesis provides the first biochemical and structural characterization of zeta toxin 
homologs from Gram-negative bacteria - EzeT from Escherichia coli and the plasmidic 
epsilon/zeta systems from Neisseria gonorrhoeae - showing that these proteins exhibit zeta-like 
kinase activity. Moreover, several differences to the hitherto described streptococcal epsilon/zeta 
systems provide evidence for the diversity of the epsilon/zeta TA family. 
The first part of this thesis describes the characterization of the elongated zeta homolog 
EzeT, which was found to combine toxin and antitoxin functionalities in one polypeptide chain. 
The protein consists of two domains, one of which was demonstrated to have UNAG kinase 
activity in vitro and in vivo. The enzymatic activity is abrogated in the presence of the N-terminal 
antitoxin domain and mutational analysis indicated that inhibition is performed by an epsilon-like 
mechanism. Furthermore, EzeT toxicity is temperature dependent, leading to a lytic phenotype and 
spherical morphology at ambient temperature. The presented novel type of toxin inhibition by a 
covalently linked antitoxin sets EzeT apart from other TA systems and necessitates the analysis of 
other elongated or orphan toxin homologs that have been identified in bacterial genomes. 
In the second part of this thesis, the X-ray crystal structure of the epsilon/zeta system ε1/ζ1 
of N. gonorrhoeae is presented, together with biochemical studies that confirmed ζ1 as a UNAG 
kinase, which is inhibited by binding of ε1. Bioinformatic analysis of ζ1 showed that in the amino 
acid sequence the catalytically important Walker A motif, commonly found in P-loop kinases, is 
located closer to the C-terminus than in homologous proteins. Nevertheless, ζ1 adopts a typical 
zeta-like three-dimensional structure with a conserved architecture of the catalytic center. This is 
achieved by a rearrangement of the secondary structure elements and a corresponding topological 
rewiring, forming a fold unusual for P-loop kinases. However, nucleotide binding and hydrolysis 
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xi 
are not impaired and have been observed spectroscopically and by determination of the ADP-
bound complex structure. 
In addition to the zeta-like domain, ζ1 contains a C-terminal domain that comprises an OB-
fold with similarity to DNA-binding modules. This domain is also present in two other gonococcal 
epsilon/zeta homologs, which are located on the same plasmid. As presented in this work, these 
systems, called ε2/ζ2 and ε3/ζ3, phosphorylate UNAG, but do not directly interact with ε1/ζ1. 
Furthermore, the X-ray crystal structure of the heterodimeric ε1/ζ1 complex revealed that inhibition 
is mediated by ε1 wrapping around the zeta core, indicating a different mode of inhibition 
compared to the streptococcal antitoxins. 
In conclusion, data presented in this thesis show that Gram-negative bacteria encode active 
UNAG kinases. The characterization of these systems reveals novel inhibition mechanisms by the 
antitoxins and highlights the structural diversity of zeta toxins. 
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Zusammenfassung 
Die Anpassungsfähigkeit von Bakterien basiert auf ihren im Verlauf der Evolution 
erworbenen Erbinformationen, die ihnen ermöglichen, sich an wechselnde Umweltbedingungen 
anzupassen und auch in unwirtlichen Umgebungen zu bestehen. Zu den genetischen Modulen, die 
das Überleben der Gesamtpopulation sichern, gehören die Toxin-Antitoxin-Systeme (TA-Systeme). 
Diese Systeme können Zellen in eine Art Ruhezustand versetzen oder bei einem Teil der Bakterien 
zum Zelltod führen. Um dies zu erreichen kodieren TA-Systeme intrazelluläre Toxine, welche zum 
bakteriellen Zelltod führen indem sie in lebenswichtige zelluläre Prozesse wie Replikation, 
Translation oder Homöostase eingreifen. Daher müssen diese Toxine stark reguliert werden, 
weshalb Bakterien immer auch entsprechende Antitoxine produzieren, welche die Toxine 
inhibieren. 
In der Familie der Epsilon/Zeta Systeme, neutralisieren kleine Proteine, die Epsilon-
Antitoxine, die toxische Aktivität der Zeta-Toxine. Zeta-Toxine beeinträchtigen die 
Zellwandsynthese durch Phosphorylierung von UDP-N-acetylglukosamin (UNAG), einem 
essentiellen Bestandteil des bakteriellen Mureins. Epsilon/Zeta TA-Systeme wurden zuerst als 
Plasmid-stabilisierende Module in Gram-positiven Streptokokken entdeckt und man ging lange 
davon aus, dass sie auf Gram-positive Bakterien beschränkt seien. 
Die vorliegende Arbeit umfasst die erste biochemische und strukturelle Beschreibung von 
Zeta-Toxinen Gram-negativer Bakterien (EzeT von Escherichia coli und die plasmidischen 
Epsilon/Zeta-Systeme von Neisseria gonorrhoeae). Es konnte gezeigt werden, dass diese Proteine 
UNAG-Kinase-Aktivität besitzen, aber im Vergleich zu den bisher beschriebenen Epsilon/Zeta-
Systemen in Streptokokken eine Reihe von Unterschieden aufweisen. Damit geben sie einen 
Einblick in die Diversität innerhalb der Epsilon/Zeta-Familie. 
Der erste Teil der Arbeit beschreibt das auffällig verlängerte Zeta-Homolog EzeT, welches 
toxische und antitoxische Funktionen innerhalb einer Polypeptidkette vereint. EzeT besteht aus 
zwei Proteindomänen, von denen für die C-terminale Domäne UNAG-Kinase-Aktivität in vitro und 
in vivo nachgewiesen werden konnte. Die toxische Wirkung des Enzyms wird durch das N-
terminale Antitoxin unterbunden. Weitergehende Untersuchungen mittels Mutationsanalyse zeigen, 
dass dies auf einen Epsilon-ähnlichen Inhibierungsmechanismus zurückzuführen ist. Zudem wurde 
eine Temperaturabhängigkeit der Toxizität nachgewiesen, die bei niedrigen Temperaturen zur Lyse 
und zur Ausbildung einer abgerundeten Zellmorphologie führt. Diese neue Form der Inhibierung 
von Toxinen durch ein kovalent gebundenes Antitoxin unterscheidet EzeT von anderen TA-
Systemen. Dies legt die Untersuchung von weiteren verlängerten oder bisher als ´verwaist` 
geltenden Toxin-Homologen nahe, die bereits in den Genomen von anderen Bakterien identifiziert 
worden sind. 
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Im zweiten Teil der Arbeit wird die Röntgenkristallstruktur des Epsilon/Zeta-Systems ε1/ζ1 
von N. gonorrhoeae vorgestellt, zusammen mit biochemischen Studien, die die UNAG-Kinase-
Aktivität von ζ1 und dessen Inhibierung durch ε1 beweisen. Die bioinformatische Untersuchung 
von ζ1 zeigt, dass in der Aminosäuresequenz das essentielle Walker A Motiv näher beim C-
Terminus liegt als in homologen Proteinen. Trotzdem besitzt ζ1 eine typische dreidimensionale 
Struktur ähnlich den bekannten Zeta-Toxinen und eine konservierte Architektur des katalytischen 
Zentrums. Dies wird durch eine veränderte Reihung der Sekundärstrukturelemente und einer 
dementsprechenden topologischen Neuordnung erreicht, was zu einer für P-loop Kinasen 
unüblichen Faltung führt. Dabei wird der katalytische Mechanismus nicht beeinträchtigt, wie durch 
spektroskopische Messungen und durch Bestimmung der ADP-gebundenen Komplexstruktur 
nachgewiesen werden konnte. 
Zusätzlich zur Zeta-ähnlichen Domäne enthält ζ1 eine weitere abgegrenzte C-terminale 
Domäne. Diese beinhaltet eine OB-Faltung, die Ähnlichkeiten mit DNS-bindenden Modulen 
aufweist. Eng verwandte C-terminale Domänen konnten auch in zwei weiteren Epsilon/Zeta-
Systemen von N. gonorrhoeae identifiziert werden, die gemeinsam mit ε1/ζ1 auf einem Plasmid 
vorkommen. Diese Systeme, genannt ε2/ζ2 und ε3/ζ3, phosphorylieren ebenfalls UNAG. Sie treten 
aber nicht direkt mit ε1/ζ1 in Wechselwirkung. Zudem legt die Röntgenkristallstruktur des ε1/ζ1-
Komplexes im Vergleich zu den bereits beschriebenen Epsilon-Antitoxinen einen geänderten 
Inhibitionsmechanismus nahe, in dem ε1 in gestreckter Konformation um das Zeta-Toxin 
gewunden ist. 
Zusammenfassend beweist diese Arbeit, dass Gram-negative Bakterien aktive Zeta-Toxine 
kodieren. Die genauere Untersuchung dieser Systeme zeigt nicht nur bisher unbekannte 
Inhibitionsmechanismen, sondern gibt auch einen Einblick in die strukturelle Vielfalt und 
enzymatische Variabilität der Zeta-Toxine. 
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1 Introduction 
Bacteria are versatile unicellular organisms that thrive in virtually every habitat on earth 
including the deep sea [1], hot springs [2] and Antarctica [3]. Under favorable conditions, for 
example in surface sea water, bacterial densities can reach up to 106 cells per milliliter [4]. In these 
dense communities, bacteria are in constant competition for resources and subject for predation by 
bacteriophages and larger organisms [5, 6]. In addition, natural habitats are exposed to climatic and 
meteorological changes and bacteria need to adjust to nutrient fluctuations, oxygen availability and 
the presence of damaging agents like radiation and oxidizing agents [7]. Moreover, bacteria can 
live in close association with larger organisms, either as commensals or as pathogens, where they 
have to cope with attacks by the immune system and antibiotics [8]. 
In response to these cues, bacteria can regulate gene expression to switch between different 
metabolic pathways, activate repair systems or synthesize resistance proteins that inactivate 
stressors such as antibiotics [9]. During evolution, the acquisition of novel genes by horizontal gene 
transfer can expand the genetic repertoire of bacteria, allowing them to exert new functions or to 
exploit new ecological niches [10]. To evade stressful conditions, bacteria can form biofilms, 
matrix-enclosed populations in which the cells are protected against physical or chemical 
challenges such as desiccation and phagocytosis [11]. When the conditions are too inhospitable to 
sustain metabolism, bacterial growth ceases and individual cells survive in the form of dormant 
persister cells [12] or spores [13]. 
 
Many of the bacterial strategies to adapt to environmental stresses involve social behaviors 
that reach beyond the historical perception of bacteria as purely unicellular organisms. 
Multicellularity has not only been observed in highly specialized species like filamentous 
cyanobacteria or streptomycetes [13], which differentiate into distinct cell types with specific 
functions, but in most bacteria that use quorum sensing to coordinate cellular behaviors like 
predation, sporulation and competence [14]. These strategies generally aim to ensure the survival 
of a population, instead of individual cells, and bacterial altruistic behavior has been described, for 
instance in phage abortive infection, where infected cells undergo cell lysis to prevent the spread of 
phages [15]. Cell death has also been implicated in biofilm formation [16] and sporulation [13] and 
it was found that these death pathways are regulated by intracellular programs displaying a form of 
programmed cell death (PCD) in bacteria [17]. 
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1.1 Toxin-antitoxin systems 
Systems that can induce bacterial PCD are so-called toxin-antitoxin (TA) systems[18]. 
TA modules commonly consist of two genes with antagonistic functions [18, 19]. One gene 
product- the toxin - has the potential to induce cell death or stasis, while the second gene product    
– the antitoxin - neutralizes this toxicity. Usually both genes are co-regulated, ensuring that 
sufficient antitoxin levels are produced to inhibit the toxic activity. However, degradation of the 
antitoxin can free the toxin to fulfil its intracellular function [18]. These functions can range from 
the stabilization of mobile genetic elements to the induction of dormancy or PCD [20]. 
 
 Types of TA systems 1.1.1
While all identified toxins are proteins, the nature and the inhibition mechanism by the 
antitoxins can vary, which is used to classify TA systems into different types [21]. In type I 
systems the antitoxin is transcribed as a small RNA that binds to the toxin mRNA and thereby 
interferes with toxin translation [21]. In type II and type III systems the toxin is inhibited by 
complex formation with a proteinaceous antitoxin [19] or a folded RNA molecule [22], 
respectively. Recently, three new types of TA systems with only few studied representatives were 
discovered. In type IV systems the antitoxin is a nuclease that specifically degrades toxin 
mRNA [23], while in type VI systems the antitoxin targets the toxic protein for degradation [24]. In 
type V systems no direct interaction between toxin and antitoxin takes place. Instead, the antitoxin 
binds to the toxin substrate and prevents its degradation [25]. 
 
The most extensively studied TA modules are type II systems, which in general consist of 
two adjacent protein-coding genes [18, 26]. In these bicistronic operons, the antitoxin gene is 
located upstream of the toxin gene. It encodes a small, proteolytically instable protein that can bind 
to the toxin and thereby inhibit toxicity (Figure 1.1-1). Degradation of the antitoxin by cellular 
proteases releases the toxin, which can then interfere with an essential cellular process [21]. Most 
proteinaceous antitoxins contain a DNA-binding domain and bind to the promoter of the bicistron 
to autoregulate transcription. The repressor-function is further enhanced in the presence of the 
toxin, which acts as a co-repressor [18, 26]. 
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Figure 1.1-1: Schematic of a type II TA system. Toxin (red) and antitoxin (blue) are encoded in a 
bicistronic operon and form an inactive complex in the cytosol. Expression of both proteins is 
regulated by transcriptional repression by the antitoxin or the toxin-antitoxin complex. Degradation 
of the proteolytically unstable antitoxin frees the toxin, which has a bactericidal or bacteriostatic 
activity. 
 
 Functions of TA systems 1.1.2
TA systems were first discovered in 1983 as plasmid stabilization elements on low-copy 
number plasmids [27] and later shown to act as addiction modules that induce a process called 
postsegregational killing (PSK) upon plasmid loss [28, 29]. PSK depends on differential proteolytic 
stabilities of toxin and antitoxin to cause death of plasmid-free offspring. Since the antitoxin is 
rapidly degraded by cellular proteases it needs to be constantly replenished by protein synthesis. In 
cells harboring the plasmid, both TA genes are present and an inactive TA complex is formed in 
the cytosol. However, when the plasmid gets lost during segregation, the daughter cell still inherits 
the TA protein complex together with other cytosolic compounds. Since the antitoxin cannot be 
replenished any longer, the toxin is freed and kills the plasmid-free daughter cell [30] 
(Figure 1.1-2). 
 
With the advances of genomics, a plethora of TA systems and even new toxin and antitoxin 
families were identified in bioinformatic studies [31-34]. Interestingly, homologs of plasmidic TA 
systems have been identified on the chromosomes of most eubacteria and archaea [18] where they 
can be present in large numbers (e.g. 36 reported systems in Escherichia coli K-12 [35] and 79 in 
Mycobacterium tuberculosis H37Rv [36]). It has been suggested that these chromosomal systems 
originated from gene transfer between plasmids and chromosomes [37]. Indeed, chromosomal TA 
systems are prevalent on mobile genetic elements and some modules were shown to stabilize 
superintegrons in the genome [38].  
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Figure 1.1-2: Stabilization of plasmids by postsegregational killing. Schematic representation 
of plasmid loss by cells containing low-copy plasmids with (left) or without (right) TA systems. While 
daughter cells that lose a plasmid encoding a TA system are killed by PSK, plasmid loss in cells 
without TA systems gives rise to plasmid-free offspring. Figure adapted from Ref. [39]. 
 
However, it has been recognized that chromosomal TA systems can exert functions beyond 
the stabilization of DNA elements [20]. For instance, the simultaneous presence of interacting 
TA systems on plasmid and chromosome can also enable daughter cells that lose the plasmid to 
avoid PSK [40]. In this case, the chromosomal antitoxin gene produces sufficient antitoxin to 
counteract the toxicity of the encoded toxins, even when the antitoxin gene of the plasmid is lost. 
As plasmids that are actively maintained have a higher chance to get transferred, evolution drives 
mutational adaptations to diminish this cross-reactivity of plasmidic and chromosomal systems, 
leaving orphan TA systems on the chromosome that can potentially evolve to fulfill novel 
functions [40]. One of these novel functions is phage abortive infection, where cells that are 
infected by phages undergo autolysis before phage particles can assemble and spread [15]. 
However, toxin activation is not always bactericidal, but can also reduce metabolic activity 
and evoke dormancy, which can be utilized as a stress response mechanism [19, 41]. For example, 
the chromosomal hipA toxin of E. coli was shown to mediate persister cell formation by 
phosphorylation of glutamyl-tRNA synthetase [42, 43]. Furthermore, TA systems are implicated in 
cell differentiation and death during biofilm development [44] and sporulation [45] and as factors 
that promote the virulence of pathogens [46, 47]. 
 
 Intracellular poisons 1.1.3
Consistent with their distribution across multiple phyla, toxins target ubiquitous cellular 
functions [48]. For example, type I pore-forming toxins perforate the plasma membrane and disturb 
ATP synthesis [49], while the type IV toxin CbtA inhibits MreB and FtsZ polymerization and 
thereby cell division [50]. The thoroughly studied type II toxins are amongst others DNA gyrase 
inhibitors that interfere with replication [51], endonucleases that cleave mRNA [18] or kinases that 
phosphorylate EF-TU and thereby inhibit translation [52]. Furthermore, type II toxins of the zeta 
family disturb the integrity of the bacterial cell wall and as a result cause autolysis [53]. 
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1.2 Epsilon/zeta systems 
 Zeta toxins inhibit cell wall synthesis 1.2.1
The type II epsilon/zeta systems contain an epsilon antitoxin that inhibits the toxic action of 
the zeta toxin by protein complex formation. Zeta toxins are kinases that phosphorylate the 
peptidoglycan precursor UDP-N-acetylglucosamine (UNAG) under consumption of ATP [53] 
(Figure 1.2-1, top). UNAG is required for the synthesis of cell wall peptidoglycan [54] and 
glycoconjugates like teichoic acids [55] and lipopolysaccharides [56]. During the cytosolic steps of 
peptidoglycan synthesis the carboxyvinyltransferase MurA adds an enolpyruvyl to the 3’-hydroxy 
group of the acetylglucosamine moiety of UNAG [54] (Figure 1.2-1, left). The same hydroxyl 
group is phosphorylated by zeta toxins yielding UNAG-3P, which competitively inhibits 
peptidoglycan synthesis and accumulates in the cytosol, because it cannot be incorporated into 
peptidoglycan [53]. As a consequence the stability of the cell wall is decreased, which ultimately 
leads to lysis of the cell. UNAG phosphorylation is detrimental to a wide range of cells including 
eukaryotes, as ζspy overexpression causes growth inhibition even in the eukaryotic yeast 
Saccharomyces cerevisiae [57]. 
 
 
Figure 1.2-1: Reaction catalyzed by zeta toxins. Zeta toxins catalyze the phosphorylation of 
UNAG under consumption of ATP (top row). The reaction product UNAG-3P inhibits MurA, an 
enzyme that attaches an enolpyruvyl moiety to the same hydroxyl group (left). Enolpyruvyl-UNAG 
is an essential component in the synthesis of peptidoglycan. 
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 Streptococcal epsilon/zeta systems 1.2.2
Epsilon/zeta systems were originally discovered as plasmid maintenance modules on low-
copy number plasmids and are there denoted with Greek letters: ε/ζ [58]. In addition, homologous 
systems were found on the chromosomes of various streptococci [59, 60]. One representative of 
each of these two variants has been extensively studied, the chromosomally encoded pneumococcal 
epsilon zeta antitoxin toxin (pezAT) locus from Streptococcus pneumonia and the genes ε and ζ 
located on plasmid pSM19035 from Streptococcus pyogenes (ε/ζspy) [61]. From the analysis of 
these streptococcal systems, general assumptions on the functionalities of epsilon/zeta systems 
have been drawn. 
 
The streptococcal zeta toxins PezT and ζspy adopt a common fold, which closely resembles 
that of phosphotransferases, consisting of a central β-sheet surrounded by α-helices (Figure 1.2-2A) 
[62, 63]. This is also reflected in a similar length of 253 (PezT) or 286 (ζspy) amino acids. Both 
proteins share 42 % amino acid sequence identity [62] and contain a Walker A motif characteristic 
for ATP binding proteins [64, 65]. By homology to other P-loop proteins, the ATP-binding site of 
zeta toxins could be located in a shallow cleft on one side of the protein. On the opposite side of the 
β-sheet resides the UNAG-binding site (Figure 1.2-2B), which is characterized by the highly 
conserved GTXR consensus sequence (where X can be any residue) [66]. Truncation of residues 
especially at the C-terminus attenuates UNAG kinase activity, suggesting that this globular domain 
comprises the enzymatically required UNAG kinase core fold [53, 63]. 
The cognate antitoxins, PezA and εspy, are less conserved. The carboxy (C)-terminal domain 
of PezA (residues 70-158) and εspy share 21 % amino acid sequence identity, while the amino (N)-
terminal domain of PezA is predicted to fold into a helix-turn-helix domain typical for 
transcriptional regulators [62]. 
 
In both streptococcal systems, inhibition of UNAG kinase activity is mediated by binding of 
the cognate epsilon antitoxins. The inhibited complex consists of a dumbbell-shaped 
heterotetrameric arrangement of two zeta toxins bound to a central epsilon dimer [62, 63] 
(Figure 1.2-2C). The C-terminal domains of PezA and εspy both fold into a three-helix bundle. In 
the inhibited epsilon/zeta complex this bundle binds on top of the ATP binding cleft of zeta and 
thereby prevents ATP binding and hydrolysis [62, 63]. Several side chains of residues in the 
amino-terminal helix (Tyr, Phe/Leu, Glu, Glu) protrude into the ATP binding site and sterically 
block ATP binding (Figure 1.2-2D). Specifically, the large hydrophobic side chains of tyrosine and 
phenylalanine (εspy) or leucine (PezA) occupy the binding sites of adenine and the ribose, while the 
glutamate side chains form hydrogen bonds to residues of the zeta toxin that are required for 
binding of the phosphoryl-groups of ATP.  
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Figure 1.2-2: Structural features of epsilon/zeta systems. (A) Zeta toxin fold of ζspy (PDB ID: 
1GVN). α-helices are shown in red, β-strands in blue, loop regions in gray. (B) UNAG binding 
pocket of ζspy (gray). Residues previously described to coordinate UNAG and bound UNAG are 
shown as stick model. PDB ID: 3Q8X (C) The heterotetrameric arrangement of the inhibited ε/ζspy 
complex. Two ζspy molecules (red) bind to a central εspy dimer (blue). The antitoxins adopt a three-
helix bundle fold. (D) Inhibition by εspy (green). ADP (stick model) is modelled according to the 
homologous T4 polynucleotide kinase (PDB ID: 1LTQ) and residues from εspy that interfere with 
nucleotide binding are shown as stick models. 
 
Despite their similarities in structure and enzymatic activity the streptococcal epsilon/zeta 
systems differ in their transcriptional regulation and activation mechanisms and their function. An 
overview on differences and similarities of these systems can be found in Table 1.1.  
 
The function of the plasmidic ε/ζspy module has been thoroughly investigated, showing that it 
acts as a plasmid addiction system that evokes PSK of plasmid-free daughter cells and, together 
with a plasmid partitioning system, ensures a more than 1000 fold better-than-random segregation 
efficiency of pSM19035 [58]. In contrast, PezAT is encoded on the hypervariable region of the 
chromosomal pneumococcal pathogenicity island of some pneumococcal strains [47, 60, 67]. 
Analysis of pneumococcal strains with different variants of this island with or without active PezT 
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showed attenuated virulence of strains in the absence of PezT [47, 59]. These results indicate that 
PezAT is important to establish full virulence of S. pneumoniae. 
 
The transcriptional regulation of the chromosomal PezAT system resembles that of other 
type II TA systems. The N-terminal helix-turn-helix motif of PezA is a DNA-binding domain that 
enables PezA to bind to the pezAT promoter region and to repress transcription of the bicistron 
(compare Figure 1.1-1). The toxin PezT was shown to act as a co-repressor [62]. In contrast, ε/ζspy 
expression is regulated by a third protein, the transcriptional regulator ω [68]. ω is encoded in an 
operon with εspy and ζspy and represses expression from the promoter of the tricistron. In contrast to 
the helix-turn-helix motif of PezA, the DNA binding domain of ω folds into a ribbon-helix-helix 
motif [69], indicating a different evolutionary origin of transcriptional regulation. 
 
The binding affinities of εspy and ζspy from S. pyogenes were reported to be moderate with a 
dissociation constant of 1.1 µM [70]. This suggests that in vivo the heterotetrameric ε2ζ2spy complex 
is in a dynamic equilibrium with the individual proteins. The protease ClpXP constantly degrades 
the εspy antitoxin and leads to activation of the toxin ζspy, when the antitoxin cannot be 
replenished [71]. Strikingly, PezAT binding is extremely tight with an apparent binding constant of 
65 fM [72]. Furthermore, PezT release was not observed in E. coli and PezA was not degraded in 
the PezAT complex in Bacillus subtilis crude extracts [72]. This high stability of the complex 
suggests that specialized factors are required to activate PezT under certain circumstances. These 
factors might be host-specific, which is corroborated by BLAST searches that indicate that PezAT 
systems are restricted to streptococci (unpublished results). A similar host adaptation was found for 
ε/ζspy which stabilizes plasmids in firmicutes to varying degrees [73] and is only weakly effective in 
E. coli [74].  
 
Table 1.1: Comparison of the streptococcal epsilon/zeta toxins 
 ε/ζspy PezAT 
Enzymatic activity                                  UNAG kinase 
Oligomeric State ε2ζ2 PezA2T2 
Transcriptional regulator ω PezA(1-68) 
(co-repressor PezT) 
Function PSK virulence? 
Binding affinity 1.1 µM 65 fM 
Protease/activator ClpXP ? 
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1.3 Epsilon/zeta systems and Gram-negative bacteria 
The differences in ζspy activity observed between Gram-negative E. coli and Gram-positive 
B. subtilis [74] provoked the question, whether UNAG kinase activity has different effects in 
Gram-positive and Gram-negative bacteria and might therefore restrict epsilon/zeta systems to 
Gram-positive strains. 
The major difference between Gram-positive and Gram-negative bacteria lies in the 
composition of their cell wall. While Gram-positive bacteria possess a thick peptidoglycan layer 
surrounding their cell membrane, the peptidoglycan layer of Gram-negative bacteria is much 
thinner and surrounded by a second, outer membrane [75]. Nevertheless, both bacterial classes 
depend on the rigidity of the peptidoglycan layer to preserve the cellular shape and integrity [76]. 
Furthermore, the basic structure of the glycan strands is conserved [77] and homologs of the 
enzyme MurA are found in Gram-positive and Gram-negative bacteria [78]. In addition, 
recombinant overexpression experiments of streptococcal zeta toxins in E. coli revealed a growth 
phenotype and lysis, indicating that UNAG kinase activity is detrimental to E. coli [53, 74, 79]. 
In addition, bioinformatics analysis identified a plethora of zeta toxins in all bacterial 
phyla [31], which indicates a general functionality of UNAG kinases within the bacterial domain. 
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1.4 Scope of this thesis 
Although bioinformatics studies proof that epsilon/zeta homologs are present in all bacterial 
phyla [31], profound characterizations were restricted to the two streptococcal systems, ε/ζspy and 
PezAT. These experiments revealed that epsilon/zeta systems, although sharing the same 
mechanism, can show profound differences in binding affinities, regulation and cellular function. 
Therefore, the objective of this thesis was to investigate novel epsilon/zeta TA systems in Gram-
negative bacteria. 
A chromosomal zeta homolog from E. coli and the plasmidic epsilon/zeta systems from 
N. gonorrhoeae were chosen for thorough investigation. 
 
 Escherichia coli EzeT 1.4.1
E. coli is the prokaryotic model organism and has been extensively studied and manipulated. 
Naturally, this Gram-negative γ-proteobacterium is part of the human gut microbiota, but virulent 
strains can cause diarrhea, urinary tract infections and meningitis. On the E. coli chromosome, a 
gene with homology to zeta toxins (ECO103_4771 in E. coli O103:H2 12009) was identified and 
termed ezeT. Interestingly, no putative antitoxin gene was found in its vicinity. Closer investigation 
showed that the ezeT open reading frame (ORF) is unusually long with 308 amino acids compared 
to approximately 250 residues that form the zeta toxin core. While the 3’-end of ezeT is 
homologous to other zeta genes, its 5’-end is translated into approximately 80 additional residues. 
To explain the presence of an active UNAG kinase without an obvious inhibitor the hypothesis 
was proposed that EzeT is an autoinhibited UNAG kinase in which toxin and antitoxin 
functionalities are linked. 
To test this hypothesis various microbiological and biochemical experiments were conducted 
which are described in the first section of the results. The experiments aimed to investigate 
expression and UNAG kinase activity of EzeT, and to characterize toxicity and inhibition by the 
two putative domains. Furthermore, experiments were performed to investigate transcriptional 
regulation, activation and possible functions of this TA system. 
 
 Neisseria gonorrhoeae epsilon/zeta 1.4.2
N. gonorrhoeae is a human pathogen that causes the sexually transmitted disease gonorrhea. 
Virulence factors, which contribute to pathogenicity, can be carried and transferred by mobile 
genetic elements like the gonococcal conjugative plasmid pLE2451 [80]. Sequencing of pLE2451 
variants with or without a tetracycline resistance determinant, called tetM, identified two adjacent 
epsilon/zeta homologs on each of these plasmids [81]. In tetracycline-resistance plasmids, these 
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putative TA systems were denoted ε1/ζ1 and ε2/ζ2, while plasmids without the tetM determinant 
encode ε1/ζ1 and ε3/ζ3, the latter sharing 67 % nucleotide sequence identity with ε2/ζ2 [81]. 
These plasmids are the first described cases, where two putative epsilon/zeta TA systems 
reside on one plasmid. To get insights into the functional relevance of these two systems, the aim 
of this thesis was to characterize the gonococcal epsilon/zeta homologs, in order to show that all 
three modules are functional TA systems comprising active UNAG kinases. 
Therefore, the ability of the recombinantly expressed epsilon/zeta complexes to 
phosphorylate UNAG was tested, as well as the interactions between the individual proteins. To 
measure the phosphorylation efficiency and nucleotide binding properties of ζ1, the wild-type 
protein was separated from the complex and subjected to biochemical and biophysical studies in 
vitro. Furthermore, the structure of the ε1/ζ1 complex was determined and the mechanism of 
inhibition by ε1 was investigated by measuring enzyme kinetics. 
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2 Materials and Methods 
2.1 Materials 
 Standard chemicals 2.1.1
Manufacturer Product 
Carl Roth chloramphenicol, kanamycin 
GERBU Biotechnik dithioerythritol (DTE), ethylenediaminetetraacetic acid (EDTA), 
glycerol, glycine, isopropyl β-D-1-thiogalactopyranoside (IPTG), 
urea 
Merck CaCl2, HCl, NH4Cl, (NH4)2SO4, KCl, K2HPO4, KH2PO4, MgCl2, 
MgSO4, NaCl, Na2HPO4, NaH2PO4, NaOH, Na2S2O3, ammonium 
acetate, ammonium peroxydisulfate (APS), bromphenol blue, 
isopropanol, methanol, potassium acetate, tri-sodium citrate, 
β-mercaptoethanol 
Serva N,N,N′,N′-tetramethylethane-1,2-diamine (TEMED), 
sodium dodecyl sulfate (SDS), Tween 20 
Sigma-Aldrich MnCl2, RbCl2, 2-(N-morpholino)ethanesulfonic acid (MES), 
2-[4-(2-hydroxyethyl)piperazin-1-yl] ethanesulfonic acid 
(HEPES), acetic acid, acetone, acetonitrile, L-(+)-arabinose, 
ampicillin, boric acid, ethanol, imidazole, 
tris(hydroxymethyl)-aminomethan (Tris), tri-sodium citrate1 
Fluka (NH4)2SO41, D(+)-Glucose, tetracycline 
Riedel-de Haën formalin 
1Bold chemicals were used for protein crystallization.
 
 Microorganisms 2.1.2
Strain Genotype Manufacturer 
DH5α E. coli K-12 F– Φ80lacZΔM15 Δ(lacZYA-argF) 
U169 recA1 endA1 hsdR17(rK–, mK+) phoA 
supE44 λ– thi-1 gyrA96 relA1 
Life Technologies 
BL21-
CodonPlus(DE3)-RIL 
E. coli B F– ompT hsdS(rB– mB–) dcm+ Tetr gal 
λ(DE3) endA Hte [argU ileY leuW Camr] 
Stratagene 
W wild-type DSM1116 
OverExpress 
C43(DE3) 
E. coli B F– ompT hsdS(rB– mB–) dcm+ gal 
λ(DE3) 
Lucigen 
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 Plasmids 2.1.3
Plasmid Resistance Manufacturer 
pMK/RQ Kanamycin GeneArt 
pET28b Kanamycin Novagen 
pM11-1a Kanamycin Gunter Stier 
pBAD/Myc-His A Ampicillin Invitrogen 
pET21d Ampicillin Novagen 
pETN-Strep Kanamycin Gunter Stier 
pRedET Tetracycline Gene Bridges 
 
 Metal affinity resins and chromatography columns 2.1.4
Resin/column Manufacturer 
Ni-NTA agarose  Qiagen 
MonoS 5/50 GL  GE Healthcare 
MonoQ 5/50 GL GE Healthcare 
MonoQ 10/100 GL GE Healthcare 
Superdex 75 10/300 GL GE Healthcare 
Superdex 200 10/300 GL GE Healthcare 
Partisil-5 SAX RACII Whatman 
 
 Crystallization screens 2.1.5
Screen Manufacturer 
JCSG Core I – IV Suite Qiagen 
AmSO4 Suite Qiagen 
 
 Buffers 2.1.6
Buffer Composition 
TFB-1 buffer 30 mM Potassium actetate-HCl pH 5.8 
50 mM MnCl2 
100 mM RbCl, 
10 mM CaCl2  
15 % (v/v) Glycerol 
TFB-2 buffer 10 mM MOPS-NaOH pH 7.0 
10 mM RbCl 
75 mM CaCl2 
15 % (v/v) Glycerol  
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TBE buffer 89 mM Tris-HCl pH 8.0 
89 mM Boric acid 
2 mM EDTA 
6× DNA loading buffer 30 % (v/v) Glycerol 
0.25 % (w/v) Bromphenol blue 
0.25 % (w/v) Xylene cyanol FF (Serva) 
Separation gel buffer 1.5 M Tris-HCl pH 8.8 
0.4 % (w/v) SDS 
Stacking gel buffer  0.5 M Tris-HCl pH 6.8 
SDS running buffer 25 mM Tris-HCl pH 8,0 
200 mM Glycine 
0.1 % (w/v) SDS 
5× SDS loading buffer 50 mM Tris-HCl pH 7.0 10 % (w/v) SDS 
0.1 % (w/v) Bromphenol blue 
143 mM β-Mercaptoethanol 
14 % (w/v) DTE 
10 % (v/v) Glycerol 
Fixing solution  50 % (v/v) Methanol 
12 % (v/v) Acetic acid 
0.05 % (v/v) Formalin 
Staining solution 0.2 % (w/v) AgCO3 
0.076 % (v/v) Formalin 
Developing solution 6 % (w/v) Na2CO3 (Merck) 
0.05 % (v/v) Formalin 
0.0004 % (w/v) Na2S2O3 
Stop solution 50 % (v/v) Methanol 
12 % (v/v) Acetic acid 
Friendly transfer buffer 25 mM Tris-HCl pH 8.3 
192 mM Glycine 
5% (v/v) Isopropanol 
0.1% (w/v) SDS 
TBS 10 mM Tris-HCl pH 7.5 
150 mM NaCl 
TBS-T 25 mM Tris-HCl pH 7.4 
137 mM NaCl 
2.7 mM KCl 
0.1 % (v/v) Tween 20 
PBS 8 mM Na2HPO4 pH 7.4 
2 mM KH2PO4 
137 mM NaCl 
2.7 mM KCl 
PBS-T 8 mM Na2HPO4 pH 7.4 
2 mM KH2PO4 
137 mM NaCl 
2.7 mM KCl 
0.02 % (v/v)Tween 20 
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Conjugation buffer 20 mM NaH2PO4/Na2HPO4 pH 7.5 
150 mM NaCl 
Resuspension buffer 100 mM Tris-HCl pH 8.0 
150 mM NaCl 
1 mM DTE 
2 mM EDTA 
Buffer A1 50 mM Tris-HCl pH 8.0 
150 mM NaCl 
50 mM (NH4)2SO4 
Buffer A2 50 mM Tris-HCl pH 8.0 
10 mM (NH4)2SO4 
5 % (w/v) Glycerol 
250 mM Imidazole 
2 mM DTE 
Buffer A3 50 mM Tris-HCl pH 8.0 
10 mM (NH4)2SO4 
5 % (w/v) Glycerol 
0.5 mM EDTA 
2 mM DTE 
Buffer A4 50 mM Tris-HCl pH 9.0 
2.5 mM (NH4)2SO4 
5 % (w/v) Glycerol 
0.5 mM EDTA 
2 mM DTE 
Buffer A5 50 mM Tris-HCl pH 9.0 
10 mM (NH4)2SO4 
5 % (w/v) Glycerol 
0.5 mM EDTA 
2 mM DTE 
1 M KCl 
Buffer A6 50 mM HEPES-NaOH pH 7.5 
250 mM KCl 
5 % (w/v) Glycerol 
2 mM DTE 
Buffer B1 50mM Tris pH 7.0 
150mM NaCl 
50mM (NH4)2SO4 
Buffer B2 50 mM MES-NaOH pH 6.0 
50 mM NaCl 
50 mM (NH4)2SO4 
500 mM Imidazole 
2mM DTE 
Buffer B3a 50 mM MES-NaOH pH 6.0 
50 mM (NH4)2SO4 
0.5 mM EDTA 
2 mM DTE 
Buffer B3b 50 mM MES-NaOH pH 6.0 
150 mM NaCl 
50 mM (NH4)2SO4 
2 mM DTE 
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Buffer B4 50 mM MES-NaOH pH 6.0 
50 mM (NH4)2SO4 
2 mM DTE 
Buffer B5 50 mM MES-NaOH pH 6.0 
50 mM (NH4)2SO4 
2 mM DTE 
1 M NaCl 
Buffer B6 50 mM MES-NaOH pH 6.0 
200 mM NaCl 
2 mM DTE 
MALS buffer 50 mM MES-NaOH pH 6.0 
200 mM NaCl 
Phosphorylation buffer 25 mM HEPES-NaOH pH 7.5 
100 mM NaCl 
5 mM MgCl2 
ATPase buffer 50 mM HEPES-NaOH pH 7.5 
100 mM NaCl 
14 mM KCl 
10 mM MgCl2 
1 mM EDTA 
1 mM Phosphoenolpyruvate (Roche) 
0.35 mM NADH (Roche) 
Titration buffer 50 mM MES-NaOH pH 6.0 
200 mM NaCl 
10 mM MgCl2 
 
 
 Growth media 2.1.7
Bacteria were grown in lysogeny broth (LB) medium [82] unless otherwise indicated. For 
agar plates, the medium was solidified with 15 g agar-agar (Carl Roth) per liter. Medium and agar 
plates were produced and autoclaved by the media kitchen of the Max Planck Institute for Medical 
Research. 
 
LB medium   10 g/l bacto-tryptone (Becton Dickinson) 
     5 g/l bacto-yeast extract (Becton Dickinson) 
     10 g/l NaCl 
     Final pH adjusted to 7.0 with NaOH 
 
All media and plates were supplied with appropriate antibiotics to select for the different 
plasmid constructs (see section 2.1.3) in the following concentrations: 34 µg/ml chloramphenicol, 
50 µg/ml kanamycin, 100 µg/ml ampicillin, 3 µg/ml tetracycline. A kanamycin concentration of 
15 µg/ml was used for selection for the genomically integrated kanamycin resistance cassette. 
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To obtain selenomethionine labeled protein cells were grown in minimal medium substituted 
with SeMet based on Van Duyne et al. [83]: 
SeMet medium   5.6 g/l K2HPO4 
     1.6 g/l KH2PO4 
     0.8 g/l (NH4)2SO4 
     0.2 g/l tri-sodium citrate · 2H2O 
     0.08 g/l MgSO4 · 7H2O 
     5.8 g/l D(+)-Glucose 
     40 mg/l Alanine 
     40 mg/l Arginine 
     40 mg/l Asparagine 
     40 mg/l Cysteine 
     40 mg/l Glutamic acid 
     40 mg/l Glycine 
     40 mg/l Histidine 
     40 mg/l Proline 
     40 mg/l Serine 
     40 mg/l Tryptophan 
     40 mg/l Tyrosine 
     40 mg/l Glutamine 
     40 mg/l Aspartic acid 
     0.1 g/l Isoleucine 
     0.1 g/l Leucine 
     0.1 g/l Lysine 
     0.1 g/l Phenylalanine 
     0.1 g/l Threonine 
     0.1 g/l Valine 
     40 mg/l Thiamine 
     40 mg/l Thymine 
     50 mg/l Selenomethionine (Acros Organics) 
     Final pH adjusted to 7.5 with NaOH 
All amino acids as well as thiamine and thymine were purchased from Sigma-Aldrich. 
  
Materials and Methods 
18 
Growth experiments with arabinose-induction were performed in glucose-free rich medium 
(RM) to prevent glucose-mediated repression of the pBAD promoter. 
RM medium    6 g/l Na2HPO4 
     3 g/l KH2PO4 
     0.5 g/l NaCl 
     1 g/l NH4Cl  
     20 g/l casein hydrolysate (Merck) 
     0.2 % (v/v) glycerol 
     1 mM MgCl2 
Final pH adjusted to 7.4 with NaOH 
 
2.2  Molecular biology 
 Transformation of chemically competent Escherichia coli 2.2.1
cells 
A single colony was inoculated into 200 ml LB-medium supplemented with the appropriate 
antibiotics. The culture was grown at 37 °C overnight and subsequently 1 ml was diluted into 
500 ml fresh LB-medium supplemented with the appropriate antibiotics. The cell suspension was 
incubated at 37 °C until an OD600 of 0.5 was reached. 200 ml of culture were harvested by 
centrifugation (5,500 × g, 10 min, 4 °C) and washed with 50 ml ice cold TFB-1 buffer (the buffer 
compositions of all buffers can be found in section 2.1.6). After centrifugation the cell pellet was 
resuspended in 4 ml ice cold TFB-2 buffer and 50 µl aliquots were flash frozen in liquid nitrogen 
and stored at -80 °C until further use. 
For chemical transformation, aliquots of competent cells were thawed on ice before adding 
0.5 µl to 4 µl of plasmid DNA. The transformation mix was incubated on ice for 30 min, subjected 
to a heat shock at 42 °C for 45 s followed by a second incubation on ice for 2 min. 450 µl LB-
medium were added to induce cell recovery and the cells were shaken at 750 rpm and 37 °C on a 
Thermomixer comfort (Eppendorf). After 1 h, cells were plated on pre-warmed LB-agar plates 
supplemented with the appropriate selection antibiotics and incubated at 37 °C overnight. 
 
 Transformation of electrocompetent Escherichia coli cells 2.2.2
A single colony was inoculated into 100 ml LB-medium supplemented with the appropriate 
antibiotics. The culture was grown overnight at 37 °C and subsequently 1 ml was diluted into 
100 ml of fresh LB-medium supplemented with the appropriate antibiotics. Cells were grown at 
37 °C to an OD600 of 0.6 and the cell suspension was harvested by centrifugation (3,320 × g, 4 °C, 
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10 min). The cells were washed twice in 10 ml ddH2O and subsequently resuspended in 1 ml 10 % 
(v/v) glycerol. 100 µl aliquots were flash frozen in liquid nitrogen and stored at -80 °C. 
For electroporation, one aliquot of competent cells was thawed on ice and mixed with 1 µl to 
4 µl plasmid DNA. Cells were directly transferred to a 2 mm electroporation cuvette (biolab 
products) and subjected to a short electric pulse (~ 5 ms) using an electro cell manipulator 600 
(BTX). For general plasmid transformation, a voltage of 1350 V was applied at 50 µF and 128 Ω, 
transfer of DNA fragments for genomic integration was performed using the same voltage at 25 µF 
and 480 Ω. Afterwards, the cells were mixed immediately with 1 ml LB-medium, transferred to a 
microreaction tube and incubated on a Thermomixer comfort (Eppendorf) at 750 rpm and 37 °C. 
After 1 h, the mixture was plated on pre-warmed LB-agar plates supplemented with the appropriate 
selection antibiotics and incubated at 37 °C overnight. 
 
 Preparation of plasmid DNA 2.2.3
A single colony of E. coli DH5α was inoculated into 5 ml LB-medium supplemented with 
the appropriate antibiotics, grown at 37 °C overnight and harvested by centrifugation. Isolation of 
plasmid DNA was performed using the QIAprep Spin Miniprep Kit (Qiagen) following the 
manufacturer’s instructions.  
The nucleotide concentration was determined spectroscopically by measuring the absorption 
at 260 nm (A260 nm =1 ≙ 50 µg/µl) using a NanoDrop ND‐1000 spectrophotometer (NanoDrop 
Technologies). Correctness of the nucleotide sequence was confirmed by sequencing at Eurofins 
Genomics. 
 
 Agarose gel electrophoresis 2.2.4
DNA fragments were separated according to electrophoretic mobility in an agarose gel 
matrix. The agarose gels were prepared by mixing 1 % (w/v) universal agarose (Bio&SELL) with 
TBE buffer. The suspension was heated to dissolve the agarose, cast and 1 µl GelRed Nucleic Acid 
Gel Stain 10,000× (Biotium) was added per 70 ml gel solution. Prior to loading, DNA loading 
buffer was added to the DNA samples. In addition, dependent on the size of the desired fragment 
100 bp or 1 kb DNA ladders (NEB) were loaded as a standard. 2 µl of a 1:5 dilution were loaded 
per lane. Electrophoresis was performed in TBE buffer at a voltage of 100 V for 30 min to 90 min.  
DNA fragments were visualized by GelRed fluorescence under UV irradiation. If required, 
DNA fragments of the appropriate size were excised and isolated from the gel slices using the 
QIAquick Gel Extraction Kit (Qiagen) following the manufacturer’s instructions. 
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 Polymerase chain reaction  2.2.5
Amplification of DNA fragments was performed by polymerase chain reaction (PCR) using 
Vent DNA Polymerase (NEB) in a TPersonal thermocycler (Biometra). Primers were synthesized 
by Eurofins Genomics and the reactions components were purchased from New England Biolabs 
(NEB) except for formamide (Sigma-Aldrich). 
Primer annealing temperature and elongation time of the three-step protocol (see below) 
were adjusted to the melting temperature of the primer and the desired product length, respectively. 
For a typical reaction the following concentrations and cycling protocol were used: 
 
Component Volume (µl) Final concentration 
10x Thermopol buffer1 5 1x 
Deoxynucleotide (dNTP) solution mix2 1 200 µM 
Forward primer (100 µM) 0.5 1 µM 
Reverse primer (100 µM) 0.5 1 µM 
MgSO4 (100 mM) 1.25 2.5 mM 
Formamide 3.5 7% (v/v) 
Vent DNA polymerase (2000 units/ml) 0.5 0.02 units/µl 
DNA template x 1-4 ng/µl 
Add H2O to a final volume of 50 µl 
1 200 mM Tris-HCl pH 8.8, 100 mM (NH4)2SO4, 100 mM KCl, 20 mM MgSO4, 1% (v/v) Triton® X-100 
2 dATP, dCTP, dGTP, dTTP (10 mM each) 
 
Step Temperature (°C) Time (s) Cycles 
Initial denaturation 95  300 1 
Denaturation 95  30  
Primer annealing 45-65  30 30 
Elongation 72  60 s per 1000 bp  
Final elongation 72  600 1 
Hold 4  -  
 
PCR products were either purified using the QIAQuick PCR Purification Kit (Qiagen) or 
separated on a preparative 1 % (w/v) agarose gel (see section 2.2.4) and extracted from excised gel 
slices.   
 
 Restriction digestion 2.2.6
Restriction digestions of PCR products or DNA plasmids were performed with restriction 
enzymes purchased from New England Biolabs (NEB) using the buffer provided. The following 
reaction mixture was incubated at 37 ºC over night: 
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Component Volume (µl) Final concentration 
10x CutSmart buffer1 5 1x 
Restriction enzyme 1 (5-20 units/µl) 1 0.4-0.1 units/µl 
Restriction enzyme 2 (5-20 units/µl) 1 0.4-0.1 units/µl 
DNA x 0.02 µg/µl 
Add H2O to a final volume of 50 µl 
1 500 mM potassium acetate pH 7.9, 200 mM Tris-acetate, 100 mM magnesium acetate, 1 mg/ml bovine 
serum albumin 
 
Samples of preparative restriction digestions were either purified using the QIAQuick PCR 
Purification Kit (Qiagen) or separated on a 1 % (w/v) agarose gel (see section 2.2.4) and extracted 
from excised gel slices. 
 
 DNA ligation 2.2.7
Digested DNA inserts were ligated into a vector with compatible cohesive or blunt ends 
using the Rapid DNA Ligation Kit (Fermentas). The vector and insert concentrations were adjusted 
to a final vector amount of 50 ng and a molar vector:insert ratio of 1:3. The reaction mixture was 
incubated at room temperature for 15 min. 
 
Component Volume (µl) Final concentration 
5x Rapid ligation buffer 2 1x 
Rapid T4 DNA Ligase (5 units/µl) 1 0.1 units/ µl 
Vector DNA x 1 ng/µl 
Insert DNA x 1-4 ng/µl 
Add H2O to a final volume of 10 µl 
 
4 µl of the ligation mixture were transformed into E. coli DH5α cells and single colonies 
were inoculated into 5 ml LB medium for the preparation of plasmid DNA (see section 2.2.3). To 
verify successful ligation of insert DNA into plasmid DNA, a restriction digest (see section 2.2.6) 
was performed in a volume of 10 µl and incubated at 37 ºC for 2 h. Digestion mixtures were loaded 
on an analytical 1 % (w/v) agarose gel (see section 2.2.4) for separation and fragments were 
visualized by GelRed fluorescence. 
 
 Site directed mutagenesis 2.2.8
Nucleotide alterations, insertions or deletions were introduced by site-directed mutagenesis 
according to the QuikChange protocol (Agilent Technologies). Primers were synthesized by 
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Eurofins Genomics and the reaction components including Herculase II Fusion DNA polymerase 
were purchased from Agilent Technologies and deoxynucleotides were purchased from NEB. 
For a typical reaction the following protocol was used: 
 
Component Volume (µl) Final concentration 
5x Herculase II reaction buffer1 10 1x 
Deoxynucleotide (dNTP) solution mix (10 mM each)2 1 200 µM 
Forward primer (10 µM) 1.25 250 nM 
Reverse primer (10 µM) 1.25 250 nM 
DMSO 2 4 % (v/v) 
Herculase II Fusion DNA polymerase 1 N.D.1 
DNA template x 0.1-1 ng/µl 
Add H2O to a final volume of 50 µl 
1 Buffer composition and Polymerase concentration not stated by manufacturer. N.D. = not determined 
2 dATP, dCTP, dGTP, dTTP 
 
Step Temperature (°C) Time (s) Cycles 
Initial denaturation 95  120 1 
Denaturation 95  20  
Primer annealing 55  20 30 
Elongation 72  300  
Final elongation 72  600 1 
Hold 4  -  
 
Subsequently, methylated template DNA was removed by digestion with DpnI (20 units, 
New England Biolabs) at 37 °C for 2 h and 4 µl of the digestion mixture were used for 
transformation into DH5α cells. Plasmid DNA was isolated from cultures grown from a single 
colony (see section 2.2.3) and successful mutation was verified by sequencing.  
 
 Cloning of ezeT 2.2.9
The nucleotide sequence of the genomic region of open reading frame (ORF) ECO103_4771 
including 250 base pairs upstream of the start codon was synthetically manufactured (GeneArt, 
Life Technologies). To facilitate subcloning and protein purification the locus was designed to 
include DNA sequences encoding for a N-terminal hexahistidine (His6)-tag, a tobacco etch virus 
(TEV) protease recognition site and an NcoI restriction site overlapping with the ezeT start codon. 
The synthetic construct was ligated into pMK/RQ by the manufacturer (pMK/RQ(His-EzeT)). 
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Cloning of full-length ezeT 
For recombinant overexpression, the ezeT ORF was subcloned into an IPTG-inducible 
expression vector. Therefore, the ORF was PCR amplified from pMK/RQ(His-EzeT) with the 
primers T7_for1 (priming within the promoter region) and EzeT_3’NotI_His_r, which primes 
upstream of the stop codon and introduces a NotI recognition site at the 3’-end of the ORF. After 
restriction digestion with NcoI and NotI the DNA fragment was ligated into pET28b 
(pET28b(EzeT)), thereby exchanging the coding sequence of an N- for a C-terminal His6-tag. Note, 
that expression tests with full-length EzeT showed that the solubility of N-terminally tagged 
protein is significantly decreased when compared to C-terminally tagged protein. 
In addition, EzeT was expressed from an arabinose-inducible vector (pBAD(EzeT)). 
Therefore, the ezeT ORF was PCR-amplified from pET28b(EzeT) using pET_bone_for (priming 
upstream of the promoter region) and EzeT_3’HindIII_r (introducing a HindIII recognition site 
downstream of the stop codon), digested with NcoI and HindIII and ligated into pBAD/Myc-His A. 
 
Cloning of truncated ezeT 
The DNA fragment containing the ORF encoding for the N-terminal domain of EzeT 
(residues 1 to 82) was PCR-amplified from pET28b(EzeT) with T7_for (priming within the 
promoter region) and EzeT_83stop_HindIII_r (which exchanges the codon for residue 83 to a stop 
codon and introduces a HindIII restriction site). After restriction digestion with NcoI and HindIII 
this fragment was ligated into pM11-1a (pET(EzeT(1-82))). 
The N-terminal truncation construct EzeT∆N83 and the two longer constructs EzeT∆N62 
and EzeT∆N36 were created by PCR-amplification of the corresponding fragment from 
pET28b(EzeT) with EzeT_5’NcoI_start82_f, EzeT_5’NcoI_start62_f or EzeT_5’NcoI_start36_f, 
respectively, and EzeT_3’SalI_r (which introduces a SalI site downstream of the stop codon), 
digestion with NcoI and SalI and ligation into pET28b. EzeT_5’NcoI_start82_f introduces an NcoI 
site overlapping with a start codon at position Thr82 and mutates the His83 codon to an Asp codon 
(pET(EzeT∆N83)). EzeT_5’NcoI_start62_f mutates the codon for Gln62 to an NcoI site 
overlapping with a start codon (pET(EzeT∆N62)) and EzeT_5’NcoI_start36_f mutates the codon 
for Ser36 to an NcoI site overlapping with a start codon (pET(EzeT∆N36)). 
To be able to induce expression of the N- and C-terminal domains with two different 
inducers, the ORF encoding for EzeT∆N83 was excised from pET28b(EzeT∆N83) with NcoI and 
HindIII and cloned into pBAD/Myc-His A (pBAD(EzeT∆N83)). 
 
 
 
1 All primer sequences can be found in the Appendix (section 7.1). 
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Cloning of catalytically inactive variants 
The Walker A lysine (K121) was exchanged for an alanine by site directed mutagenesis (see 
2.2.8) in the vector constructs pET28b(EzeT), pBAD(EzeT) and pET28b(EzeT∆N83) using 
EzeT_K121A_f and EzeT_K121A_r (pET28b(EzeT_K121A), pBAD(EzeT_K121A) and 
pET28b(EzeT∆N83_K121A)). Similarly, codons in the N-terminal domain were mutated to 
alanines by two consecutive site-directed mutagenesis steps on pET28b(EzeT) using the primer 
pairs EzeT_M5A_D8A_f / EzeT_M5A_D8A_r and EzeT_N12A_Q16A_f / EzeT_N12A_Q16A_r 
(pET28b(EzeT_M5A_D8A_N12A_Q16A)). 
 
Cloning of Strep-ezeT-His 
A plasmid encoding N-terminally Strep-tagged and C-terminally His-tagged EzeT 
(pET28b(Strep-EzeT-His)) was generated by restriction digestion of pET28b(EzeT) with NcoI and 
BlpI to obtain a DNA fragment encoding for C-terminally His6-tagged EzeT and ligated into 
similarly digested pETN-Strep (constructed and provided by Gunter Stier, University of 
Heidelberg, Germany), providing the coding sequence for an N-terminal Strep-tag. 
 
 Cloning of ε1/ζ1 2.2.10
The plasmid DNA of pEP5289 from Neisseria gonorrhoeae encoding for ε1/ζ1 and ε2/ζ2 
was kindly provided by Chris van der Does from the Max Planck Institute for Terrestrial 
Microbiology in Marburg, Germany. The bicistronic operon was PCR-amplified from this plasmid 
and cloned into inducible expression vectors for recombinant protein expression in E. coli. 
 
Cloning of the ε1/ζ1_K115A bicistron 
To facilitate cloning of a potentially toxic protein, a two-step protocol was applied to 
introduce a Walker A lysine (K115) to alanine mutation during subcloning of the bicistronic ε1/ζ1 
operon. In the first step, the operon was amplified from pEP5289 with E1_5’NdeI_f and 
Z1_3’HindIII_r to introduce an NdeI restriction site on the 5’-end of the ε1 ORF. The PCR product 
was digested with NdeI and EcoRI (present in the ζ1 ORF close to the Walker A lysine) to obtain 
the 5’-fragment of the operon and ligated into pET28b (pET28b(His-TEV-epsilon)). Thereby, the 
coding sequence for a TEV-cleavable His6-tag was introduced at the 5’-end of ε1. In a second step, 
the 3’-half of the operon was amplified from pEP5289 with Z1_EcoRI_K115A_f and 
Z1_3’HindIII_r. The former primer contained an EcoRI recognition sequence and altered the 
Walker A lysine codon into an alanine codon. The latter primer provided a HindIII recognition site 
to allow for cloning into pET28b(His-TEV-epsilon) (obtained in the first cloning step) with EcoRI 
and HindIII (pET28b(ε1/ζ1_K115A)). Cloning of this construct was performed by Marion Gradl. 
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Cloning of the individual genes 
The two ORFs of the bicistronic ε1/ζ1_K115A operon were cloned individually into pET28b 
by Roman Sakson. To obtain pET(ε1), the ε1 ORF was amplified from pET28b(ε1/ζ1_K115A) by 
PCR using pETbone_for and E1_3’HindIII_r (which introduces a HindIII restriction site 
downstream of the stop codon of ε1), digested with NcoI and HindIII and ligated into pET28b. For 
pET28b(ζ1_K115A-His) the ζ1_K115A ORF was amplified from pET28b(ε1/ζ1_K115A) by PCR 
using Z1_5’NcoI_f (introducing an NcoI restriction site upstream of the start codon of ζ1) and 
Z1_3’XhoI_His_r. The latter primer omits the stop codon of the ORF and allows the fusion of the 
coding sequence for a His6-tag to the gene product upon ligation into pET28b. 
For pull-down experiments, a DNA fragment encoding ζ1_K115A without an affinity tag 
was ligated into pET28b after PCR amplification from pET28b(ε1/ζ1_K115A) using Z1_5’NcoI_f 
and T7_rev and restriction digestion with NcoI and XhoI (pET28b(ζ1_K115A)). In addition, the 
DNA fragment encoding His6-tagged ε1 was cloned into pET21d (pET21d(ε1)) and an arabinose-
inducible pBAD vector (pBAD(ε1)). The former construct was prepared by restriction digestion of 
pET21d and pET28b(ε1) with NcoI and NotI and subsequent ligation of the two fragments. 
Similarly, the latter construct was prepared by restriction digestion of pBAD/Myc-His A and 
pET28b(ε1) with NcoI and HindIII and subsequent ligation. 
 
Cloning of wild-type ε1/ζ1 
To provide sufficient amounts of ε1 in the competent cells used for cloning of wild-type 
ε1/ζ1, ε1 was provided from an arabinose-inducible vector. Therefore, DH5α cells were 
transformed with pBAD(ε1) (see former paragraph), a single colony was picked and the cells were 
grown at 37 ºC in LB medium supplemented with ampicillin until an OD600 of 0.2 was reached. 
Then, protein expression was induced by addition of L-(+)-arabinose to a final concentration of 
0.15 % (w/v). Cells were further grown at 37 ºC until an OD600 of 0.6 was reached and 
electrocompetent cells were prepared as described in section 2.2.2. 
These cells were transformed with 2 µl of a site directed mutagenesis reaction on 
pET28b(ε1/ζ1_K115A) using Z1_A115K_f and Z1_A115K_r to yield pET28b(ε1/ζ1). The 
transformation mixture was then plated on LB-agar plates containing ampicillin, kanamycin and 
0.02 % (w/v) L-(+)-arabinose. Plasmid DNA isolated from single colonies contained a mixture of 
pET28b(ε1/ζ1) and pBAD(ε1) introduced during preparation of competent cells. To obtain pure 
pET28b(ε1/ζ1), this plasmid DNA mixture was retransformed into plasmid-free DH5α cells, which 
were then plated on LB-agar plates containing only kanamycin. After incubation, two 
morphologically different colony types were visible: colonies with normal size and unusually small 
colonies, probably due to low levels of ζ1 kinase activity. These smaller colonies were not able to 
grow on ampicillin and plasmid DNA preparations from these colonies contained exclusively 
pET28b(ε1/ζ1).  
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 Cloning of ε2/ζ2 2.2.11
Similar to the cloning of ε1/ζ1 the bicistron of ε2/ζ2 was amplified by PCR from pEP5289 
and cloned into inducible expression vectors for recombinant expression in E. coli. 
 
Cloning of ε2/ζ2_K46S 
Analogous to the preparation of ε1/ζ1_K115A (compare 2.2.10, Cloning of the inactive 
complex) a two-step protocol was used to introduce a Walker A lysine (K46) to serine mutation 
during cloning of ε2/ζ2 (pET28b(ε2/ζ2_K46S)). 
Exchange of the lysine for a serine codon was coupled to the introduction of a BamHI 
restriction site. The mutation was introduced by PCR-amplification from pEP5289 with the primer 
pairs E2_5’NdeI_f (introduces an NdeI restriction site at the start codon) / Z2_K46S_r (introduces 
the mutation) and Z2_K46S_f (introduces the mutation) / Z2_3’XhoI_r (introduces an XhoI 
restriction site downstream of the stop codon) to obtain fragments for the 5’- and 3’-fragement of 
the operon, respectively. A second PCR was performed on these two DNA fragments using 
E2_5’NdeI_f and Z2_3’XhoI_r. The resulting fragment was digested with NdeI and XhoI and 
ligated into pET28b. Thereby the sequence coding for a thrombin-cleavable His6-tag is fused 5’ to 
the ε2 ORF. 
 
Cloning of the individual genes 
A DNA fragment encoding N-terminally His6-tagged ε2 was cloned into pET28b by PCR-
amplification of the ORF from pEP5289 using E2_5’NdeI_f and E2_3’HindIII_r (introduces a 
HindIII restriction site downstream of the ε2 stop codon), restriction digestion with NdeI and 
HindIII and ligation into pET28b (pET28b(ε2)). For pull-down experiments, the ε2-His ORF was 
subsequently cloned into pET21d by digestion of pET28b(ε2) with NcoI and NotI and ligation to 
yield pET21d(ε2). 
In addition, a DNA fragment encoding ζ2_K46A without an affinity tag was cloned into 
pET28b by Florence Jungblut. The ORF was amplified by PCR from (pET28b(ε2/ζ2_K46S)) using 
Z2_5’NcoI_f (introduces an NcoI restriction site at the start codon of ζ2 and changes the codon for 
isoleucine 2 to a valine) and Z2_3’XhoI_r, digested with NcoI and XhoI and ligated into pET28b 
(pET28b(ζ2_K46A)). 
 
Cloning of wild-type ε2/ζ2 
To provide sufficient amounts of ε2 in the competent cells used for cloning of wild-type 
ε2/ζ2, a cloning strategy similar to cloning of ε1/ζ1 was applied (see former paragraph), but ε2 was 
provided from an IPTG-inducible vector (pET21d(ε2)) that confers kanamycin resistance. 
OverExpress C43(DE3) cells were transformed with pET21d(ε2) (see former paragraph), a single 
colony was picked and the cells were grown at 37 ºC in LB medium supplemented with ampicillin 
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until an OD600 of 0.6 was reached. Then protein expression was induced by addition of 0.5 mM 
IPTG and cells were further grown at 37 ºC. As IPTG induction led to an expression phenotype the 
culture was grown over night. The cultures were diluted to OD600=0.1 in fresh LB medium and 
grown at 37 ºC until an OD600 of 0.6 was reached. Then, chemically competent cells were prepared 
from these cultures as described in 2.2.1. 
These competent cells were transformed with 5 µl of a site directed mutagenesis reaction on 
pET28b(ε2/ζ2_K46A) using Z2_S46K_f and Z2_S46K_r to yield pET28b(ε2/ζ2) and plated on 
LB-agar plates containing kanamycin. However, separation of pET28b(ε2/ζ2) from pET21d(ε2) as 
reported for pET28b(ε1/ζ1) (section 2.2.10, Cloning of wild-type complex) was not successful. 
 
 Cloning of ε3/ζ3 2.2.12
The nucleotide sequence of the ε3/ζ3 bicistron from the N. gonorrhoeae plasmid pEP5233 
was ordered from GeneArt (Life Technologies). To allow subcloning, an NcoI restriction site was 
added to the 5’-end of ε3 and a NotI restriction site to the 3’-end of ζ3 and the stop codon of ζ3 was 
omitted. The synthetic construct was ligated into pMK/RQ by the manufacturer (pMK/RQ(ε3/ζ3)). 
All cloning steps regarding ε3/ζ3 were performed by Florence Jungblut. 
 
Cloning of the ε3/ζ3 bicistron 
In contrast to cloning of ε1/ζ1 and ε2/ζ2, cloning of wild-type ε3/ζ3 did not require additional 
expression of ε3 in the competent cells. The bicistron was excised from pMK/RQ(ε3/ζ3) by 
restriction digestion with NcoI and NotI and cloned into pET28b (pET28b(ε3/ζ3)) whereby the 
coding sequence for a non-cleavable His6-tag was added at the 3’-end of the ζ3 ORF. 
A plasmid encoding the inactive variant (pET28b(ε3/ζ3_K46A)) was generated by side 
directed mutagenesis using the primer pair Z3_K46A_f / Z3_K46A_r. 
 
Cloning of the individual genes 
A DNA fragment encoding N-terminally His6-tagged ε3 was cloned into pET21d by PCR-
amplification of the ORF from pET28b(ε3/ζ3) using E3_5’NdeI_f (introduces an NdeI restriction 
site at the ε3 start codon) and E3_3’HindIII_r (introduces a HindIII restriction site downstream of 
the ε3 stop codon), restriction digestion with NdeI and HindIII and ligation into pET21d 
(pET21d(ε3)). 
The ORF encoding ζ3_K46A was cloned into pET28b by PCR-amplification from 
pET28b(ε3/ζ3_K46A) using Z3_5’NcoI_f (introduces an NcoI restriction site at the ζ3 start codon 
and changes S2 to a glycine) and Z3_404stop_HindIII_r (re-introduces the original ζ3 stop codon 
followed by a HindIII restriction site), restriction digestion with NcoI and HindIII and ligation into 
pET28b (pET28b(ζ3_K46A)). 
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 Cloning of GFP reporter plasmids and promoter mutants 2.2.13
For reporter assays, the T7 promoter region was removed from pMK/RQ(EzeT). Therefore, 
plasmid DNA was digested with the FspI and AscI restriction enzymes, single stranded overhangs 
were filled in with the Klenow fragment and the blunted ends were religated. Subsequently, an 
NdeI restriction site was introduced at the start codon upstream to the His6-tag coding sequence by 
site directed mutagenesis (see 2.2.8) using EzeT_5’NdeI_His_f and EzeT_5’NdeI_His_r. The 
coding region for superfolder GFP (sfGFP) [84] was amplified from the pET expression vector of 
sfGFP using T7_for (priming in the promoter region) and GFP_3’EcoRI_r (priming downstream of 
the T7 terminator region of pET28b). Both, the PCR product for sfGFP and the modified 
pMK/RQ(EzeT) vector DNA, were digested with the NdeI and EcoRI restriction enzymes and 
ligated (pREP(sfGFP)).  
All alterations of the ezeT promoter region were introduced by site directed mutagenesis (see 
2.2.8) on pREP(sfGFP). The Shine-Dalgarno sequence in ezeT (pREP(delSD) was mutated using 
GFP_delSD_f and GFP_delSD_r. The region downstream of the Pribnow-Schaller box 
(pREP(delPSdown) was mutated using GFP_delPSdown_f and GFP_delPSdown_f. The Pribnow-
Schaller box in ezeT (pREP(delPS) was mutated using GFP_delPS_f and GFP_delPS_r. The 
putative -35 region (pREP(s70)) was altered to the -35 consensus sequence of the σ70 factor using 
GFP_s70_f and GFP_s70_r or a random sequence (pREP(del35)) using GFP_del35_f and 
GFP_del35_r. The region upstream of the putative -35 region (pREP(delUPE)) was deleted after 
introduction of HindIII restriction sites in the vector backbone (GFP_delUPE_1_f / 
GFP_delUPE_1_r) and immediately upstream to the putative -35 region (GFP_delUPE_2_f / 
GFP_delUPE_2_r) into pREP(sfGFP) by site directed mutagenesis, subsequent excision by 
restriction digestion and re-ligation of the residual vector. Similarly, the region upstream of the 
Pribnow-Schaller box (pREP(delprom)) was deleted by introduction of a second HindIII restriction 
site immediately upstream to the putative -10 region (GFP_delprom_f / GFP_delprom_r), 
restriction digestion and re-ligation. 
 
 Genomic integration 2.2.14
For the isolation of endogenous EzeT, an epitope-tagged version was integrated into the 
E. coli W genome into the ezeT locus to give E. coli W(EzeT-HA). To this end, the coding 
sequence of the His6-tag of pET(EzeT) was exchanged for one of an influenza hemagglutinin 
(HA)-tag in two consecutive site-directed mutagenesis reactions (pET28b(EzeT-HA)) using the 
primer pairs HA-tag_1_f / HA-tag_1_r and HA-tag_2_f / HA-tag_2_r. This ORF was PCR-
amplified using EzeT_5’NdeI_f (introduces an NdeI restriction site at the start codon) and HA-
tag_3’BamHI_r (introduces a BamHI restriction site downstream of the stop codon), digested with 
NdeI and BamHI and cloned into pREP(sfGFP) from which the gfp ORF was excised by NdeI and 
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BamHI restriction digestion (pREP(EzeT-HA)). A kanamycin/neomycin resistance cassette was 
PCR-amplified from a FRT-PGK-gb2-neo-FRT fragment (E. coli gene deletion kit, Gene Bridges) 
using Neo_5’MfeI_f and Neo_3’Mfe_r. This PCR product was digested using MfeI and inserted 
between EzeT-HA and the residual EzeT coding fragment of pREP(EzeT-HA). For that purpose, 
the plasmid was digested with EcoRI to create compatible single stranded overhangs for ligation 
yielding pINT(ezeT::ezeT-HA,neo).  
Similarly, a second integration construct was prepared by insertion of the 
kanamycin/neomycin resistance cassette into pREP(sfGFP) yielding pINT(ezeT::GFP, neo). 
Integration of this DNA fragment into E. coli W creates an ezeT knock-out strain (E. coli W ezeT -) 
in which the ezeT ORF is replaced by gfp. Both constructs contain the ezeT promoter region and the 
C-terminal part of EzeT that served as homology arms for homologous recombination into 
E. coli W. 
Genomic integration was performed according to the Red/ET recombination protocol from 
Gene Bridges. Recombination competent E. coli W were prepared by electroporation with the 
thermosensitive plasmid pRedET (Gene Bridges). This plasmid encodes for the λ phage 
recombination proteins Redα, Redβ and Redγ and is maintained at 30 ºC but cured at 37 ºC to 
allow temporal control of recombination. Therefore, plasmid transformation and incubation of the 
plates were performed at 30 ºC. Single colonies were used to inoculate LB-medium containing 
tetracycline and cultures were grown at 30 ºC. The expression of the recombination proteins was 
induced at OD600=0.3 with 0.3 % (w/v) L-(+)-arabinose and after 1 h cells were harvested and made 
electrocompetent. 
The integration constructs were PCR-amplified from pINT(ezeT::ezeT-HA,neo) using Int_f 
and M13_rev and purified following the QIAquick PCR purification kit (Qiagen) protocol. Cells 
were transformed with 800 ng purified, linear PCR product, incubated at 37 ºC for 3 h to allow 
recombination to occur and streaked on LB-agar plates containing 15 µg/ml kanamycin. Successful 
integration was confirmed by sequencing of the PCR-amplified genomic DNA region using the 
Int_control_f (priming upstream of the ezeT locus in lysC) and Int_control_f (priming downstream 
of ezeT in the hypothetical gene ECW_m4384). 
 
2.3 Microbiology 
 Growth kinetics 2.3.1
To investigate the toxicity in vivo, E. coli BL21-CodonPlus(DE3)-RIL were transformed 
with plasmids expressing full-length, truncated or mutated EzeT. Single colonies were used to 
inoculate 100 ml LB medium supplemented with kanamycin and chloramphenicol, and were grown 
over night in 250 ml baffled flasks at 37 °C. The pre-cultures were diluted into 100 ml fresh 
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medium to an OD600 of 0.05 and cultures were grown to OD600=0.1 in 250 ml baffled flasks at 
various temperatures before protein expression was induced with 1 mM IPTG. Cell proliferation 
was monitored regularly by measuring the OD600 and by determination of colony forming units 
(CFUs).  
For CFU determination, ten-fold serial dilutions in LB medium were prepared and 10 µl of 
the appropriate dilutions were plated on pre-warmed LB-agar plates supplemented with kanamycin. 
The plates were incubated at the respective incubation temperature of the expression culture until 
visible colonies formed. All experiments were performed in triplicates. 
Experiments studying the inhibition by the N-terminal domain in trans were performed in 
glucose-free RM medium to prevent catabolite repression of the arabinose-inducible promoter. 
E. coli BL21-CodonPlus(DE3)-RIL cells were co-transformed with pET28b(EzeT(1-82)) and 
pBAD(EzeT∆N83) and the expression culture was grown at 37 °C to OD600=0.1-0.2, cooled to 
16 °C and expression of the C-terminal domain from pBAD(EzeT∆N83) was induced with 0.2 % 
(w/v) L-(+)-arabinose after 1 h. Expression of the N-terminal domain from pET28b(EzeT(1-82)) 
was induced by addition of 1 mM IPTG at various time points. 
 
 Propidium iodide influx 2.3.2
The break-down of the osmotic barrier was followed using the membrane-impermeable 
DNA-intercalator propidium iodide. As described in section 2.3.1 pre-cultures of E. coli BL21-
CodonPlus(DE3)-RIL cells carrying plasmids encoding full-length, truncated or mutated EzeT 
were prepared. These were diluted into 50 ml fresh medium to an OD600 of 0.025 and grown at 
16 °C. When an OD600 ~ 0.1 was reached, these cultures were mixed with an equal volume of LB 
medium supplemented with 0.1 mg/ml propidium iodide (Sigma-Aldrich) and 100 µg/ml ampicillin 
or 2 mM IPTG. 200 µl of these mixtures were transferred into a 96-well plate (Corning 3651, 
Corning) and OD600 and propidium iodide fluorescence (excitation: 520 nm, emission: 620 nm) 
were monitored over 5 h using a Varioscan Flash Multimode Reader (Thermo Scientific). 
 
 GFP reporter assay 2.3.3
E. coli DH5α or E. coli W cells were transformed with plasmids expressing sfGFP 
(pREP(sfGFP)) under control of various versions of the endogenous promoter region of the ezeT 
operon from E. coli W (see section 2.2.13). A single colony was used to inoculate 5 ml LB medium 
and grown at 37 °C overnight. Subsequently, cell cultures were diluted to an OD600 of 0.1 and 
200 μl aliquots of each culture were further incubated in 96-well plates (Corning 3651, Corning) 
under constant shaking at 37 °C until stationary phase was reached. GFP fluorescence (excitation: 
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485 nm, emission: 510 nm) was monitored using a Varioscan Flash Multimode Reader (Thermo 
Scientific). Untransformed E. coli DH5α were used for background correction.  
To test for autorepression by EzeT, E. coli DH5α or E. coli W cells were co-transformed 
with an additional pBAD(EzeT) plasmid and grown in RM medium. Expression was induced by 
addition of 0.2 % (w/v) L-(+)-arabinose. As a control, DH5α cells only transformed with 
pREP(sfGFP) were similarly exposed to arabinose. 
 
To measure the influence of different stress conditions, E. coli DH5α, E. coli BL21-
CodonPlus(DE3)-RIL, E. coli W or E. coli W ezeT – cells were transformed with pREP(sfGFP). A 
single colony was used to inoculate 5 ml LB medium and grown at 37 °C overnight. Subsequently, 
cell cultures were diluted to an OD600 of 0.1 and 200 μl aliquots of each culture were further 
incubated in 96-well plates (Corning 3651, Corning) under constant shaking at 37 °C. GFP 
fluorescence (excitation: 485 nm, emission: 510 nm) was monitored using a Varioscan Flash 
Multimode Reader (Thermo Scientific). 
The cultures in the individual wells were treated with different chemicals (Fe(III)Cl3, DTE, 
sodium cacodylate, sodium citrate, hydrogen peroxide, chloramphenicol, bipyridyl), high 
temperature (95 ºC for 1 min, or 45 ºC for 60 min) or UV irradiation, or grown in medium without 
nutrients or with glycerol as a carbon source. 
 
 Microscopy 2.3.4
Phase contrast images were taken from E. coli BL21-CodonPlus(DE3)-RIL cells transformed 
with plasmids expressing EzeT∆N83 and EzeT∆N83. Expression cultures were grown as described 
in section 2.3.1 at 20 ºC. Phase contrast and fluorescence microscopy was performed on an 
Axiovert 135 microscope (Zeiss) using a 100 x oil immersion objective lens (Plan-Neofluar, N.A. 
1.3, Zeiss). Images were captured with a ProgRes C3 CCD camera (Jenoptic). Life/dead staining 
was performed using the LIVE/DEAD BacLight bacterial viability kit (Molecular Probes). 20 µl 
cell suspension was mixed with 0.4 µl of a solution containing 1.67 mM SYTO 9 and 9.99 mM 
propidium iodide. SYTO 9 (live) fluorescence was visualized with a 450 nm to 490 nm excitation 
filter and a 520 nm long pass emission filter, while propidium iodide (dead) fluorescence was 
visualized using 545 nm band pass excitation filter and a 590 nm long pass emission filter. 
Electron microscopic images were taken from E. coli BL21-CodonPlus(DE3)-RIL cells 
transformed with plasmids expressing full-length or mutated EzeT 
(EzeT_M5A_D8A_N12A_Q16A). Expression cultures were grown as described in section 2.3.1 
and protein expression was induced at 16 ºC for 16 h. Samples were harvested by mild 
centrifugation (300 × g, 4 ºC, 10 min) and resuspended in 100 µl LB medium. Cells were further 
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concentrate by centrifugation (300 × g, 4 ºC, 10 min) and the pellet was resuspended in 50 µl LB 
medium containing 40 % (w/v) bovine serum albumin (Sigma-Aldrich). 
Cryo-electron microscopy and high-pressure freezing was performed by Ulrike Mersdorf. 
Cells were cryopreserved using a Leica EM HPM100 high pressure freezer and transferred under 
liquid nitrogen into a Leica AFS system for freeze-substitution. Samples were incubated in acetone 
containing 0.5 % (w/v) osmium tetroxide (Serva), 0.5 % (w/v) tannic acid (Sigma-Aldrich), 0.5 % 
(v/v) glutaraldehyde (Sigma-Aldrich) and 0.2 % (w/v) uranyl acetate (Ted Pella) for 50 h using a 
temperature gradient from -90 ºC to -30 ºC. Subsequently, the samples were washed three times for 
1 h with 100 % acetone, equilibrated to room temperature and gradually infiltrated with Epon 
embedding medium according to Luft (glycidyl ether 100, dodecenyl succinic anhydride, methyl 
nadic anhydride, dimethylbenzylamine; all Serva) [85]. Samples were polymerized for 2 days at 
60 ºC and 50 nm thin sections were obtained using a diamond knife (DiATOME) and an Ultracut E 
ultramicrotome (Reichert-Jung). The sections were stained for 15 min in 7 % (w/v) aqueous uranyl 
acetate (Ted Pella) and 5 min in Reynold’s lead citrate (26.6 g/l lead nitrate (Sigma-Aldrich), 
35.2 g/l sodium citrate (Merck), 160 mM sodium hydroxide (Merck)). Image data were recorded on 
a Zeiss EM 912 transmission electron microscope at 120 kV. Adobe Photoshop CS5 was used to 
compile the transmission electron microscopy images. 
 
 Plasmid stabilization assay 2.3.5
To test whether EzeT is able to stabilize plasmids, the ezeT ORF was cloned into a derivative 
of the enteric low-copy number plasmid R1, pOU82 [86]. pOU82 contains an ampicillin resistance 
gene, the lacZYA operon and the origin of replication of R1. Replication of pOU82 is controlled in 
two ways. On the one hand, the replication control genes are under control of the λPr promoter that 
is regulated by the temperature-sensitive lambda repressor λcI 857. This results in a low copy 
number at a growth temperature of 30 ºC and run-away replication at 42 ºC. On the other hand, the 
replication control region does not encode for CopA. CopA is an antisense RNA that negatively 
regulates RepA and thereby downregulates replication. Overexpression of CopA from an IPTG-
inducible promoter on a second plasmid, pKG339 [86], prevents plasmid replication. pKG339 
confers tetracycline resistance. pOU82 and pKG339 were generously provided by Kenn Gerdes, 
University of Copenhagen, Denmark. 
ezeT was cloned into pOU82 under control of its endogenous promoter or the constitutive 
lacI promoter. E. coli W ezeT - were co-transformed with one of these two vectors or the empty 
vector together with pKG339 and plated on LB-agar plates containing ampicillin and tetracycline. 
Cells were grown in 5 ml RM medium supplemented with ampicillin and tetracycline at 30 ºC over 
night. This pre-culture was diluted into fresh medium and grown at 30 ºC. At OD600=0.5 the 
cultures were diluted again to OD600=0.01 in RM medium containing tetracycline and 2 mM IPTG 
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to induce pOU82 replication arrest. The OD600 values and CFUs were measured every hour over 
the course of 6 h. CFUs were plated on LB-agar plates with and without ampicillin to distinguish 
between plasmid-containing and plasmid-free cells. In addition, blue-white screening allows to 
determine the percentage of colonies that retained pOU82. 
 
 Plaque assay 2.3.6
To determine whether ezeT contributes to phage resistance, E. coli cells transformed with 
pBAD, pBAD(EzeT) or pBAD(EzeT_K121A) were grown in the presence of T4 phages. T4 phage 
solutions were kindly provided by Elisabeth Hartmann and used in hundred-fold dilution series. For 
the assay, E. coli pre-cultures were grown at 37 ºC in LB medium supplemented with ampicillin 
and diluted to reach OD600=0.2. After 30 min, 0.2 % (w/v) L-(+)-arabinose was added. 30 min after 
induction (OD600≈0.6) cells were diluted to OD600=0.4 in LB medium and 100 µl of these cultures 
were mixed with 100 µl phage solution and 3 ml prewarmed (~ 45 ºC) LB medium containing 
0.75 % (w/v) agar-agar (Carl Roth). These reaction mixtures were poured immediately onto LB-
agar plates and incubated at 37 ºC over night. Bacteria-devoid regions (plaques) were counted on 
the next day. 
 
 Persister assay 2.3.7
The ability to form persister cells was tested by antibiotic treatment with ciprofloxacin, 
gentamicin and tetracycline. E. coli W, E. coli W ezeT - and E. coli W ezeT - harboring 
pBAD(EzeT) were grown in LB medium over night. This pre-culture was diluted to OD600=0.05 
and incubated at 37 ºC. 0.1 % (w/v) L-(+)-arabinose was added after 3 h and cells were further 
incubated. 1 h later, 2 ml of culture were harvested by centrifugation (6,000 × g, 4 ºC, 5 min), 
washed with 0.85 % (w/v) NaCl and resuspended in 0.85 % (w/v) NaCl to an OD600 of 1.5. 
Ciprofloxacin (Sigma-Aldrich), gentamicin (Life Technologies) or tetracycline (Sigma-Aldrich) 
were added to final concentrations of 0.1 µg/ml, 4 µg/ml or 10 µg/ml, respectively. The cells were 
incubated at 37 ºC and serial dilutions were prepared after 4 h and 24 h and plated on LB-agar 
plates for CFU determination.  
 
 Biofilm assay 2.3.8
The ability to form biofilms was assessed by crystal violet staining. E. coli W, 
E. coli W ezeT - and E. coli W ezeT - harboring pBAD(EzeT), pBAD(EzeT∆N83), 
pBAD(EzeT∆N83_K121A) or an empty pBAD vector were grown in LB medium over night. This 
pre-culture was diluted to OD600=0.05 in LB medium containing 0.1 % (w/v) L-(+)-arabinose. Per 
culture, 200 µl each were aliquoted into four wells of a sterile, transparent 96-well flat-bottom 
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polystyrene plate (Costar tissue-culture treated cell culture plates, Corning, or Nunc MaxiSorp, 
affymetrix). These plates were incubated without shaking at 30 ºC for 48 h. To reduce evaporation, 
surrounding wells were filled with medium and the plate was closed with a lid. 
Subsequently, the OD600 was measured and the biofilm formation was quantified. For 
staining of organic material on the walls of the wells, the remaining LB medium and non-attached 
cells were removed. The wells were washed three times with 0.85 % (w/v) NaCl and left open to 
dry. 125 µl of 0.1 % (w/v) crystal violet (Sigma-Aldrich) were applied and the wells were washed 
again three times with 0.85 % (w/v) NaCl and dried. The bound stain was dissolved in 200 µl 
ethanol/acetone (80:20, v/v) and this solution was transferred to a fresh 96-well plate for absorption 
measurements at 590 nm using a Varioscan Flash Multimode Reader (Thermo Scientific). 
 
2.4 Biochemistry 
 SDS-polyacrylamide gel electrophoresis (SDS-PAGE) 2.4.1
Proteins were separated according to their electrophoretic mobility by discontinuous SDS-
PAGE as initially described by Laemmli [87]. Gels were cast and run using the Mini-PROTEAN 
system (Bio‐Rad). The acrylamide concentration in the separation gel was adjusted to the 
molecular weight of the protein of interest for sufficient separation. 15 %, 17 % and 20 % (w/v) 
acrylamide solutions for separation gels (see below) were prepared and polymerization of the 
acrylamide was initiated by adding APS and TEMED to a final concentration of 0.1 % (w/v) and 
1 % (v/v), respectively. After polymerization, a 5 % (w/v) stacking gel was cast on top in a similar 
fashion. 
 
Gel type H2O Buffer Acrylamide solution1 
15 % separation gel 7.3 ml 7.5 ml separation gel buffer 15 ml 
17 % separation gel 5.3 ml 7.5 ml separation gel buffer 17 ml 
20 % separation gel 2.3 ml 7.5 ml separation gel buffer 20 ml 
5 % stacking gel 8.9 ml 3.8 ml stacking gel buffer 2.3 ml 
1 Rotiphorese®Gel 30 (37.5:1): 30 % Acrylamide/Bisacrylamide in the ratio 37.5:1 (Carl Roth) 
 
Prior to loading, SDS loading buffer (the buffer compositions of all buffers can be found in 
section 2.1.6) was added to the samples and the mixture was heated at 95 °C for 5 min for protein 
denaturation. Dependent on the protein concentrations, 5 µl to 15 µl of the samples were loaded per 
lane. In addition, 5 µl of the Low Range SDS-PAGE standard (Bio-Rad) diluted 1:20 in SDS 
loading buffer were loaded for size estimation. Electrophoresis was performed in SDS running 
buffer at 35 mA for about 45 min. Proteins were visualized by Coomassie staining with InstantBlue 
(Expedeon). 
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 Silver staining 2.4.2
Silver staining [88] was used to detect low amounts of proteins in polyacrylamide gels. 
Proteins species were separated by SDS-PAGE and fixed in the gel with fixing solution at RT for 
2 h. After washing three times for 20 min with 35 % (v/v) ethanol, a solution containing 0.02 % 
(w/v) of the sensitizing agent Na2S2O3 was applied for 2 min followed by washing with H2O (3 x 
5 min). Silver ions were allowed to bind to the proteins by incubating in staining solution for 
20 min. After three 1 min washes in H2O, developing solution was added to induce silver 
reduction. Development was stopped by adding stop solution as bands became visible. The gel was 
stored at 4 °C in 1 % (v/v) acetic acid. 
To identify proteins by mass spectrometry after silver staining, the reduced silver ions were 
removed from the sample [89]. Gel slices containing the protein of interest were cut from the gel 
and soaked for 5 min in 0.75 ml 15 mM K₃[Fe(CN)₆] (Sigma-Aldrich), 50 mM Na2S2O3. After 
washing three times with 1 ml H2O, the gel pieces were further analyzed by mass spectrometry (see 
section 2.4.5). 
 
 Western Blot 2.4.3
Western Blotting was used to detect proteins labeled with His6-, HA- and Strep-epitope tags. 
Protein species were separated by SDS-PAGE and then transferred onto a PVDF membrane 
(Porablot PVDF, Macherey-Nagel). Prior to blotting the membrane was activated with methanol 
and then transferred into Friendly transfer buffer together with the polyacrylamide gel and two 
appropriately sized sheets of gel blotting paper (GB005, Whatman). Between the electrodes of a 
Semidry blotter SD1 (cti) a stack of (anode side) gel blotting paper – PVDF membrane – 
polyacrylamide gel – gel blotting paper (cathode side) was assembled. The blotter was connected to 
a PowerPack Basic (Bio‐Rad) and transfer was performed at 60 mA for 1 h. 
To prevent unspecific antibody binding, the hydrophobic membrane was incubated in 
5 % (w/v) nonfat dried milk in TBS-T at 4 ºC over night. Subsequently, the membrane was washed 
twice in TBS-T for 10 min and incubated with the primary antibody at room temperature for 2 h. 
The membrane was washed again in TBS-T before adding the secondary antibody at room 
temperature for 1 h. Next, the membrane was washed three times in TBS-T and three times in TBS 
for 10 min each. Horse-radish peroxidase coupled antibodies were used for protein detection by 
chemiluminescence. To start the reaction the membrane was incubated for 2 min in freshly 
prepared detection reagent (Amersham ECL Prime Western Blotting Detection Reagent, 
GE Healthcare). The solution was removed and the membrane was either exposed to a sheet of 
BioMax light film (Kodak) for 30 ‐	300 s which was developed using an Optimax TR X‐ray film 
processor (Protec) or chemiluminescence was directly detected with a ChemiDoc MP Imaging 
System (Bio-Rad). 
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Both primary and secondary antibodies were diluted in 5 % (w/v) nonfat dried milk in TBS-T 
and stored at -20 ºC between repeated uses. For the detection of the HA epitope the rabbit anti-HA 
antibody (abcam ab9110, dilution 1: 4000) was used as primary antibody. The horseradish 
peroxidase-conjugated anti-rabbit IgG antibody (Delta Biolabs, dilution 1: 5000) was used as 
secondary antibody. For detection of His6-tagged proteins the Penta·His HRP conjugate (Qiagen, 
mouse monoclonal IgG1 horse‐radish peroxidase conjugate, final dilution 1:2000) was used. This 
primary antibody is already coupled to HRP and therefore the secondary antibody step was omitted 
and antibody incubation and washing was directly followed by chemiluminescence detection. 
 
For detection of proteins with a Strep-tag the protocol had to be modified as the streptactin 
used for detection also binds biotinylated proteins. Therefore, after protein transfer the membrane 
was incubated in PBS containing 3 % (w/v) bovine serum albumin (Sigma-Aldrich) and 0.5 % (v/v) 
Tween 20 at 4 ºC over night. The next day the membrane was washed twice in PBS-T for 10 min 
and then biotinylated proteins were blocked by avidin by washing with 0.5 ml chicken egg white in 
PBS-T at room temperature for 10 min. After washing in PBS-T the membrane was incubated with 
Strep-Tactin-HRP (iba, dilution 1:100000 in PBS-T) at room temperature for 1 h. Next, the 
membrane was washed three times in PBS-T and three times in PBS for 10 min each and 
chemiluminescence detection was performed as described above. 
 
 Determination of protein concentration 2.4.4
Protein concentration was determined by measuring the absorbance of the sample at 280 nm 
using a NanoDrop ND‐1000 spectrophotometer (NanoDrop Technologies). At this wavelength the 
absorption of a protein is dominated by the amino acids tryptophan, tyrosine and cysteine [90]. 
Based on the amino acid sequence the molar extinction coefficient of a linear polypeptide chain at 
280 nm (εP, 280 nm) can be calculated [91]. Using the online tool ProtParam [92] 
(http://web.expasy.org/protparam/) the following extinction coefficients were calculated for each 
construct: 
 
Table 2.1: Molar extinction coefficient and molecular weight of purified proteins 
Protein Extinction coefficient at 280 nm (M-1cm-1) Molecular weight (Da) 
EzeT-CHis 25,900 35,806 
ε1/ζ1 27,390 51,902 
ε1-His 8,480 9,583 
ζ1 20,400 44,618 
ε2/ζ2 31,860 54,468 
ε2/ζ2-His 31,860 56,351 
ε3/ζ3 28,880 54,454 
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Protein concentrations (cp) were calculated according to the law of Lambert-Beer:  
 
ܿ௉ሾ݃ ݈⁄ ሿ ൌ 	 ஺ು,మఴబ	೙೘∙ெௐఌು,మఴబ	೙೘∙ௗ 																																																																																															ࡱ࢛ࢗࢇ࢚࢏࢕࢔	૚			 
Where AP, 280 nm is the absorbance of the protein at 280 nm at path length d and εP, 280 nm and 
MW are the molar extinction coefficient and molecular weight of the protein as given in Table 2.1. 
 Mass spectrometry 2.4.5
Peptide mass fingerprinting [93] for the identification of proteins by mass spectrometry was 
performed by Melanie Müller and Marion Gradl.  
Proteins were separated on an SDS-PAGE gel and protein containing gel slices were 
subjected to in-gel digestion by trypsin (proteomics grade, Sigma-Aldrich). The mass of the eluted 
peptides was determined by MALDI-TOF using a Shimadzu Axima Performance mass 
spectrometer (Shimadzu/Kratos Analytical) in reflectron mode. The combination of characteristic 
peptide masses was used for protein identification using Mascot PMF (Matrix Science) by 
comparison against a library of E. coli and recombinant proteins. 
 
 Immunoprecipitation 2.4.6
Prior to immunoprecipitation, 5 µg antibody (rat anti-HA high affinity antibody 3F10, 
Roche) was chemically cross-linked to 50 µl protein G-Dynabeads (Life Technologies) using 
5 mM bis(sulfosuccinimidyl)suberate (BS3, Thermo Scientific) in conjugation buffer at ambient 
temperature. The reaction was quenched after 1 h by adding Tris-HCl pH 7.5 to a final 
concentration of 50 mM. The beads were thoroughly washed with PBS-T to remove non-cross-
linked antibodies. 
E. coli W (control) and E. coli W(EzeT-HA) were grown at 37 °C to OD600=1, 1 l of culture 
was harvested by centrifugation and incubated in 10 ml resuspension buffer in the presence of 
10 mg/ml lysozyme at 4 °C for 30 min. After addition of 0.2 % (v/v) Tween 20, the cells were lysed 
in an M-110S microfluidizer (Microfluidics) and cell debris was cleared by centrifugation. The 
cross-linked antibody was added to the supernatant and incubated under constant rotation at 4 °C 
for 2 h. Beads were retrieved using a magnetic field and washed several times with PBS-T. Bound 
proteins were eluted by denaturation with 8 M urea. 
For co-precipitation of bound proteins, the antibody was not cross-linked to the beads. 
Instead, 10 µg antibody (rat anti-HA high affinity antibody (3F10, Roche)) was added to the 
cleared lysate and allowed to bind under constant rotation at 4 °C for 1 h before 200 µl protein G-
Dynabeads (Life Technologies) were added and incubated for additionally 1 h. After washing, the 
proteins were eluted in 40 µl 5x SDS loading buffer. 
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The elutions were separated by SDS PAGE (see 2.4.1) and protein expression was analyzed 
by Western blotting using an anti-HA antibody (abcam ab9110, dilution 1: 4000) as primary 
antibody and a horseradish peroxidase-conjugated anti-rabbit IgG antibody (Delta Biolabs, dilution 
1: 5000) as secondary antibody. In addition, gels from co-immunoprecipitation were stained by 
silver staining and potential binding partners were identified by mass spectrometry. 
 
 Recombinant expression of native proteins 2.4.7
Proteins were recombinantly overexpressed in E. coli BL21-CodonPlus(DE3)-RIL cells, 
which carry a λ DE3 construct encoding IPTG-inducible T7 polymerase, were transformed with the 
expression constructs. Cells were grown in LB medium supplemented with the appropriate 
selection antibiotic and chloramphenicol to stabilize the pRIL plasmid. Freshly transformed cells 
were used to inoculate a 100 ml pre-culture which was grown at 37 °C for 5 h to 6 h. 10 ml of this 
pre-culture were used for inoculation per liter of medium and incubated under constant shaking in 
baffled flasks at 37 °C until an OD600 of 1 (EzeT) or 0.6 (gonococcal proteins) was reached. At this 
time point, the temperature was reduced to 16 ºC (EzeT) or 18 ºC (gonococcal proteins) and 
expression was induced by addition of 1 mM (EzeT) or 0.5 mM (gonococcal proteins) IPTG. The 
next day, cells were harvested by centrifugation at 5,000 × g and 4 ºC for 15 min and the cell pellet 
was resuspended in lysis buffer (for EzeT buffer A1, for the gonococcal proteins buffer B1; the 
buffer compositions of all buffers can be found in section 2.1.6). The suspension was either 
immediately subjected to protein purification or flash frozen in liquid nitrogen and stored at -80 °C. 
 
 Recombinant expression of selenomethionine labeled protein 2.4.8
Expression of selenomethionine labeled ε1/ζ1 was performed according to the protocol from 
Van Duyne et al. [83]. The protocol for overexpression and harvest of the cells was identical to the 
native protein expression (see former section), except that LB medium was replaced with SeMet 
medium (see section 2.1.7) containing selenomethionine. As E. coli BL21-CodonPlus(DE3)-RIL 
are prototrophic for all amino acids including methionine, the medium contains an excess of amino 
acids which suppress the bacterial methionine biosynthesis by negative feedback inhibition. 
 
 Cell disruption and lysate clarification 2.4.9
Cell lysis and all following steps of protein purification and handling were performed at 4 °C 
and with pre-chilled buffers. Prior to cell lysis, β-mercaptoethanol was added to the resuspended 
cells to a final concentration of 5 mM. Cells walls were disrupted by 20 min sonication using a 
W-450D Sonifier (Branson) at 50 % amplitude and cycles of 0.5 s sonication followed by 0.5 s 
recovery. Subsequently, bacterial lysates were clarified by centrifugation at 48,000 × g and 4 °C for 
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1 h. To analyze protein solubility, samples of pellets and supernatant were taken. The pellets were 
resuspended in an equal volume of 8 M urea for solubilization of insoluble proteins. 
 
 Purification of recombinant EzeT 2.4.10
The clarified lysate from 2 l expression culture resuspended in 40 ml buffer A1 was loaded 
on 2 ml Ni-NTA agarose (Qiagen) equilibrated with buffer A1. After washing with 20 ml 
buffer A1, the bound proteins were eluted with 20 ml buffer A2 into a reservoir containing 25 ml 
buffer A3 and dialyzed over night against 1 l buffer A4 using a 14,000 Da molecular weight cut-off 
(MWCO) dialysis tube (Visking, Medicell). The next day, the dialyzed protein was loaded onto a 
MonoQ 10/100 GL column (GE Healthcare) equilibrated with buffer A4 using an ÄKTApurifier 
system (GE Healthcare). Proteins were eluted with a linear gradient of 7.5 column volumes (CV) to 
buffer A5. Eluting proteins were collected in 0.8 ml fractions in tubes prefilled with 0.2 ml buffer 
A5. Fractions were analyzed on a 15 % (w/v) SDS-PAGE gel and EzeT containing fractions were 
pooled and concentrated using an Amicon-Ultra centrifugal filter unit (10,000 MWCO, Millipore). 
The concentrated protein was applied to a Superdex75 10/300 GL column (GE Healthcare) 
equilibrated with buffer A6. Protein purity was verified by SDS-PAGE and EzeT containing 
fractions were pooled and concentrated using an Amicon-Ultra centrifugal filter unit (10,000 
MWCO, Millipore). The purified protein proved to be instable at higher concentrations 
(> ~1 mg/ml) and could not be stored for extended periods of time. 
The doubly-tagged Strep-EzeT-His was purified according to the same protocol, except that 
the final size exclusion step was omitted and that 0.5 ml Ni-NTA agarose were used for 6 l of 
expression culture to account for the decreased solubility of this protein variant. 
 
 Purification of recombinant epsilon/zeta complexes from 2.4.11
N. gonorrhoeae 
For ε1/ζ1, ε2/ζ2 and ε3/ζ3 complex purification, the clarified lysate from 4 l expression 
culture resuspended in 80 ml buffer B1 was loaded on 1 mL Ni-NTA agarose (Qiagen) equilibrated 
with buffer B1. After washing with 10 ml buffer B1, the bound proteins were eluted with 10 ml 
buffer B2. The eluate was collected in 10 fractions which were loaded on a 20 % (w/v) SDS-PAGE 
gel. Protein containing fractions were pooled and dialyzed against 1 l buffer B3a over night. During 
dialysis, the His6-tag of epsilon was cleaved off by protease digest depending on the construct. 
Undigested protein and the protease were removed by re-chromatography on Ni-NTA agarose 
(Qiagen). Hereby, the His6-tag of ε1 was cleaved off by TEV digest, while ε2 contained a thrombin 
recognition site. Cleavage by thrombin required the addition of 2 mM CaCl2 during dialysis. ζ3 
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contained an un-cleavable C-terminal His6-tag and therefore no protease digestion and re-
chromatography was performed.  
The conductivity of the sample was adjusted to less than 10 millisiemens prior to loading 
onto a MonoS 10/100 GL column (GE Healthcare) equilibrated with buffer B4 using an 
ÄKTApurifier system (GE Healthcare). Proteins were eluted with a linear gradient of 30 CV to 
buffer B5. 1 ml fractions were collected and analyzed on a 20 % (w/v) SDS-PAGE gel and 
epsilon/zeta complex containing fractions were pooled and concentrated using a Vivaspin 
centrifugal filter unit (10,000 MWCO, Sartorius stedim biotech). The concentrated proteins were 
applied to a Superdex75 10/300 GL column (GE Healthcare) equilibrated with buffer B6. Protein 
purity and complex composition was verified by SDS-PAGE. Epsilon/zeta complex containing 
fractions were pooled and concentrated using a Vivaspin centrifugal filter unit (10,000 MWCO, 
Sartorius stedim biotech) and aliquots were flash frozen in liquid nitrogen and stored at -80 ºC.  
Wtε/1ζ1, ε1/ζ1_K115A, wtε2/ζ2 and wtε3/ζ3 were purified according to the same protocol. 
SeMet-labeled ε1/ζ1_K115A was purified similar to the native proteins, except that in each buffer 
the concentration of the reducing agent was increased to 5 mM DTE. 
For initial crystallization trials of the ε1/ζ1 complex, the His6-tag was not proteolytically 
removed from ε1. Therefore, TEV protease was omitted from the dialysis and the dialyzed proteins 
were loaded onto the MonoS column immediately. 
 
 Purification of recombinant ε1 2.4.12
Purification of His6-tagged ε1 was performed similar to purification of the complexes (see 
section 2.4.11). Due to decreased protein stability at low ionic strength, dialysis was performed 
against 1 l buffer B3b. Dialyzed protein was concentrated using a Vivaspin centrifugal filter unit 
(3,000 MWCO, Sartorius stedim biotech) and loaded onto a MonoS 10/100 GL column (GE 
Healthcare) without prior dilution. After elution, protein containing fractions were pooled and 
concentrated before loading on a Superdex75 10/300 GL column (GE Healthcare) equilibrated with 
buffer B6. Protein purity was verified using 20 % SDS-PAGE gels and ε1 containing fractions 
were pooled and concentrated to 4.7 mg/ml (558 µM) using a Vivaspin centrifugal filter unit (3,000 
MWCO, Sartorius stedim biotech). 
 
 Purification of recombinant wild-type ζ1 2.4.13
Wild-type ζ1 was isolated from the ε1/ζ1 complex by complex separation and subsequent 
purification using a protocol modified from section 2.4.11. The complex was purified using metal 
affinity chromatography and cation exchange chromatography as described before. After elution 
from the MonoS column, the pooled protein fractions were re-loaded onto 1 ml Ni-NTA agarose 
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(Qiagen) equilibrated with buffer B1. The flow-through from loading as well as from the following 
wash with 10 ml buffer B5 was pooled and concentrated. The protein solution was applied to a 
Superdex75 10/300 GL column (GE Healthcare) equilibrated with buffer B6. However, free ζ1 
tended to stick to the column material and had to be removed by washing the column with free ε1. 
Protein purity was verified by SDS-PAGE and Western Blotting to detect remnants of His6-
tagged ε1. ζ1 containing fractions were pooled and concentrated to 25.4 mg/ml (570 µM) using a 
Vivaspin centrifugal filter unit (10,000 MWCO, Sartorius stedim biotech) and aliquots were flash 
frozen in liquid nitrogen and stored at -80 ºC. 
 
 Interaction of gonococcal epsilon and zeta proteins 2.4.14
E. coli BL21-CodonPlus(DE3)-RIL were co-transformed with two expression plasmids, a 
pET21d plasmid carrying a His6-tagged epsilon (pET21d(ε1), pET21d(ε2) or pET21d(ε3)) and a 
pET28b plasmid carrying a untagged zeta (pET28b(ζ1), pET28b(ζ2) or pET28b(ζ3)) and plated on 
LB-agar plates containing both ampicillin and kanamycin. 100 ml pre-cultures were grown at 37 ºC 
in LB medium supplemented with ampicillin and kanamycin over night. The next morning, the 
cultures were diluted 1:100 into 2 l fresh medium and cells were grown at 37 ºC before protein 
expression was induced with 0.5 mM IPTG at OD600=0.6 and the cultures were further incubated at 
20 ºC. 
The next morning, cultures were harvested by centrifugation (5,000 × g, 4 ºC, 15 min), 
resuspended in 30 ml buffer B1 and lysed as described in section 2.4.9. The cleared lysate was 
applied to 0.2 ml Ni-NTA agarose (Qiagen) equilibrated with buffer B1. After washing with 10 ml 
buffer B1, bound proteins were eluted with 2 ml buffer B2. Samples of the individual purification 
steps were analyzed using 20 % (w/v) SDS-PAGE gels. 
Interaction studies were performed by Florence Jungblut. 
 
 Low-molecular-weight-metabolite extraction 2.4.15
Low-molecular-weight-metabolite extraction and analysis was performed similarly as 
described by Mutschler et al. [53]. E. coli BL21-CodonPlus(DE3)-RIL cells were transformed with 
plasmids expressing either full-length, truncated or inactive EzeT. Single colonies were used to 
inoculate 100 ml LB medium and grown over night at 37 ºC. 20 ml of this pre-culture were used to 
inoculate 2 l of LB-medium supplemented with kanamycin and chloramphenicol and the cultures 
were grown in unbaffled flasks at 37 °C. At OD600=0.2, cell cultures were cooled to 16 °C and 
protein expression was induced by addition of 1 mM IPTG at OD600=0.6. After 2 h of incubation, 
cells were harvested by centrifugation at 5,000 × g and 4 ºC for 15 min. The cell pellets were 
resuspended in 20 ml ice-cold 80 % (v/v) aqueous acetonitrile and incubated for 30 min on ice with 
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regular agitation. Subsequently, the insoluble material was removed by centrifugation at 20,000 × g 
and 4 ºC for 30 min and the supernatant was flash frozen in liquid nitrogen and stored at -80 °C. 
For high-performance liquid chromatography (HPLC) analysis the solvent was evaporated 
by vacuum concentration using a Speed Vac Concentrator (Bachofer) and the samples resuspended 
in 1.5 ml deionized H2O. Insoluble compounds were removed by high‐speed centrifugation at 
20,000 × g and 4 ºC for 30 min and filtration with Ultrafree‐MC centrifugal filter units (0.22 µm 
cut-off, Millipore). The absorption at 260 nm was measured with a NanoDrop ND‐1000 
spectrophotometer (NanoDrop Technologies) and adjusted to a value of 10 AU. 30 µL of sample 
was applied to a Partisil‐5 SAX RACII column (Whatman) equilibrated with 5 mM KH2PO4. 
Bound metabolites were eluted with a linear gradient of 36 CV to 500 mM KH2PO4 at a flow rate 
of 1 mL/min using a Prominence liquid chromatography system (Shimadzu). The absorbance at 
260 nm was monitored. Under these conditions, UNAG elutes at 12 ml, UNAG-3P at 22.5 ml and 
ATP at 48 ml, respectively. 
 
 EzeT stability in E. coli crude extract 2.4.16
Crude extracts were obtained from 150 ml stationary phase E. coli W culture. The culture 
was grown in LB medium at 37 ºC over night and harvested by centrifugation (5,000 × g, 4 ºC, 
15 min). The cell pellet was resuspended in 20 ml buffer A1 and lysed by passing it three times 
through an M-110S microfluidizer (Microfluidics). 450 µl of the resulting crude extract was 
supplemented with an ATP regeneration system [1 mM ATP (Jena Bioscience), 2 µl pyruvate 
kinase / lactate dehydrogenase (Pyruvate Kinase/Lactic Dehydrogenase enzymes from rabbit 
muscle (682 U/ml / 990 U/ml), Sigma-Aldrich), 0.8 mM phosphoenolpyruvate (Roche)] and Strep-
EzeT-His to a final concentration of 0.05 mg/ml. The mixture was incubated at 30 ºC and 20 µl 
samples were taken in regular intervals. Samples were separated on a 17 % (w/v) SDS-PAGE gel 
and protein amount and electrophoretic mobility were monitored by Western Blot against the N-
terminal Strep-tag and the C-terminal His6-tag. 
 
2.5 Biophysics 
 CD spectroscopy 2.5.1
CD spectroscopy measurements were performed with a J-810 CD spectropolarimeter (Jasco) 
in quartz glass cuvettes (Hellma) with a path length of 1 mm. Protein melting curves were 
measured by recording the temperature-dependent change in ellipticity θ of the sample. Unfolding 
of 10 µM EzeT in 200 µl buffer A6 was recorded by thermal denaturation from 10 ºC to 70 ºC at a 
wavelength of 222 nm and a heat rate of 1 ºC/min. 
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The melting temperature was determined in Prism (GraphPad) by assuming a two state 
unfolding process [94]. Data were fitted to the following equation: 
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																													ࡱ࢛ࢗࢇ࢚࢏࢕࢔	૛ 
 
Where aN and bN are the baseline intercept and slope for the native state of the protein and 
aD and bD are those for the denatured state. R is the gas constant (8.31 J K-1 mol-1) and ΔH is the 
van’t Hoff enthalpy as a function of the temperature T. Tm is the melting temperature which is 
defined as the temperature at the transition midpoint where 50 % of the protein is unfolded. 
 
 Dynamic light scattering 2.5.2
Dynamic light scattering was used to determine the hydrodynamic radius of epsilon-zeta 
complexes in order to estimate their oligomeric state. Samples with a protein concentration of 
approximately 5 mg/ml in buffer B6 were measured in a quartz cuvette with a path length of 1.5 cm 
using a Viscotec 802DLS instrument (Malvern Instruments). Measurements were performed at a 
temperature of 20 ºC. The scattering signal was collected 20 times over a duration of 5 s each and 
averaged. The resulting autocorrelation curve was analyzed using the supplied OmniSIZE 3.0 
software (Malvern Instruments). 
 
 Static light scattering 2.5.3
By measuring the scattering intensity at different angles during static light scattering the 
molar mass of the epsilon-zeta complexes was determined. Therefore, the samples were separated 
on a Superdex 200 10/300 GL column connected to a Waters HPLC system (Milford). After size 
exclusion chromatography, the protein species were analyzed with a refractive index detector 2414, 
a photodiode array detector 2996 and a multiangle light scattering detector (Dawn Heleos, Wyatt). 
40 µl of sample with a protein concentration of approximately 5 mg/ml were injected at a 
flow rate of 0.5 ml/min onto the column equilibrated with MALS buffer. A gel-filtration standard 
(Bio-Rad, Order no. 151-1901) containing 5 mg/ml protein was included for calibration. Multi-
angle light scattering data were analyzed using the ASTRA software provided by the manufacturer 
(Wyatt). 
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 Chromatographic UNAG phosphorylation assay 2.5.4
UNAG phosphorylation by UNAG kinases was investigated in vitro following a protocol 
modified from Mutschler et al. [53]. 3 μM protein in phosphorylation buffer was incubated with 
1 mM ATP (Jena Bioscience) and 0.25 mM UNAG (Sigma-Aldrich) at 25 °C. After 3 h and 24 h of 
incubation, 200 µl aliquots were removed and frozen. For analysis, the samples were thawed, 
diluted 1:2 with deionized H2O and centrifuged at 21,000 × g and 4 ºC for 5 min. The mixture was 
applied to a MonoQ 5/50 GL (GE Healthcare) equilibrated with deionized H2O and bound species 
were eluted in a linear gradient of 32.5 CV to 1 M ammonium acetate pH 8.0. 
 
 Steady-state UNAG phosphorylation assay 2.5.5
The ATPase activity of free wtζ1 was measured by Annika Grimmer using a coupled 
colorimetric assay [95]. In this assay the ATP hydrolysis, that is required for UNAG 
phosphorylation, is coupled to the oxidation of NADH, which can be followed spectroscopically as 
a decrease in absorption at 340 nm. By measuring this decrease in absorption over time, the rate of 
NADH production and accordingly the rate of ATP consumption by the UNAG kinase can be 
calculated:  
 
v ൌ ∆Absଷସ଴୬୫ ∆t⁄εଷସ଴୬୫ 	 ∙ 	 c୮ 	 ∙ 	d 																																																																																																																				ࡱ࢛ࢗࢇ࢚࢏࢕࢔	૜ 
 
The apparent turnover rate v at a given substrate concentration is dependent on the wtζ1 
concentration cp (0.2 µM), the optical path length d of the cuvette (1 cm) and ε340nm the extinction 
coefficient of NADH at 340 nm (6220 M-1 cm-1). The change in absorption at 340 nm ∆Abs340nm 
over the time interval ∆t is given by the slope of a linear fit to the absorption graph. 
Absorption at 340 nm was measured in quartz cuvettes (Hellma) at 25 °C using a V-650 
UV/VIS spectrophotometer (JASCO). Data were collected and analyzed with the Spectra-Manager 
software provided by the manufacturer (JASCO). 
Reactions were prepared with 100 µl of a reaction mix containing ATPase buffer 
supplemented with 7 U pyruvate kinase / 10 U lactate dehydrogenase (Pyruvate Kinase/Lactic 
Dehydrogenase enzymes from rabbit muscle, Sigma-Aldrich) and varying concentrations of ATP 
and UNAG and incubated until a stable baseline was reached. The reaction was started by addition 
of wtζ1 to a final concentration of 0.2 µM. 
To determine the Michaelis-Menten parameters, turnover rates were determined at a constant 
ATP concentration of 10 mM while varying the UNAG concentration or at a constant UNAG 
concentration of 10 mM while varying the ATP concentration. The rates v were plotted against the 
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substrate concentration S and fitted with the GraFit data analysis software (Erithacus) using the 
Michaelis-Menten equation: 
 
v ൌ v୫ୟ୶ 	 ∙ SS ൅	K୫ 																																																																																																																																				ࡱ࢛ࢗࢇ࢚࢏࢕࢔	૝ 
 
Thereby, the apparent Michaelis-Menten constant Km and the maximal apparent reaction 
velocity vmax were determined. Inhibition of ζ1 by ε1 was determined by measuring the Michaelis-
Menten parameters for ATP at different ε1 concentrations (0 µM, 0.1 µM, 0.2 µM).  
 
 Fluorescence equilibrium titration 2.5.6
Fluorescence measurements were performed at 25 ºC in 600 µl titration buffer in quartz 
cuvettes (Hellma) using a FP-8500 fluorescence spectrometer (JASCO). Fluorescence data were 
collected at a photomultiplier voltage of 780 V. 
To account for the dilution effects during titration the observed fluorescence intensity Fobs 
was corrected for the increase in volume: 
 
Fୡ୭୰୰ ൌ F୭ୠୱ 	
vୱୟ୫୮୪ୣ
vୱ୲ୟ୰୲ 																																																																																																																					ࡱ࢛ࢗࢇ࢚࢏࢕࢔	૞ 
 
Where vstart gives the starting volume (600 µl) and vsample the volume at the time of 
measurement. The corrected fluorescence intensity Fcorr was plotted against the nucleotide 
concentration and the titration curves were fitted in Prism (GraphPad) with a quadratic binding 
equation [96]: 
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ܤ଴ 															ࡱ࢛ࢗࢇ࢚࢏࢕࢔	૟ 
 
Where F is the measured spectroscopic signal, F0 the offset and ∆Fmax the total signal change. 
A0 and B0 are the total concentrations of protein and nucleotide, respectively, and Kd is the 
dissociation constant obtained for protein and nucleotide. 
 
Tryptophan fluorescence 
Tryptophan fluorescence was measured at an excitation wavelength of 300 nm and an 
emission wavelength of 340 nm with a band width of 5 nm. 3 µM to 5 µM protein were titrated 
with nucleotides, doubling the concentration in each step from 1 µM to 8192 µM. ATP titrations 
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were performed in the presence of an ATP regeneration system (8 µg pyruvate kinase (Roche), 
200 µM phosphoenolpyruvate (Roche)) and 15 mM KCl. 
 
Mant fluorescence 
2'-/3'-O-(N'-Methylanthraniloyl) (mant) fluorescence was measured at an excitation 
wavelength of 355 nm and an emission wavelength of 448 nm with a band width of 5 nm. 2 µM 
mant-labeled nucleotides were titrated with increasing protein concentrations between 1 µM and 
15 µM. Mant-ADP and mant-ATP were purchased from Biolog, mant-APPNHP was purchased 
from Jena Biosciences. 
Fluorescence displacement titrations of mant-ADP from the mant-ADP-ε1/ζ1 complex using 
ADP were performed to determine the binding affinity for the unlabeled nucleotide. After 
correction for dilution the data were fitted in the GraFit data analysis software (Erithacus) with a 
cubic binding equation as described by Thrall et al. [97]. 
 
 Nucleotide binding kinetics 2.5.7
The kinetics of mant-ADP binding to ε1/ζ1 were measured at 25 ºC using a KinetAsyst 
stopped-flow instrument (HI-TECH). The mant-chromophore was excited at a wavelength of 
355 nm and fluorescence was detected using a high-pass filter at 420 nm and a photomultiplier 
voltage of 780 V. 
60 µl of each 2 µM mant-ADP (Biolog) and 2 µM, 4 µM or 8 µM ε1/ζ1 in titration buffer 
were mixed and mant-fluorescence was monitored over 200 s. For each protein concentration three 
mixing reactions were performed and averaged. The resulting traces were fitted to single 
exponential functions using the Kinetic Studio software (HI-TECH): 
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Where A and C are amplitude and offset of the exponential function that describes the 
change in fluorescence intensity over time t. The observed rate constants kobs were plotted against 
the respective concentrations of ε1/ζ1 after mixing ([x]). The data points could be fitted with by 
linear regression giving the association (kon) and dissociation (koff) rates of the binding: 
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From which the dissociation constant Kd could be calculated by: 
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Materials and Methods 
47 
 Fluorescence anisotropy 2.5.8
Fluorescence anisotropy of chromophore-labeled nucleotides was measured in the presence 
and absence of protein using a Fluorolog-3 (HORIBA Jobin Yvon). A T-format configuration was 
used for the simultaneous detection of horizontally and vertically polarized light at a 
photomultiplier voltage of 950 V. 
Mant-fluorescence was excited at 355 nm (bandwidth 2 nm) and anisotropy was measured at 
448 nm (bandwidth 5 nm). 1,N6-etheno-adenosine diphosphate (etheno-ADP) was provided by 
Jochen Reinstein. The chromophore was excited at 310 nm (bandwidth 5 nm) and anisotropy was 
measured at 410 nm (bandwidth 5 nm). 2 µM labeled nucleotides in titration buffer were incubated 
at 25 ºC before 4 µM ε1/ζ1 or ζ1 was added and the anisotropy signal was analyzed with the 
FluorEssence software (HORIBA Jobin Yvon). 
 
2.6 X-ray crystallography 
 Crystallization and cryoprotection 2.6.1
Possible crystallization conditions were screened using a sitting drop vapor diffusion setup. 
70 µl of commercially available sparse matrix screening solutions (see section 2.1.5) were used as 
reservoir solutions in 96-well CrystalQuick low-profile plates (Greiner bio-one). Screens were set 
up using a Mosquito nanoliter pipetter (TTP LabTech Ltd) by mixing 100 nl each of protein and 
reservoir solution. Plates were stored at 20 ºC and crystal growth was monitored over time. Images 
were taken using a Rock Imager 1000 (Formulatrix) and examined using the provided Rock Maker 
software. 
To produce larger individuals, crystals were reproduced using the hanging drop vapor 
diffusion method. The drop volume was scaled up to 2 µl in 24-well Linbro plates (Crystalgen Inc) 
with a corresponding reservoir volume of 700 µl. Plates were again stored at 20 ºC and crystal 
growth was monitored manually over time. 
 
Crystallization and cryoprotection of ε1/ζ1 complex 
Initial crystallization and optimization trials were performed by Roman Sakson. In the sparse 
matrix screens (JCSG Core I – IV Suite, Qiagen) crystalline material was observed for several 
ammonium sulfate conditions. Therefore, different ammonium sulfate containing conditions were 
tested using the AmSO4 Suite screen (Qiagen) and reservoir solutions with varying pH and 
ammonium sulfate concentrations. Crystals grew as stacked plates, but these plates were larger and 
more separated for protein batches where the His6-tag was proteolytically removed. To obtain 
larger crystals the hanging drop vapor diffusion method was used.  
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Crystals used for data collection were grown in 24-well Linbro plates (Crystalgen Inc) using 
protein concentrated to 21.5 mg/ml and the following condition: 
1.8 M (NH4)2SO4 
        100 mM sodium citrate pH 4.5 
 
ε1/ζ1 crystals appeared as clusters of stacked plates within two to three days and were 
harvested after approximately two weeks. For cryoprotection, crystals were soaked in 2 M 
(NH4)2SO4, 100 mM sodium citrate pH 4.5 and 20 % (v/v) propylene glycol (SACF) and 
subsequently flash frozen in liquid nitrogen.  
To obtain nucleotide-bound structures these conditions and the buffers used for 
cryoprotection were supplemented with 15 mM MgCl2 and 10 mM of the respective nucleotide. 
SeMet-labeled ε1/ζ1_K115A was crystallized at a concentration of 21.7 mg/ml using the 
same condition and harvested according to the same protocol. 
 
 X-ray data collection and processing 2.6.2
Prior to data collection at the X10SA beam line of the Swiss Light Source (Paul-Scherer 
Institute, Villigen, Switzerland), single diffraction images of fished crystals were measured at the 
institute to assess the diffraction quality. X-rays were generated with a MicroMax 007 HF (Rigaku) 
microfocus rotating copper anode (40 kV/30 mA), equipped with VariMax HF focusing mirrors 
(Confocal Max-FluxR CMF optics, Rigaku) and detected with a Mar345 image plate detector 
(MarResearch). Diffraction data of all crystals were collected at -173.15 °C.  
At the Swiss Light Source diffraction data were collected with a Pilatus 6M detector 
(Dectris) in a continuous shutter-less φ-scan with oscillation ranges of 0.2 º and exposure times of 
0.2 s. The measurement parameters for the different data sets can be found in Table 2.2. 
All data sets were processed with the XDS software package [98]. Reflections were 
identified, indexed and integrated with XDS and scaled and merged with XSCALE. XDSCONV 
was used for file conversion into formats suitable for successive programs. 
 
Table 2.2: Data collection parameters 
Parameters ε1/ζ1_K115A wtε1/ζ1 
Native SeMet  apo ADP 
X-ray wavelength (Å) 0.9763 0.9763 0.9780/1.000 0.9780 
Detector distance (mm) 500 500 500/555 500 
Oscillation range (°) 0.2 0.2 0.2 0.2 
Number of images 1800 7200 1800/900 1800 
Resolution range (Å) 50-2.6 50-2.8 50-2.9/50-2.9 50-2.9 
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 Structure determination 2.6.3
Single wavelength anomalous diffraction (SAD) phasing 
To obtain initial phases for structure determination of ε1/ζ1, SAD diffraction data [99] were 
recorded for crystals of SeMet-labeled ε1/ζ1_K115A. A highly redundant data set was collected at 
the K absorption edge of selenium (λ = 0.9763 nm). SAD phasing was performed using the 
SHELX-suite [100] in HKL2MAP [101]. SHELXC was used to extract and evaluate the anomalous 
signal. Estimates for the anomalous structure factor amplitudes were generated to a resolution of 
3.5 Å, at which the anomalous correlation coefficient was 33 %. SHELXD was used to locate the 
heavy atom sites using the dual space recycling method with 20 cycles. 32 selenium sites were 
searched in 100 trials to a resolution of 2.4 Å. The heavy atom substructure obtained by SHELXD 
was used for phasing of the entire structure in SHELXE. In addition, SHELXE performed 
subsequent density modification assuming a solvent content of 60 % but this did not result in an 
interpretable electron density. Pseudo-free correlation coefficients (64 % / 60 %) and map 
correlation coefficients (0.776 / 0.750) were very similar for both substructure enantiomers. 
Instead, the anomalous substructure was used for SAD phasing in Phaser [102] to a 
resolution of 3.0 Å. Phaser applies likelihood-based methods for phase determination by refining 
the phase probability (Hendrikson-Lattman coefficients) and log-likelihood gradient maps for 
substructure improvement. In the same step density modification with Parrot [103] was performed, 
which was improved by defining non-crystallographic symmetry restraints. The obtained phases 
were extended to a resolution of 2.4 Å using DM [104]. All three programs are implemented in the 
CCP4 software suite [105]. 
For the isomorphous crystals of wtε1/ζ1 the set of test reflections excluded in model building 
was inherited and initial phases were obtained using a rigid body refinement protocol [106]. 
 
Phasing by molecular replacement 
For crystals of native ε1/ζ1_K115A phase extension was not possible due to the non-
isomorphic unit cells. Therefore, the native dataset was phased by molecular replacement in 
Phaser [102] using one heterodimer (chains G and H, without water molecules or ions) of the 
SeMet-labeled ε1/ζ1_K115A model as a search structure. 
 
 Structure refinement 2.6.4
For the ε1/ζ1_K115A structure an initial model was manually built into the electron density 
obtained from SAD phasing with the modified structure factor amplitudes (FDM) and phases 
(PHIDM) obtained from DM. Models were built in Coot [107] and initially refined to a resolution 
of 2.8 Å by a simulated annealing protocol performed with CNS [108, 109] and taking into account 
the experimental phase information. 100 cycles of energy minimization were followed by melting 
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to a starting temperature of 4726.85 °C (5000 K). Subsequently, the model was cooled to 26.85 °C 
(300 K) in steps of 25 °C. All subsequent refinement and improvement of the models obtained by 
molecular replacement or rigid body refinement was performed by iterative cycles of manual 
building and refinement using phenix.refine [110] with non-crystallographic symmetry torsion-
angle restraints [111]. In addition, the model of the SeMet-labeled protein was refined taking into 
account the anomalous scattering contributions. 
As an indicator of the model quality, an R-factor was calculated, taking into account the 
differences between the observed |F0| and the calculated |Fc| structure factor amplitudes (Rwork): 
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To obtain a measure of the model bias an R-factor for the omitted reflection (Rfree) [112] was 
calculated similarly, taking in account only a randomly generated set of 5% of the measured 
reflections. These were excluded from the refinement and kept constant for all related datasets. 
The stereochemistry of the model for intermediate and final structures was evaluated using 
the subroutines implemented in Coot [107] and final structure validation was performed using 
MolProbity [113].  
 
2.7 Bioinformatics 
 Homology search and sequence extraction 2.7.1
The NCBI non-redundant nucleotide or protein collections [114] were searched for 
homologous sequences using BLAST [115, 116]. The Bio::Seq module of BioPerl [117] was used 
to automatically extract nucleotide or protein sequences that correspond to identified NCBI 
Genbank IDs as well as adjacent sequences or ORFs. The Perl script was written by Robert 
Lindner. 
 
 Sequence alignments and secondary structure prediction 2.7.2
Multiple sequence alignments and sequence identity calculations were generated with 
ClustalOmega [118, 119]. Sequence conservation values were calculated with the AMAS 
server [120] and protein secondary structure elements were predicted using PSIPRED v3.3 [121]. 
Alignments that compile this information were prepared with ALSCRIPT [122]. 
Sequence logos to highlight the conservation of specific regions were generated with 
WebLogo [123]. 
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 Protein structure analysis 2.7.3
Structurally similar proteins were identified using DaliLite v.3 [124] searching the RCSB 
Protein Data Bank (PDB) [125] for matches to a query structure. Superposition of protein chains 
was performed with LSQKAB [126] implemented in the CCP4 software suite [105] or by 
Secondary-Structure-Matching (SSM) [127] in Coot [107]. 
Contact areas of molecular interaction surfaces were calculated using the PISA server [128] 
and electrostatic surface potentials were calculated using the APBS plugin [129] in PYMOL 
(DeLano Scientific LLC). 
All protein structure figures were prepared using PYMOL (DeLano Scientific LLC). 
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3 Results 
3.1 Escherichia coli EzeT 
This section describes the identification and characterization of the type II-like TA system 
EzeT, a zeta homolog in E. coli. Bioinformatic studies showed the prevalence of EzeT in Gram-
negative bacteria and helped to analyze the ezeT promoter. Microbiological and biochemical 
studies on the expression and enzymatic activity in vivo and in vitro confirmed the presence of an 
active UNAG kinase in Gram-negative bacteria. Finally, growth analyses allowed to deduce a new 
type of toxin inhibition that might be extended to other TA systems. 
 
 N-terminally elongated Zeta toxins in Gram-negative bacteria 3.1.1
So far, only epsilon/zeta systems from Gram-positive bacteria have been characterized. To 
identify zeta toxin homologs in the genomes of Gram-negative bacteria, the nucleotide sequences 
of ζspy and PezT were used as query sequences in a BLAST search [115, 116]. When probing all 
available sequenced E. coli genomes in the NCBI Nucleotide collection [114], highly conserved, 
uncharacterized open reading frames (ORFs) were found in 364 strains. Interestingly, in spite of 
their homology to zeta toxins, no epsilon-like antitoxin gene could be identified in their vicinity. 
The encoded protein sequences could be subdivided into 37 groups of identical sequences 
with an overall sequence identity of 88 % and pairwise sequence identities above 96 % (see 
Appendix, section 7.2). Due to the computational assignment of different start codons the annotated 
protein sequences varied slightly in length (between 304 and 310 amino acids (aa)). However, the 
region at the 5’-end of all ORFs, including the putative promoter sequence, is highly conserved and 
different translational start points are therefore unlikely. Within this region, a Shine-Dalgarno 
consensus sequence was identified. This ribosome binding site is usually located 4 to 
18 nucleotides upstream of the start codon with an optimal spacing of 8 to 10 nucleotides [130]. 
The GTG start codon of the putative 310 aa polypeptide lies directly next the Shine-Dalgarno 
sequence, which is most likely too short for translation initiation, while the proposed start codon of 
the 304 aa gene product is 20 nucleotides downstream of the Shine-Dalgarno sequence, which 
would result in inefficient translation initiation. In contrast, the spacing is optimal for a 308 aa long 
polypeptide starting 8 nucleotides downstream of the Shine-Dalgarno sequence (compare 
Figure 3.1-10B). Therefore, the annotated 308 aa protein from E. coli O103:H2 12009 (locus 
ECO103_4771) was used in subsequent studies. 
 
Results 
53 
When the sequence of this zeta homolog was compared to the streptococcal zeta toxins, a 
region with high homology to ζspy and PezT having 38 % and 47 % aa similarity, respectively 
(Figure 3.1-1A), was identified in the C-terminal part of the assigned protein sequence (aa 80 
to 308). This zeta-like region comprises the catalytically important Walker A motif, the magnesium 
coordinating aspartate of a degenerate DxD motif and the UNAG binding loop characterized by the 
GTXR consensus sequence [61, 66], indicating that the protein has UNAG kinase activity. 
In addition, the protein contains 80 aa at the N-terminus, which are not found in the shorter 
streptococcal homologs (ζspy consists of 287 aa and PezT of 253 aa). Interestingly, these residues 
are predicted to form three α-helices, which are similar to the secondary structure elements that 
form the three-helix bundle of epsilon antitoxins (Figure 3.1-1A). Together, these findings led to 
the hypothesis that the identified zeta homolog is an autoinhibited UNAG kinase in which toxin 
and antitoxin functionalities are encoded in one polypeptide chain. Therefore the gene product was 
called E. coli epsilon/zeta, abbreviated as EzeT. 
 
Currently, genomic sequences of 2914 completely or partially sequenced E. coli isolates are 
available in the NCBI Nucleotide collection and the ezeT ORF was found in 364 of these genomes. 
Sorting of the sequenced strains by phylogroup revealed a clear prevalence of ezeT in 
phylogroup B1. Except for E. coli HS and E. coli N1 (phylogroup A), all of the 138 strains that 
could be assigned to a phylogroup were B1 strains. These include the laboratory strain E. coli W as 
well as the pathogenic strains E. coli O103:H2 and O104:H4, which can cause lethal hemolytic-
uremic syndrome as demonstrated in the German 2011 outbreak. In all cases, ezeT was found in a 
conserved 3.4 kb islet, located between lysC, encoding for lysine sensitive aspartokinase III, and 
yjbD, a gene of unknown function (Figure 3.1-1B). This islet contains two additional hypothetical 
ORFs further downstream on the complementary strand; a putative nucleotidyl transferase and a 
homolog of SPFH domain/band 7 proteins, which are integral membrane proteins [131]. 
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Figure 3.1-1: A zeta homolog in E. coli. (A) Amino acid sequence alignment of EzeT 
(ECO103_4771) and the two streptococcal zeta toxins ζspy and PezT shows the homology of the C-
terminal domain of EzeT to this toxin family. Residues are colored according to conservation (dark 
green: identity to yellow: low homology). Secondary structure elements of ζspy are indicated above 
the alignment as olive bars (α-helices) and red arrows (β-strands). The catalytically important 
Walker A motifs (red), the magnesium-coordinating aspartate of the DxD motif (purple) and the 
UNAG binding region (gray) are conserved. The putative N-terminal domain of EzeT comprises 
about 80 amino acids and is predicted to fold into three α-helices (blue bars). Residues that were 
mutated in this study are indicated with diamonds (). (B) Genetic organization of the ezeT 
containing 3.4 kb islet found in 364 E. coli strains. The islet is inserted between the genes encoding 
lysine sensitive aspartokinase III (lysC) and yjbD, a gene of unknown function (light gray) and 
contains three ORFs (dark gray), ezeT and two hypothetical genes encoded on the complementary 
strand. Hyp1 denotes a putative nucleotidyl transferase and hyp2 a homolog of membrane proteins 
belonging to the SPFH domain/band 7 family. 
 
 EzeT purification and stability 3.1.2
The ezeT ORF was cloned into an IPTG-inducible expression vector (pET28b(EzeT)) 
thereby adding the coding sequence for a His6-tag to the 3’-end. E. coli BL21 CodonPlus(DE3)-
RIL cells, which do not harbor an endogenous ezeT ORF, were transformed with this vector and the 
protein was recombinantly expressed at a growth temperature of 16 ºC. Recombinant EzeT was 
purified by metal affinity chromatography, anion exchange chromatography and size exclusion 
chromatography to yield a homogenous sample. Protein purity was monitored by SDS-PAGE, 
which revealed that EzeT migrated with a velocity corresponding to an apparent electrophoretic 
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mobility of 35 kDa (Figure 3.1-2A). Moreover, the elution profile from the Superdex 75 10/300 GL 
used for size exclusion chromatography showed a single peak eluting at a retention volume of 
11.5 ml (Figure 3.1-2B), which corresponds to a molecular mass of approximately 35 kDa. Since 
full-length His6-tagged EzeT has a theoretical molecular weight of 35.8 kDa, these results indicate 
that the entire ORF gets translated as a single polypeptide chain when expressed recombinantly and 
that the protein forms a monomer in solution. 
However, under the conditions used, the protein solubility was impaired and the purified 
protein tended to precipitate over time, especially at high protein concentrations. This instability 
became already evident upon protein overexpression, during which EzeT accumulated in inclusion 
bodies. The ratio between soluble protein and protein in inclusion bodies depended on the 
expression temperature; at 16 ºC more than half of the protein was found in the soluble fraction 
after cell lysis, while upon expression at 25 ºC 80 % of the protein proved to be insoluble 
(Figure 3.1-2C). Furthermore, additional experiments showed that the presence of an N-terminal 
His6-tag is detrimental to protein solubility even at 16 ºC. 
To closer investigate the stability of EzeT, the melting temperature of purified full-length 
EzeT was determined by CD spectroscopy. Thermal denaturation was followed by detection of 
light polarization at 222 nm and the data points were fitted in Prism assuming a two-state unfolding 
process (Figure 3.1-2D). The unfolding was irreversible, giving an apparent melting temperature of 
38 ºC, which is close to the standard growth temperature of E. coli of 37 ºC. In conclusion, the 
results indicate a low thermal stability of EzeT, which might have implications for EzeT 
functionality. 
 
Results 
56 
 
Figure 3.1-2: EzeT purification and stability. SDS-PAGE analysis (A) and gel filtration 
chromatography (B) of EzeT indicate that the protein is expressed as a single 35.8 kDa polypeptide 
chain and is a monomer in solution. Molecular weight estimates (in kDa) of the components of the 
Low Range SDS-PAGE standard (M) and the Gel Filtration standard (gray) are given for 
comparison. (C) EzeT is better soluble when overexpressed at lower temperatures as shown by a 
comparison of soluble (S) and insoluble (P) lysate fractions after expression at 16 ºC, 20 ºC and 
25 ºC. While 80 % of the protein is in the insoluble fraction at 25 ºC, more than half of the protein is 
soluble upon overexpression at 16 ºC. (D) Melting curve of EzeT measured by circular dichroism 
spectroscopy. The data were fitted assuming a two-state unfolding process (red line), giving an 
apparent melting temperature of 38 ºC. 
 
 
 EzeT phosphorylates UNAG in vitro 3.1.3
The conservation of the catalytically important residues in EzeT suggested that the protein 
has UNAG kinase activity, which was tested in an in vitro phosphorylation assay using purified 
full-length protein.  
 
 
 
 
Results 
57 
 
Figure 3.1-3: UNAG phosphorylation by 
EzeT in vitro. Nucleotides/ nucleotide 
sugars were separated by anion exchange 
chromatography as shown for a standard 
containing UNAG and ATP (black line). 
Incubation of EzeT with UNAG and ATP 
leads to the formation of two products, 
ADP and UNAG-3P (green lines), which 
could not be detected for the Walker A 
lysine mutant EzeT_K121A (pink line). 
After 3 hours of incubation, EzeT had 
phosphorylated 9 % of the substrate 
UNAG (dashed line) and after 24 hours 
60 %, indicating a low turn-over rate. The 
asterisk (*) denotes the retention time of 
AMP which is probably the result of a 
minor contamination. 
 
Freshly purified EzeT was incubated together with MgCl2, ATP and UNAG at 25 ºC. The 
resulting nucleotide/nucleotide sugar species were separated by anion exchange chromatography 
and monitored spectroscopically (Figure 3.1-3). Enzymatic activity of EzeT was observable as a 
decrease in UNAG levels and formation of an equimolar amount of ADP. Simultaneously, an 
additional species appeared with a retention time corresponding to UNAG-3P, showing that EzeT 
phosphorylates UNAG and encodes an active UNAG kinase in Gram-negative bacteria. The 
reaction was specific to EzeT, as no UNAG-3P production was observed for an EzeT variant in 
which the essential Walker A lysine (K121) was mutated to an alanine (EzeT_K121A). However, 
turn-over by the full-length protein was slow, as after 3 h only 9 % and after 24 h only 60 % of the 
substrate was phosphorylated.  
This enzymatic activity is much slower than for free PezT∆C242 (nearly complete turn-over 
after 1 h), but comparable to the activity observed for the ε/ζspy complex, in which UNAG kinase 
activity is inhibited by equimolar amounts of the cognate antitoxin εspy [53]. Similarly, the 
phosphorylation rate observed for EzeT is in agreement with an inhibitory function of the N-
terminal region, although a low intrinsic phosphotransferase activity of EzeT cannot be excluded. 
 
 The C-terminal domain of EzeT is toxic in vivo 3.1.4
TA systems usually consist of two parts, a toxin which is toxic upon overexpression and an 
antitoxin that inhibits toxicity. In EzeT, these two functionalities seem to be located in two domains 
connected by a linker. Based on homology to the characterized epsilon/zeta systems and analysis of 
the predicted secondary structure, the domain boundary was assigned to the region around 
residue 82 (NNTTHS, see Figure 3.1-1A) and the corresponding domains were separately cloned 
into different vectors (pbad(EzeT(1-82)) and pET28b(EzeTΔN83)). However, domain separation 
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reduced the solubility of the protein even further and overexpression and purification attempts of 
the C-terminal domain alone did not yield any protein suitable for in vitro analysis. 
Therefore, toxicity of EzeT was investigated in vivo by comparing the growth phenotype of 
cultures overexpressing full-length EzeT or the truncated C-terminal zeta-like domain 
(EzeTΔN83). Protein expression was induced with IPTG at 20 ºC and cell propagation was 
monitored by measuring the optical density at 600 nm (OD600) and the number of colony forming 
units per ml (CFUs) (Figure 3.1-4). 
As expected from the low apparent reaction rate in vitro, expression of full-length EzeT 
showed no apparent phenotype in vivo, similar to the inactive Walker A lysine mutant 
(EzeTΔN83_K121A) and the empty pET28b vector. In contrast, expression of EzeTΔN83 caused a 
rapid drop in CFUs. Within 180 min the number of CFUs decreased by 4 orders of magnitude, 
whereas a decrease in OD600 by approximately 50 % got visible after a lag phase of 90 min. This 
difference between both methods is probably due to scattering from dead cells and cell debris that 
increases the OD600, while, on the other hand, continuing intoxication after plating might decrease 
the ability of individual cells to grow into visible colonies. Furthermore, the transfer to solid media 
might impose additional stresses like the mechanical forces during plating or the lower humidity. 
Nevertheless, these results show that, like in other TA systems, overexpression of the toxin leads to 
a growth phenotype. 
 
 
Figure 3.1-4: Toxicity of EzeT∆N83 overexpression in vivo. Growth curves (A) and CFUs (B) of 
cultures expressing EzeT (green), EzeT∆N83 (red) or EzeT∆N83_K121A (blue) at 20 ºC. 
Expression from an empty pET28b (gray) was used as control. While overexpression of full-length 
protein or the Walker A mutant did not affect the growth rate compared to the control, 
overexpression of EzeT∆N83 caused a decrease in OD600 after 90 min and a rapid drop in CFUs. 
Measurements were performed in triplicates. 
 
Results 
59 
 Toxicity is temperature dependent 3.1.5
Cloning attempts for other epsilon/zeta systems failed to separate the toxin gene from the 
epsilon antitoxin gene without introducing mutations that impair enzymatic activity [53]. Most 
likely, already minor amounts of free toxin are detrimental to cell growth. Surprisingly, the 
enzymatically active C-terminal domain of EzeT could be cloned without its inhibiting N-terminal 
domain using standard cloning methods, although toxicity was detectable at 20 ºC. Together with 
the low thermal stability of full-length EzeT, this indicated that the toxicity of the C-terminal 
domain might be dependent on the growth temperature. Therefore, the effect of overexpression of 
the C-terminal domain was compared at different temperatures in E. coli BL21 CodonPlus(DE3)-
RIL (Figure 3.1-5).  
At 37 ºC, the temperature used for culture growth during cloning, overexpression of 
EzeT∆N83 did not affect cell viability, as OD600 and CFUs were identical to those for the inactive 
Walker A lysine mutant EzeT∆N83_K121A. Notably, after 180 min the number of CFUs decreases 
slightly upon expression of both protein variants, which is indicative for an overexpression artifact. 
Presumably, this acquired sensitivity to plating is caused by an accumulation of insoluble protein 
and inclusion bodies in the cytosol due to the large amount of protein synthesized upon IPTG-
induction. 
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Figure 3.1-5: Temperature dependence of EzeT∆N83 toxicity. Growth curves (A, C) and CFUs 
(B, D) of cultures expressing EzeT∆N83 (A, B) or enzymatically inactive EzeT∆N83_K121A (C, D) 
at different temperatures (16 ºC: dark blue; 20 ºC: blue; 25 ºC: purple; 30 ºC: red; 37 ºC: dark red). 
Cultures expressing EzeT∆N83_K121A grew steadily, albeit with temperature dependent doubling 
times. Cultures expressing EzeT∆N83 at 16 ºC, 20 ºC and 25 ºC showed a decrease in OD600 
90 min after induction and a rapid drop in CFUs. After 180 min the number of CFUs was decreased 
by approximately 4 orders of magnitude. Expression at 30 ºC led to a decrease in CFUs, but not in 
OD600 and at 37 ºC EzeT∆N83-expressing cultures grew similar to the EzeT∆N83_K121A control. 
Note the slightly reduced number of CFUs for both constructs at 180 min at 37 ºC, which is 
probably caused by an overexpression artifact. Measurements were performed in triplicates. 
 
In contrast, cell death was observed when overexpression of EzeT∆N83 was induced at 
16 ºC or 20 ºC, as described before. A decrease in OD600 and CFUs was also detected upon 
expression at 25 ºC, whereas at 30 ºC the OD600 constantly increased. However, although no sign of 
toxicity was evident by monitoring the turbidity of the culture, CFUs immediately dropped to 
vanishingly low levels after induction at 30 ºC. This discrepancy between the two methods used to 
study viability was already seen as a difference in lag phase at 20 ºC, but is probably even more 
pronounced at 30 ºC due to the low protein stability at this temperature. At all of these 
temperatures, expression of EzeT∆N83_K121A did not cause the loss of cell viability showing that 
the enzymatic activity is responsible for the growth phenotype. The temperature dependence and 
the low in vitro melting point suggest a temperature-sensing function of EzeT. 
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 The C-terminal domain of EzeT causes a lytic phenotype 3.1.6
UNAG-3P cannot be converted by enzymes of the peptidoglycan synthesis pathway and was 
shown to accumulate in the cytosol of PezT∆C242-expressing cells [53]. To prove that EzeT 
toxicity is similarly caused by the phosphorylation of UNAG, the accumulation of UNAG-3P was 
measured in vivo by analyzing low-molecular-weight-metabolite extracts of cells expressing 
EzeT∆N83. Therefore, protein expression was induced by IPTG at 16 ºC and cultures were 
harvested after 2 hours. Low-molecular-weight compounds were solubilized using 80 % aqueous 
acetonitrile and separated by anion exchange chromatography. Eluents were monitored 
spectroscopically and compared to authentic standards (Figure 3.1-6A). 
An accumulation of a compound with the same retention time as UNAG-3P was detected in 
extracts from cells expressing EzeT∆N83, but not from cells expressing the inactive Walker A 
lysine mutant EzeT∆N83_K121A. This shows that the UNAG kinase domain of EzeT is 
enzymatically active under physiological conditions. In agreement with the low in vitro activity and 
the inability in evoking a growth phenotype, no UNAG-3P formation was detected for the full-
length protein in vivo showing that the N-terminal domain influences the phosphorylation 
efficiency.  
 
Phosphorylation of UNAG was shown previously to decrease the stability of the bacterial 
cell wall and to lead to cell lysis [53]. Therefore, the break-down of the osmotic barrier was 
measured in E. coli BL21 CodonPlus(DE3)-RIL cells expressing truncated EzeT by following the 
influx of propidium iodide into the cell (Figure 3.1-6B). Intercalation of propidium iodide into 
DNA was measured by detecting the fluorescence signal at 620 nm upon excitation at 520 nm. 
Indeed, cultures expressing EzeTΔN83 showed a strong increase in propidium iodide fluorescence 
simultaneously with a decrease in OD600, comparable to the effect of administration of 50 µg/ml of 
the cell wall perturbing antibiotic ampicillin. In contrast, propidium iodide fluorescence of cultures 
expressing the Walker A lysine mutant was comparable to fluorescence of the non-induced control 
culture, indicating that the bacterial cell wall remains intact. These results suggest that the C-
terminal domain of EzeT is a UNAG kinase that causes a lytic phenotype due to the inhibition of 
peptidoglycan synthesis. 
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Figure 3.1-6: EzeT∆N83 causes UNAG-3P accumulation and break-down of the osmotic 
barrier. (A) HPLC analysis of small-metabolite-extracts from cultures expressing EzeT (green), 
EzeT∆N83 (red) or EzeT∆N83_K121A (blue). Only expression of EzeT∆N83 leads to the 
accumulation of a compound with the same retention time as UNAG-3P, which is included in the 
standard (black). For the full-length protein no UNAG-3P formation is observed, indicating that the 
N-terminal domain decreases the enzymatic activity. Growth curves (B) and propidium iodide (PI) 
fluorescence measurements (C) of cultures expressing EzeT∆N83 (red) or EzeT∆N83_K121A 
(blue) or non-induced cells (gray) grown in a medium containing 0.05 mg/ml propidium iodide. Cells 
treated with ampicillin (purple) show the typical increase in propidium iodide fluorescence caused 
by the break-down of the osmotic barrier. A similar increase in propidium iodide fluorescence is 
also observed for the cultures expressing EzeT∆N83, indicating that the protein also disturbs the 
bacterial cell wall. 
 
 Phenotype of EzeT expression 3.1.7
The destabilization of the bacterial cell wall is not only evident as a loss of viability and a 
break-down of the osmotic barrier of an entire culture, but can be also followed as changes in the 
morphology of individual cells. In E. coli cells overexpressing PezT∆C242 membrane bulges were 
Results 
63 
formed at the septum within 30 min and rupture of those bulges led to cell lysis and the formation 
of empty ghost cells [53]. 
The time course of morphological changes upon overexpression of EzeT∆N83 at 20 ºC was 
followed by phase contrast microscopy. The membrane integrity was assessed by fluorescent 
live/dead staining using the cell-permeant SYTO 9 and the cell-impermeant propidium iodide 
nucleic acid stains (Figure 3.1-7A). 
 
Microscopic images taken 30 min after induction revealed that the majority of cells had a 
rod-shaped morphology and an intact, propidium-iodide impermeable membrane. Later on, 
surviving cells adopted a spherical shape, while a significant number of propidium iodide-
permeable ‘ghosts’ and lysed cells became visible. During the course of the experiment, cells from 
the control culture expressing EzeT∆N83_K121A maintained their rod-like morphology and 
membrane integrity and dividing cells were commonly observed. It is therefore likely that the 
viable, spherical cells in cultures expressing EzeT∆N83 are a result of the UNAG kinase activity. 
The accumulation of UNAG-3P probably decreases the stability of the peptidoglycan layer, which 
is required to maintain the typical rod-like shape of E. coli against the internal turgor pressure. 
Interestingly, the observed morphology is reminiscent of spheroplast formation after treatment of 
cells with cell wall perturbing agents [132, 133]. These agents perturb the rigid peptidoglycan 
scaffold and thereby cause the cells to adopt a spherical morphology. 
 
Notably, the morphological studies indicate, that the onset of cell death is after 
approximately 90 min, while cells are mostly intact after 60 min. These results are in good 
agreement with the bulk measurements of propidium iodide influx (former section), which 
indicated an onset of membrane permeabilization after approximately 100 min. Together, the data 
show that OD600 measurements give a better indication of the time point of killing by the toxin than 
determination of CFUs. It is, however, conceivable that the stability of the peptidoglycan layer is 
already impaired at earlier time points. 
 
Despite their unusual shape, spherical survivors of the toxic activity seem to be viable for 
prolonged times. In cryo-electron microscopic images of cultures expressing EzeT∆N83 at 16 ºC 
for 16 h, bloated cells with irregular shapes are visible, which seem to be surrounded by an intact 
membrane (Figure 3.1-7B). Most of these cells contain one or more large, electron-lucent 
structures, which most likely are inclusion bodies. After incubation for more than 24 hours, some 
of the cells seem to be able to overcome the toxic effect of protein expression and culture growth 
resumes (data not shown). 
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Figure 3.1-7: Phenotype of EzeT∆N83 expression. (A) Representative phase contrast and 
fluorescence microscopy images of cultures expressing EzeT∆N83 at 20 ºC. Live cells are 
visualized by green fluorescence using membrane-permeable SYTO 9, dead cells are visualized 
be red fluorescence using membrane-impermeable propidium iodide. Images were taken at 
indicated time points. A reduction in the total cell number and rounding of cells is visible after 
90 min. In contrast, cells expressing EzeT∆N83_K121A (top) are viable, rod-shaped and divide 
during the course of the experiment. The black bar has a length of 5 µm. (B) Cryo-electron 
microscopy images of cultures expressing EzeT∆N83 for 16 h at 16 ºC. Cells adopt irregular 
shapes, but seem to form intact membrane-enclosed compartments. The large electron lucent 
structures most likely are inclusion bodies. 
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 The N-terminal domain of EzeT inhibits toxicity 3.1.8
In conventional TA systems co-expression of the antitoxin in trans inhibits toxicity of the 
toxin. In this study, the toxicity of EzeT was shown to be located in the C-terminal domain, while 
the presence of the N-terminal domain in the full-length protein seemed to inhibit both UNAG 
kinase activity and the lytic phenotype. To test whether the separated domains of EzeT indeed can 
function like a conventional type II TA system, E. coli BL21 CodonPlus(DE3)-RIL were co-
transformed with plasmids encoding for EzeT(1-82) and EzeT∆N83 under control of two 
separately-inducible promoters (Figure 3.1-8). 
 
Figure 3.1-8: Co-expression of the N-
terminal domain inhibits EzeT∆N83 
toxicity. Growth curves of cultures 
expressing EzeT∆N83 from an arabinose-
inducible pBAD-vector at 16 ºC. 
Expression of EzeT(1-82) from a co-
transformed IPTG-inducible pET28b-vector 
was induced separately at different time 
points (arrows; 0 min (green), 120 min 
(blue) or 240 min (red)). EzeT∆N83 
expression only (gray) leads to a decrease 
in OD600 after 240 min. Co-expression of 
the N-terminal domain can rescue this 
phenotype when induced during the lag 
phase. Induction of EzeT(1-82) after 
240 min, when OD600 started to decrease 
was not effective anymore, indicating a 
‘point-of-no-return’ [134]. 
 
As expected, no lytic phenotype was detectable upon co-expression of both domains from 
pET28b(EzeT(1-82)) and pBAD(EzeT∆N83). In contrast, upon induction of EzeT∆N83 only with 
0.2 % L-(+)-arabinose, a lytic phenotype was observed, similar as upon overexpression from the 
IPTG-inducible T7-promoter. However, the lag time until a decline in OD600 was detectable, 
increased from 90 min to 240 min. This is probably due to a lower level of protein expression from 
the arabinose-inducible promoter, as well as low-level expression of EzeT(1-82) due to leakiness of 
the T7 promoter. Induction of EzeT(1-82) within this lag time was sufficient to restore normal 
growth. In contrast, induction of EzeT(1-82) after 240 min, when the OD600 already decreased, 
could not rescue cell viability anymore. This phenomenon, known as the ‘point-of-no-return’, has 
been described earlier for other TA systems including the homologous ε/ζspy system [79, 135] and 
is thought to occur when the damage caused by the toxin reaches irreversible levels [134].  
In conclusion, the two domains of EzeT show toxin and antitoxin properties similar to the 
two individual proteins of type II systems, but are covalently linked into one polypeptide chain. 
This type of TA system inhibition has not been described earlier. 
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 Residues at the N-terminus are required for inhibition 3.1.9
In the structurally characterized epsilon/zeta systems, the three-helix bundle of epsilon 
antitoxins binds to zeta and inhibits enzymatic activity by steric hindrance of ATP binding [62, 63]. 
This is accomplished by side chains of the N-terminal helix of epsilon that protrude into the active 
site of zeta. The conservation of predicted secondary structure elements (see Figure 3.1-1) raises 
the possibility that this mechanism of inhibition is conserved in EzeT. 
To narrow down the region within the N-terminal domain of EzeT required for inhibition, 
constructs with truncations after the first (EzeT∆36) or second (EzeT∆62) predicted α-helix were 
expressed in E. coli BL21 CodonPlus(DE3)-RIL and OD600 and CFUs were compared to cultures 
expressing the full-length protein or EzeT∆N83 (Figure 3.1-9). For both truncation constructs, a 
decrease in OD600 was detected, although with a longer lag phase of 360 min or 210 min, 
respectively, when compared to cultures expressing the C-terminal domain alone (90 min). 
Determination of CFUs showed a strong drop in viability after 180 min (2500 fold) for EzeT∆N62 
and a moderate 30 fold decrease for EzeT∆N36, which was more pronounced after 300 min 
(300 fold). The weaker toxicity could be caused by differences in protein stability of the truncated 
constructs, leading to lower levels of active enzyme in the cell for EzeT∆36 and EzeT∆62. 
However, the loss of inhibitory function indicates that the N-terminal helix is required for 
inhibition, either because residues in this helix are directly involved in blocking ATP binding or 
because the helix is required for domain stability or binding to the toxin. 
In order to discern the effects on tertiary structure destabilization from the requirement of 
individual side chains, residues that presumably interfere with ATP binding were mutated to 
alanine residues. In εspy and PezA these residues (tyrosine, phenylalanine (εspy) / leucine (PezA) and 
two glutamates [62, 63]) are located on one side of the N-terminal α-helix in the three-helix bundle. 
Correspondingly, methionine 5, aspartate 8 and the carbamoyl-containing amino acids 
asparagine 12 and glutamine 16 of EzeT are predicted to be located in successive turns of the first 
α-helix and might therefore protrude into the ATP binding site. Therefore, these residues were 
mutated to alanine and the corresponding construct (EzeT_M5A_D8A_N12A_Q16A) was 
expressed in E. coli BL21 CodonPlus(DE3)-RIL. Measurement of OD600 and CFUs showed a 
steady increase in OD600, but similarly to EzeT∆N36 CFUs dropped 30 fold after 180 min and 
200 fold after 300 min (Figure 3.1-9). This shows that these residues in the N-terminal domain are 
indeed required to block substrate binding to the C-terminal domain. It is likely that the N-terminal 
domain inhibits UNAG kinase activity by preventing ATP binding similar as described for PezA 
and εspy [62, 63]. 
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Figure 3.1-9: Truncation or mutation of the ultimate N-terminal residues relieves inhibition. 
Growth curves (A) and CFUs (B) of cultures expressing EzeT∆N83 (red), EzeT∆N62 (orange), 
EzeT∆N36 (yellow), EzeT(M5A_D8A_N12A_Q16A) (light green) or full-length EzeT (dark green) at 
20 ºC. Similar to expression of the C-terminal domain (EzeT∆N83), expression of EzeT∆N36 and 
EzeT∆N62 leads to a decrease in OD600, albeit with a longer lag phase of 360 min and 210 min, 
respectively. A reduction in CFUs is visible for both cultures after 180 min. In addition, a decrease 
in CFUs is visible for EzeT(M5A_D8A_N12A_Q16A), while the OD600 increases similarly to non-
toxic full-length EzeT. 
 
 EzeT is expressed from its endogenous promoter 3.1.10
To monitor expression from the endogenous ezeT promoter an HA-tagged version of EzeT 
was integrated into the genome of E. coli W in place of the wild-type ezeT locus yielding 
E. coli W(EzeT-HA). This strain and wild-type E. coli W were grown at 37 ºC to an OD600 of 1, 
harvested and lysed. The cleared lysate was then subjected to immunoprecipitation with antibodies 
against the HA-epitope coupled to magnetic beads. Bound proteins were eluted by denaturation 
with 8 M urea and analyzed by Western blotting. A species with the same electrophoretic mobility 
as recombinant HA-tagged EzeT was detected in the lysate of E. coli W(EzeT-HA), but was not 
present in the lysate of E. coli W (Figure 3.1-10A). This proved the expression of full-length EzeT 
in vivo and showed that the protein is indeed synthesized as an autoinhibited UNAG kinase. 
However, under the applied growth conditions, the expression of EzeT was low as the protein 
could hardly be detected without enrichment. 
 
 Regulation of ezeT transcription 3.1.11
To identify factors that influence the expression from the ezeT promoter, the genomic region 
comprising 250 nucleotides upstream of the EzeT start codon was cloned into a reporter plasmid 
(pREP(sfGFP). In this plasmid, ezeT promoter activity can be probed by spectroscopically 
following the synthesis of superfolder GFP (sfGFP) [84]. Indeed, GFP fluorescence was detected in 
E. coli DH5α cells transformed with this reporter plasmid. The fluorescent signal was followed 
from initial inoculation at an OD600 = 0.1 till stationary phase, but was only discernible after more 
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than 5 h, when a high cell density was reached and growth had ceased. This probably depends on a 
number of different factors that influence the amount of mature GFP: the increasing number of 
cells, the time needed for GFP maturation and, potentially, a dependence of GFP expression on 
growth phase. 
 
Bioinformatic analysis of the promoter region (Figure 3.1-10B) indicated the presence of a 
conventional Pribnow-Schaller box (TATAAT) [136, 137] 31 nucleotides upstream of the start 
codon of EzeT. This Pribnow-Schaller box is usually bound by the housekeeping sigma factor 
σ70 [138]. In addition, this sigma factor recognizes a region approximately 25 nucleotides further 
upstream (-35 region). However, the consensus sequence TTGACA is not present at this position in 
the ezeT promoter. To verify the regulatory function of the Pribnow-Schaller box, this sequence 
was mutated to random nucleotides (pREP(delPS)) and GFP fluorescence was measured 
(Figure 3.1-10C). No fluorescence could be detected, showing that this region is essential for 
transcription factor binding. Similarly, randomization of the Shine-Dalgarno sequence (AGGAG, 
pREP(delSD)) required for ribosome binding to the mRNA completely abolished GFP 
fluorescence. In contrast, mutation of the -35 region to a conventional binding site for σ70 
(pREP(s70)) strongly increased fluorescence levels. These results show the functionality of the 
Pribnow-Schaller box and the Shine-Dalgarno sequence and suggest that the promoter is weak 
under standard growth conditions, but might be activated in specific situations.  
To further investigate transcriptional regulation, individual parts of the sequence were 
mutated subsequently. Most alterations in the promoter region did not significantly change the GFP 
fluorescence levels, excluding that the mutated nucleotides are important for transcriptional 
regulation. Nevertheless the promoter sequence upstream of the Pribnow-Schaller box seems to 
contain elements required for transcription, as deletion of this entire region (pREP(delprom)) 
reduced fluorescence. Notably, GFP fluorescence was increased upon mutation directly 
downstream of the Pribnow-Schaller box (pREP(delPSdown)) and for random mutations in 
the -35 region (pREP(del35)). 
It is conceivable, that the ezeT promoter evolved to restrict protein expression to a low level 
under normal growth conditions and that transcription is only activated under certain conditions, 
for instance by binding of the alternative sigma factor σ38 at high cell densities or under stress. σ38 
recognizes promoters with similar consensus sequences as σ70 but has a higher tolerance to 
deviations from the ideal sequence and spacing of the promoter elements [139]. However, when 
E. coli cells carrying the reporter plasmid were subjected to different stress conditions no 
significant alteration in GFP fluorescence levels was detected. The stress conditions tested included 
different osmolarity, pH or nutrient availability and the exposure to reducing/oxidizing agents, UV 
irradiation or antibiotics. 
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Figure 3.1-10: EzeT expression from its endogenous promoter. (A) Western Blot detection of 
hemagglutinin-epitopes after immunoprecipitation of tagged proteins from E. coli W and E. coli 
W(EzeT-HA). A protein with the same electrophoretic mobility as recombinant EzeT-HA (control) is 
only present using E. coli W(EzeT-HA). (B) ezeT promoter sequence upstream of the start codon 
(light blue). The putative Shine-Dalgarno sequence (pink), the Pribnow-Schaller box (dark blue) as 
well as the corresponding location of the -35 region (red) and the palindrome (gray) are highlighted. 
The ‘x’ denotes deletion sites, indicating the 3’-end of the putative promoter region that has been 
deleted. (C) Analysis of ezeT promoter activity measured as GFP fluorescence intensity of dense 
cultures. The colors indicate the region of the promoter which was mutated according to (B) 
(Pribnow-Schaller box, DelPS, blue; Shine-Dalgarno, DelSD, pink; -35 region, S70 (to ideal σ70 
sequence), red, and Del35 (to random sequence), orange; region downstream of the Pribnow-
Schaller box, DelPSdown, green; the wild-type ezeT promoter is colored light blue. Delprom 
denotes a deletion upstream of X, DelUPE a deletion upstream of x. No difference is seen in GFP 
fluorescence after addition of arabinose in the presence (purple) or absence (violet) of EzeT under 
control of an arabinose-inducible promoter excluding autorepression of the promoter. 
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In addition to sigma factors and the RNA polymerase, DNA-binding proteins that act as 
activators or repressors can alter transcriptional rates. In many type II TA systems protein synthesis 
is regulated by autorepression by the antitoxin or the toxin-antitoxin complex [18]. A DNA-
recognition motif of the antitoxin binds to palindromic sequences in the promoter region, e.g. the 
E. coli TA systems MazEF (overlapping with the core promoter, nucleotides -34 to +6 [140]) and 
RelBE (overlapping with the transcription start site, nucleotides -5 to +19 [141]). A palindromic 
sequence was found upstream of the ezeT start codon. However, this sequence could not be 
attributed to binding of a known bacterial transcription factor and no homologous palindromes 
could be identified in the E. coli genome. This could in principle imply gene-specific regulation by 
autorepression of EzeT, but the palindromic sequence is located approximately 120 nucleotides 
upstream of the start codon, which is presumably to far for the bound protein to interact with the 
RNA polymerase complex. 
 
To investigate a possible repressor function of EzeT, cells were co-transformed with the 
GFP-reporter plasmid and a plasmid encoding for arabinose-inducible EzeT and the fluorescence 
intensity was compared to the fluorescence of cells carrying only the reporter plasmid 
(Figure 3.1-10C). No difference in intensity was measurable between both cultures upon addition 
of arabinose, thereby excluding autorepression of the ezeT promoter. In addition, GFP fluorescence 
of cells carrying a reporter plasmid in which the entire region more than 70 nucleotides upstream of 
the start codon was removed (pREP(delUPE)) did not change when compared to the GFP 
fluorescence observed for the original plasmid. The experiments were performed with the E. coli 
DH5α laboratory strain, which does not have an endogenous ezeT locus, and with E. coli W, which 
harbors the ezeT locus, thereby excluding strain specific regulation.  
 
 EzeT activation 3.1.12
Expression from the endogenous ezeT promoter yields full-length protein, in which the N- 
and C-terminal domain are covalently bound. This protein was demonstrated to be non-toxic, while 
the separated C-terminal domain alone showed UNAG kinase activity in vivo, suggesting that the 
inhibition by the N-terminal domain has to be relieved to activate the toxic function. 
In type II TA systems, the inactive protein-protein complex dissociates and the antitoxin is 
degraded to activate the toxin [18]. In EzeT, complete dissociation of the two domains is prevented 
by the connecting linker. Instead, toxin activation could involve binding of a factor that favors an 
‘open’ complex in which the active site is not blocked or chaperones that induce unfolding of the 
N-terminal domain. Furthermore, proteases could degrade the N-terminal part of EzeT or cleave 
the interdomain linker followed by domain separation. 
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Figure 3.1-11: EzeT activation. (A) Western Blot detection of the His6- (left) and Strep-epitopes 
(right) of N-terminally Strep- and C-terminally His6-tagged EzeT after incubation in E. coli W lysate 
for the indicated time periods. (B) Silver stained SDS-PAGE gel of a co-immunoprecipitation using 
HA-tagged EzeT from E. coli W(EzeT-HA). The amount of unspecific binding was monitored 
following the same protocol using E. coli W lysate that does not contain tagged EzeT. Additional 
and more intense bands are observed when HA-tagged EzeT is present. Five of the co-precipitated 
proteins could be identified by mass spectrometry. 1: Formate C-acetyltransferase 1, 2: EF-TU, 
3: Threonine dehydratase, 4: MinD, 5: 50S ribosomal protein L6. 
 
Proteolytic degradation of EzeT in E. coli lysate was monitored by mixing purified protein 
with cell lysate. The protein contained an N-terminal Strep-tag and a C-terminal His6-tag to be able 
to independently detect N- and C-terminally truncated fragments in a Western Blot (Figure 3.1-
11A). However, EzeT proved to be very stable over 24 h and no faster migrating, supposedly 
cleaved fragment was observed. 
In addition, co-immunoprecipitation of proteins interacting with endogenous EzeT-HA was 
performed. In a silver stained gel (Figure 3.1-11B) additional protein species were observed that 
were more prominent than in the control in which the HA-tag was not present. Five co-eluting 
proteins could be identified by mass spectrometry as formate C-acetyltransferase 1 (pflB), EF-Tu, 
threonine dehydratase (tdcB), MinD and the 50S ribosomal protein L6 (rplF). Of these, formate 
C-acetyltransferase 1 and the proteins of the translation machinery EF-Tu and L6 are common 
cytosolic proteins [142] that might have bound unspecifically. Nevertheless, it should be mentioned 
that an interaction of the homolog PezT with ribosomes was observed previously [143], although 
the functional implications of this binding are unclear. MinD is required for correct positioning of 
the septum at midcell [144] and threonine dehydratase is involved in the synthesis of branched-
chain amino acids [145]. None of the identified proteins is a protease or chaperone that could be 
involved in EzeT activation and the in vivo functionality of an interaction with those co-purified 
proteins is enigmatic. 
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In conclusion, no activation of EzeT was observed under the tested conditions. As only 
standard growth conditions were applied, it is still conceivable that EzeT activity is tightly 
regulated and only evoked under certain circumstances. However, how and when this occurs is 
unknown both for its transcriptional as well as enzymatic regulation. 
 
 EzeT function 3.1.13
Originally, TA systems were discovered as plasmid addiction systems that ensure the 
persistence of a plasmid in a bacterial population [27] and even some chromosomally encoded 
TA systems were found to stabilize genetic loci [38]. 
To test whether EzeT is able to stabilize plasmids, the ezeT ORF was cloned into a derivative 
of the enteric low-copy number plasmid R1, pOU82 [86]. pOU82 contains an ampicillin resistance 
gene, the lacZYA operon and the origin of replication of R1, but does not encode CopA. CopA is an 
antisense RNA that negatively regulates RepA and thereby downregulates replication. To study 
stabilization efficiencies, CopA is provided from an IPTG-inducible promoter on a second plasmid, 
thereby arresting pOU82 replication. After the addition of IPTG, no further copies of pOU82 are 
synthesized and plasmid numbers stay constant. After a few rounds of cell divisions each mother 
cell will only contain a single plasmid, such that only one daughter cell can inherit the encoded 
genetic information. If the plasmid contains a module that induces PCD upon loss of the plasmid, 
all plasmid-free cells will be killed, which limits the number of cells to the number of plasmids 
present. In this case, the number of CFUs should remain constant after addition of IPTG, while 
they will steadily increase, when PCD is not induced and the plasmid-free daughter cells survive. 
The loss rates of plasmids with and without ezeT were determined, but no difference in 
plasmid stabilization efficiency was observed (Figure 3.1-12). Instead, CFUs steadily increased, 
while the number of colonies containing pOU82 remained constant. Furthermore, there was no 
significant difference detectable, whether EzeT was under control of its own ezeT promoter or a 
constitutive lacI promoter. Apparently, EzeT belongs to the group of chromosomal TA systems 
that do not stabilize their genetic loci, like the ccdAB modules of Erwinia chrysanthemi and 
E. coli [40, 146]. 
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Figure 3.1-12: Plasmid maintenance assay. pOU82 (A) is a conditionally unstable plasmid and 
the stabilizing effect of EzeT under control of the ezeT promoter (B) or the constitutive lacI 
promoter (C) was tested. Cell numbers per ml were determined by CFUs (green) and calculated 
from OD600 (red) and compared to the number of bacteria carrying pOU82 (blue). Due to the 
replication arrest of the pOU82 derivatives the number of plasmids remains constant, which is 
equivalent to a constant value for the plasmid containing cells (blue). If a plasmid stabilizing 
TA system is present, the plasmid-free cells are killed and culture growth ceases. The total number 
of viable cells (green) will then equal the number of plasmid containing cells (blue). Without a 
plasmid stabilization system, total cell numbers increase, while the number of plasmid containing 
cells remains constant, revealing the emergence of viable plasmid-free cells. This scenario is 
observed for all three plasmids, with or without EzeT, indicating that the protein does not induce 
post-segregational killing. 
 
 
Chromosomal TA systems are often regulated in response to external stimuli and induce 
phage abortive infection, biofilm and persister cell formation. To test whether EzeT is involved in 
any of these processes, assays were performed with E. coli W and an ezeT knock-out strain 
(E. coli W ezeT -).  
The ability of EzeT to cause abortive infection upon exposure to T4 phage was tested in a 
plaque assay. However, E. coli W was not sensitive to T4 phage infection. Therefore, E. coli DH5α 
cells were transformed with pBAD vectors containing EzeT or EzeT_K121A or an empty control 
vector and exposed to the phages. Although a considerable number of plaques was observed, no 
difference was seen between the different constructs. In conclusion, EzeT does not induce abortive 
infection in response to T4 infection. 
Similarly, the propensity to form biofilms can depend on the expression of certain 
TA systems [147], which was compared for E. coli W, E. coli W ezeT - and E. coli W ezeT - 
harboring pBAD(EzeT). Cultures were grown in 96-well plates at 30 ºC for 48 h without agitation 
to allow attachment. Biofilm formation was quantified by crystal violet staining of adherent cells 
after rigorously washing the wells. No difference was seen between the amounts of biofilm formed 
for both strains, indicating that EzeT does not influence biofilm formation. 
Persisters are dormant cells with a reduced metabolism, which makes them tolerant to 
antibiotics [12]. Their frequency is thought to be regulated by various factors including 
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TA systems [148] and can be assessed by determination of the number of CFUs after exposure to 
different antibiotics. To test whether EzeT can influence the number of persisters in a population, 
stationary phase cultures of E. coli W, E. coli W ezeT - and E. coli W ezeT - harboring pBAD(EzeT) 
were treated with gentamicin, tetracycline and ciprofloxacin and CFUs were determined. No 
difference was seen between all three strains, indicating that EzeT does not change the relative 
amount of persister cells in response to these antibiotics. 
 
 Summary 3.1.14
The results described in this section provide the characterization of EzeT, a type II-like 
TA system with a novel mechanism of inhibition. The protein is the first characterized UNAG 
kinase in Gram-negative bacteria and expression of the C-terminal domain leads to a lytic 
phenotype caused by the accumulation of UNAG-3P. EzeT toxicity is temperature dependent, 
which is in accordance with low protein stability and a thermal melting point of 38 ºC in vitro. In 
the presence of the N-terminal domain the UNAG kinase activity is abrogated, presumably by in an 
epsilon-like mechanism of inhibition. EzeT is the first described TA system, in which the toxin and 
antitoxin functionalities are linked in one polypeptide chain, thereby constituting a new type of 
proteinaceous TA system. 
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3.2 Neisseria gonorrhoeae epsilon/zeta systems 
This section describes the characterization of the three plasmidic epsilon/zeta systems of 
N. gonorrhoeae, ε1/ζ1, ε2/ζ2 and ε3/ζ3, all of which were found to form protein-protein complexes 
and to be able to phosphorylate UNAG in vitro. Beyond these characteristics of epsilon/zeta 
TA systems, several variations to the streptococcal systems have been observed. In particular, 
structural and biophysical studies on ε1/ζ1 showed a novel zeta toxin topology and a different 
mode of complex formation and inhibition. 
 
 Multiple epsilon-zeta systems on N. gonorrhoeae plasmids 3.2.1
Antibiotic resistance genes in the Gram-negative bacterium N. gonorrhoeae are often carried 
and transferred by plasmids and spread by horizontal gene transfer [149]. Conjugative plasmids 
like those of the pLE2451-group contribute on the one hand to the mobilization of genetic 
material [150]; on the other hand, they themselves contain genetic load regions that encode genes, 
which increase pathogen survival or virulence, like the tetracycline-resistance gene tetM [81]. 
Sequencing of pLE2451-like plasmids with and without the tetM determinant revealed the presence 
of two putative epsilon/zeta systems in their genetic load regions [81].  
One of these systems, termed ε1/ζ1, was found on all pLE2451 variants. The closest 
homolog of ζ1, as identified with 50 % aa sequence identity, is CAMGR0001_1552 of 
Campylobacter gracilis, a protein that has been annotated as putative zeta toxin. Therefore, the 
ε1/ζ1 locus has been proposed to encode a hitherto uncharacterized epsilon/zeta system [81]. 
The epsilon/zeta homolog encoded adjacent to ε1/ζ1 differed between plasmids with or 
without the tetM determinant. In plasmids without antibiotic resistance gene it was designated ε2/ζ2 
and in those that carry tetM ε3/ζ3, respectively (Figure 3.2-1). Nevertheless, both systems share 
67 % nucleotide sequence identity and were proposed to be closely related [81]. 
ζ2 and ζ3 contain a region of 260 aa with 38 % sequence similarity to PezT and ζspy 
(Figure 3.2-2D). In particular, the Walker A motif, the UNAG binding motif and the magnesium 
coordinating DxD motif are conserved [66], indicating that both proteins are functional UNAG 
kinases. Furthermore, the predicted secondary structure of ζ2 and ζ3 corresponds well to the 
structure of the streptococcal zeta toxins (Figure 3.2-2D). 
In contrast, the secondary structure prediction of ζ1 differs from the structure of these toxins, 
especially in the N-terminal part of the polypeptide chain (Figure 3.2-2B). Structural differences 
are also evident in a shifted position of the Walker A motif in the aa sequence, which was 
identified as residue 115 in ζ1, whereas it can be found at position 64 in ζ2 and ζ3. Regions with 
homology to the DxD motif or the UNAG binding motif could not be identified by sequence 
alignment. 
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Figure 3.2-1: Comparison of the genetic organization of the gonococcal epsilon/zeta 
systems. Schematic representation of the epsilon/zeta systems of pLE2451 (A) and a variant 
carrying the tetM determinant (B). ε1/ζ1 (green) and the transcriptional repressor MarR (dark gray) 
are encoded on both plasmids, while ε3/ζ3 (blue) is found only in plasmids, which do not carry an 
antibiotic resistance gene. The tetracycline-resistance determinant tetM and the hypothetical ORF 
11375 (light gray) were integrated into the genetic load region adjacent to ε2/ζ2 (red). The 
conserved C-terminal domain present in all gonococcal zeta proteins is marked in purple. 
 
 
All three proposed zeta toxins are located downstream of ORFs encoding small, 61 to 84 aa 
proteins, which were called ε1, ε2 and ε3, respectively. The close proximity of the corresponding 
epsilon and zeta genes suggests that they are transcribed in one mRNA.  
Similar to the toxin homologs ζ2 and ζ3, ε2 and ε3 share 56 % aa sequence identity 
(Figure 3.2-2C), while ε1 is different both in aa sequence and in length (Figure 3.2-2A). Although 
the aa sequence similarity of all three proteins to εspy and PezA is low (approximately 20 %), 
secondary structure prediction indicates the presence of three α-helices in all gonococcal epsilon 
homologs (Figure 3.2-2A/C), that might adopt the three-helix bundle fold described for the 
streptococcal antitoxins [62, 63]. 
 
 
 
Figure 3.2-2: Amino acid sequences of gonococcal epsilon/zeta systems. (A) Amino acid 
sequence of ε1. The protein was predicted to fold into three α-helices (blue bars). (B) Amino acid 
sequence of ζ1 excluding the 130 residues at the C-terminus. The identified Walker A motif is 
highlighted in red, the Walker A lysine (K115), which was mutated in this study, is marked with a 
diamond (). Predicted secondary structure elements are shown as green bars (α-helices) and 
pink arrows (β-strands). (C) Amino acid sequence alignment of ε2 and ε3. Residues are colored 
according to conservation (dark green: identity to yellow: low homology). The proteins were 
predicted to fold into three α-helices (blue bars). (D) Amino acid sequence alignment of ζ2, ζ3, ζspy 
and PezT. Secondary structure elements of ζspy are indicated above the alignment as olive bars (α-
helices) and red arrows (β-strands). The catalytically important Walker A (red) and DxD (purple) 
motifs and the UNAG binding region (gray) are conserved and the Walker A lysines (K46 in ζ2 and 
ζ3), which were mutated in this study, are marked with a diamond (). Note that the additional C-
terminal domains of ζ2 (residues 266 to 402) and ζ3 (residues 266 to 403) are excluded from this 
alignment and are shown in (E) together with the C-terminal domain of ζ1 (residues 271 to 401) to 
show the high degree of conservation in this region. 
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Further investigation of the sequences of the gonococcal zeta proteins indicated that - similar 
to EzeT – all three polypeptide chains are longer when compared to their streptococcal homologs, 
with 401 aa, 402 aa and 403 aa for ζ1, ζ2 and ζ3, respectively. In contrast, PezT consists of 253 aa 
and ζspy 287 aa. The approximately 140 additional residues are located at the C-terminal end of the 
three proteins and form a conserved putative domain with high mutual sequence identity (43 % to 
86 %, Figure 3.2-2E). The function of these C-terminal domains has not been investigated yet, but 
they show homology to the plasmid stable inheritance protein KfrB and the conjugal transfer 
protein TraB. 
 
Except for the additional C-terminal domain, ε2/ζ2 and ε3/ζ3 are highly similar to the 
streptococcal epsilon/zeta systems; in contrast, ε1/ζ1 differs much more in its primary and 
secondary structure. Research on the gonococcal epsilon/zeta homologs was, therefore, primarily 
focused on this module, aiming to confirm ε1/ζ1 as a bona fide epsilon/zeta system consisting of a 
UNAG kinase and an inhibiting antitoxin. This might help to answer the question why two 
epsilon/zeta homologs coexist on one plasmid. 
 
 ε1/ζ1 complex formation 3.2.2
In type II TA systems, inhibition is performed by protein-protein complex formation [18]. 
For the streptococcal epsilon/zeta systems, these complexes were shown to adopt a 
heterotetrameric epsilon2zeta2 arrangement [62, 70]. To analyze the oligomeric state of ε1/ζ1, the 
complex was purified by metal affinity chromatography, cation exchange chromatography and size 
exclusion chromatography, which yielded pure recombinant complex used in light scattering 
experiments.  
Dynamic light scattering experiments yielded an apparent molecular mass of 56.0 kDa for 
the complex (Figure 3.2-3A/B), while static light scattering indicated a mass of 43.4 kDa 
(Figure 3.2-3C). Both experiments indicate that ε1/ζ1 forms a heterodimer in solution given a 
theoretical molecular mass of 51.9 kDa. 
 
 UNAG kinase activity of ε1/ζ1 3.2.3
The purified complex containing wild-type ε1/ζ1 was subjected to an in vitro 
phosphorylation assay as described for EzeT (see section 3.1-3). The reaction mixture was 
separated by anion exchange chromatography after 3 h of incubation and monitored 
spectroscopically (Figure 3.2-3D). A species with a retention time corresponding to UNAG-3P and 
the typical uridine absorption ratio of 2.8:1 (absorption at 260 nm : absorption at 280 nm) was 
formed and 50 % of the substrate was turned-over after 3 h. Surprisingly, a significant amount of 
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ADP was produced. When integrating the area under the curves of the absorption at 260 nm for 
ADP and UNAG-3P and scaling those values by the extinction  coefficients of ADP (15,400 M-1 
cm-1) and UNAG-3P (10,100 M-1 cm-1), respectively, a 1.5 fold higher production of ADP when 
compared to UNAG-3P was observed. In contrast, UNAG-3P formation by PezT and EzeT 
involved equimolar amounts of UNAG and ATP.  
 
 
Figure 3.2-3: ε1/ζ1 forms a heterodimer in solution and phosphorylates UNAG. (A) Relative 
distribution of the hydrodynamic radius (Rh) of ε1/ζ1 as determined by dynamic light scattering. (B) 
shows the experimentally determined autocorrelation function (black) and the corresponding fit 
(red), which allowed to determine the molecular mass (MW) as 56.0 kDa with a relative standard 
deviation (RSD) of 17.5 % (C) Elution profile of purified ε1/ζ1 (black line) from a Superdex 200 size 
exclusion column. The molecular masses of the species in the peak have been determined by 
static light scattering (green dots). A slight tailing of the eluting peak suggests that the complex 
dissociates during size exclusion chromatography at the concentration used (final concentration in 
peak approximately 2 µM), pointing at a Kd in the micromolar range. (D) Separation of nucleotides/ 
nucleotide sugars by anion exchange chromatography after incubation of ε1/ζ1 with UNAG and 
ATP for 3 h. The ratio of the absorption at 260 nm and 280 nm helps to distinguish compounds 
containing adenine (ratio ~7:1) from compounds containing uridine (ratio ~2.8:1). 
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 Structure determination of the ε1/ζ1 complex 3.2.4
Despite the differences in amino acid sequence and predicted secondary structure of ζ1 when 
compared to the streptococcal zeta toxins, it could be shown that ε1/ζ1 is an active UNAG kinase 
encoded on a plasmid of the Gram-negative bacterium N. gonorrhoeae,. To gain insights into the 
structural characteristics that allow UNAG binding and the phosphoryl transfer reaction, the 
structure of the ε1/ζ1 complex was determined by X-ray crystallography. 
 
Crystallization of ε1/ζ1_K115A 
Purified ε1/ζ1_K115A complex was subjected to initial crystallization trials by Roman 
Sakson, revealing (NH4)2SO4 as a suitable precipitant for crystal formation. Initially, crystals grew 
as clusters of thin needles, but stacks of thin plates were obtained after proteolytic removal of the 
His6-tag of ε1. Further optimization of the crystallization conditions in order to slow down crystal 
growth yielded larger and more separated individuals (Figure 3.2-4). For data collection, crystals 
were grown in 1.8 M (NH4)2SO4 and 100 mM sodium citrate pH 4.5 using a protein concentration 
of 21.5 mg/ml. Individual plates were broken from the stacks and transferred to solutions 
containing cryoprotectants before flash-cooling in liquid nitrogen. Different substances with the 
ability to prevent ice crystal formation during flash-cooling were investigated for their influence on 
diffraction quality, but yielded comparable results. In several cases, multiple diffraction lattices 
were observed, most likely due to slightly different orientations of the crystal layers within one 
morphological unit. Moreover, crystals diffracted anisotropically and strong variations in 
diffraction quality were observed, which required harvesting and testing of multiple crystals for 
optimization. 
 
 
Figure 3.2-4: Crystals obtained for ε1/ζ1_K115A. (A) Crystals grew as clusters of large, thin 
plates in 1.8 M (NH4)2SO4 and 100 mM sodium citrate pH 4.5 after proteolytic removal of the His6-
tag of ε1. (B) shows a 2.5 fold magnification from (A). 
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Eventually, diffraction data for crystals of native ε1/ζ1_K115A were collected to a resolution 
of 2.6 Å at the X10SA beam line of the Swiss Light Source. The crystal symmetry belonged to 
space group P21 with unit cell dimensions a = 80.99 Å, b = 148.89 Å, c = 95.06 Å, α = 90 º, 
β = 98.32 º, γ = 90 º. The Matthews coefficient of 2.73 Å3/Da indicated 4 dimers per asymmetric 
unit with a solvent content of 54.9 % and molecular replacement with search models derived from 
PezAT or ε/ζspy was attempted. However, the obtained phase information was not sufficient to build 
an initial model and, instead, phases were determined experimentally using SAD of SeMet-labeled 
protein crystals. 
SeMet-labeled ε1/ζ1_K115A crystallized from the same conditions and in a similar plate-like 
morphology as native ε1/ζ1_K115A. Highly-redundant SAD diffraction data were collected to a 
resolution of 2.4 Å. To reduce the effects of radiation damage during the long exposure, the crystal 
was translated during data collection and diffraction images were collected in 4 wedges of 1800 
images each. Although the crystal symmetry belonged to the same space group, P21, the crystals of 
the SeMet-labeled protein were non-isomorphous to the native protein crystals with unit cell 
parameters a = 79.76 Å, b = 149.58 Å, c = 125.09 Å, α = 90 º, β = 94.82 º, γ = 90 º. The data 
collection and refinement statistics of ε1/ζ1_K115A are summarized in Table 3.2-1. 
 
Crystallization of wild-type ε1/ζ1 
In order to closer investigate the active site region of ε1/ζ1, wild-type protein was purified 
and crystallized in the apo-form and in the presence of nucleotides. 
Apo-wtε1/ζ1 crystallized from the same conditions as ε1/ζ1_K121A in a similar plate-like 
morphology and diffraction data were collected to a resolution of 2.9 Å. The crystal symmetry 
belonged to space group P21 with unit cell parameters similar to the crystals of SeMet-labeled 
ε1/ζ1_K115A with a = 79.72 Å, b = 150.72 Å, c = 124.59 Å, α = 90 º, β = 94.95 º, γ = 90 º. 
Nevertheless, the unit cell parameters, especially the monoclinic angle β, varied slightly between 
crystals even within the same crystal shape indicating some degree of flexibility in the protein or 
the molecular contacts formed within the crystal. 
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Table 3.2-1: X-ray data collection and refinement statistics of ε1/ζ1_K115A 
Crystal Native SeMet-labeled 
Space group P21 P21 
Cell parameters   
a, b, c [Å] 80.99, 148.89, 95.06 79.76, 149.58, 125.09 
α, β, γ [°] 90, 98.32, 90 90, 94.82, 90 
Resolution [Å]1 50.0-2.6 (2.7-2.6) 50.0-2.4 (2.8-2.4) 
Number of reflections, all1 469,491 (50,862) 3,128,956 (1,146,656) 
Number of reflections, unique1 133,525 (14,322) 224,611 (83,134) 
Completeness [%]1 98.8 (98.5) 99.7 (99.6) 
Redundancy1 3.5 (3.6) 13.9 (13.8) 
<I/σ(I)>1 13.27 (2.9) 11.8 (2.5) 
Rmeas1,2 8.3 (64.5) 21.5 (152.2) 
CC1/21,3 99.8 (82.9) 99.8 (92.6) 
Wilson B-factor [Å2] 51.26 51.77 
Phasing 
Selenium sites expected / observed - 32 / 45 
Correlation coefficient all / weak [%] - 44.85 / 27.20 
Rotational / Translational Z-score 9.75 / 22.87 - 
Log likelihood gain after final refinement 3169 - 
Refinement 
Resolution range in refinement [Å] 49.3 – 2.6 48.9 – 2.4 
Rwork/Rfree4 0.211 / 0.262 0.218 / 0.261 
Number of:   
Protein atoms 13986 (4 dimers) 13,973 (4 dimers) 
Water molecules 33 438 
Ions 20 SO42- 51 SO42- 
Other solvent molecules 3 glycerol - 
Average B-factor [Å2]:   
Protein atoms  53.6 51.7 
Water molecules 45.0 49.4 
Ions 65.5 74.8 
Other solvent molecules 48.7 - 
RMSD from target values:   
Bond lengths [Å] 0.010 0.011 
Bond angles [°] 1.352 1.249 
Ramachandran statistics:   
Preferred [%] 98.1 98.7 
Allowed [%] 1.9 1.3 
Outliers [%] 0.0 0.0 
Values in parentheses are for the highest resolution shell 
2R୫ୣୟୱ ൌ ∑ ඥ݊ ݊ െ 1⁄ ∑ หI୦୩୪,୨ െ 〈I୦୩୪〉ห௡௝ୀଵ୦୩୪ ∑ ∑ I୦୩୪,୨୨୦୩୪ൗ  where 〈I୦୩୪〉 is the average of symmetry related observations of a unique reflection. 
3CC1/2 gives the Pearson correlation coefficient of two ‘half’ data sets derived by averaging half of the observations for a given reflection. 
4R ൌ ∑ห|F୭| െ |Fୡ|ห ∑|F୭|⁄  where Rwork is calculated for the working set, while Rfree is calculated for the test set excluded from refinement. 
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To get closer insights into the nucleotide binding properties of ε1/ζ1 the crystallization 
solution was supplemented with 15 mM MgCl2 and different nucleotides to final concentrations of 
10 mM. UNAG, UNAG-3P and different adenine nucleotides, i.e. ADP, ATP, ATPγS and 
APPNHP, were used as well as the transition state analog aluminium fluoride together with ADP 
and UNAG. To prevent ligand dissociation during harvest, the cryoprotectant solution was 
similarly supplemented with the respective nucleotides and MgCl2. Crystals formed in all 
conditions, but data analysis revealed that either no nucleotide was present (UNAG, UNAG-3P, 
APPNHP) or the bound nucleotide was identified as ADP in cases where ADP was applied to the 
crystallization conditions or likely arose form hydrolysis of ATP or ATPγS. Similarly, apo-crystals 
that were incubated in nucleotide containing solution for five to 15 minutes did not take up the 
nucleotide or started to dissolve. 
Diffraction data of a crystal of wtε1/ζ1 bound to ADP were collected to a resolution of 2.9 Å. 
The crystal symmetry belonged to space group P21 with unit cell parameters of a = 79.94 Å, 
b = 149.82 Å, c = 124.21 Å, α = 90 º, β = 95.04 º, γ = 90 º. The data collection and refinement 
statistics of wtε1/ζ1 in the apo- and ADP-bound form are summarized in Table 3.2-2. 
 
De novo phasing of ε1/ζ1_K115A by single wavelength anomalous diffraction 
The anomalous signal measured from the SeMet-labeled ε1/ζ1_K115A allowed to determine 
initial phases by SAD. 45 selenium atoms were placed in the heavy atom substructure by 
SHELXD [100] with correlation coefficients of 44.85 % (all) and 27.20 % (weak), but the electro 
density obtained from SHELXE [100] did not allow model building. Instead, the heavy atom 
substructure was used for SAD phasing in Phaser [102] followed by density modification in 
Parrot [103] and DM [104] to obtain an interpretable electron density map. 
Four ε1/ζ1 dimers were identified in the asymmetric unit with a Matthews coefficient of 
3.58 Å3/Da and an estimated solvent content of 65.6 %. The model was built manually and 
improved by refinement with torsion-angle non-crystallographic symmetry restraints [111] in 
phenix.refine [110]. 
A continuous polypeptide chain spanning almost the entire molecule could be modeled for 
all eight proteins, comprising residues 5 to 61 (of 61) for the longest ε1 chain and residues 1 to 396 
(of 401) for the longest ζ1 chain. In addition, water molecules and sulfate ions were placed into the 
electron density, considering the signal intensity, coordination distances and charge interactions. In 
particular, well-defined electron density suggested the presence of a sulfate atom bound to the 
backbone amides of residues in the P-loop. The refinement converged at a free R-factor of 26.1 % 
and a Rwork of 21.8 %. 
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Table 3.2-2: X-ray data collection and refinement statistics for wtε1/ζ1, wtε1/ζ1+ADP 
Crystal Apo-wtε1/ζ1 wtε1/ζ1+ADP 
Space group P21 P21 
Cell parameters   
a, b, c [Å] 79.72, 150.72, 124.59 79.94, 149.82, 124.21  
α, β, γ [°] 90, 94.95, 90 90, 95.04, 90 
Resolution [Å]1 50.0-2.9 (3.0-2.9) 50.0-2.9 (3.0-2.9) 
Number of reflections, all1 445,976 (44,363) 444,481 (44,059) 
Number of reflections, unique1 64,694 (6,207) 64,331 (6,202) 
Completeness [%]1 99.6 (99.5) 99.6 (99.6) 
Redundancy1 6.9 (7.1) 6.9 (7.1) 
<I/σ(I)>1 14.36 (2.71) 12.74 (2.70) 
Rmeas1,2 11.4 (93.3) 15.0 (91.1) 
CC1/21,3 99.8 (84.1) 99.7 (84.6) 
Wilson B-factor [Å2] 53.98 45.41 
Refinement 
Resolution range in refinement [Å] 49.0 – 2.9 48.3 – 2.9 
Rwork/Rfree4 0.201 / 0.246 0.217 / 0.260 
Number of:   
Protein atoms 14,087 (4 dimers) 13,958 (4 dimers) 
Water molecules 53 51 
Ions 54 SO42- 39 SO42- / 4 Mg2+ 
Ligands  4 ADP 
Average B-factor [Å2]:   
Protein atoms  54.2 49.9 
Water molecules 45.1 40.9 
Ions 78.6 78.2 / 36.0 
Ligands  50.62 
RMSD from target values:   
Bond lengths [Å] 0.011 0.011 
Bond angles [°] 1.347 1.360 
Ramachandran statistics:   
Preferred [%] 98.8 99.0 
Allowed [%] 1.2 1.0 
Outliers [%] 0.0 0.0 
1Values in parentheses are for the highest resolution shell 
2R୫ୣୟୱ ൌ ∑ ඥ݊ ݊ െ 1⁄ ∑ หI୦୩୪,୨ െ 〈I୦୩୪〉ห௡௝ୀଵ୦୩୪ ∑ ∑ I୦୩୪,୨୨୦୩୪ൗ  where 〈I୦୩୪〉 is the average of symmetry related observations of a unique reflection. 
3CC1/2 gives the Pearson correlation coefficient of two ‘half’ data sets derived by averaging half of the observations for a given reflection. 
4R ൌ ∑ห|F୭| െ |Fୡ|ห ∑|F୭|⁄  where Rwork is calculated for the working set, while Rfree is calculated for the test set excluded from refinement. 
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Phasing of apo- or nucleotide-bound wtε1/ζ1 
The model obtained for SeMet-labeled ε1/ζ1_K115A, excluding water molecules and ions, 
was used for phasing of the diffraction data of the isomorphous wtε1/ζ1 crystals. Initial phases 
were obtained using a rigid body refinement protocol [106] and the models were subsequently 
improved by iterative cycles of manual model building and refinement till convergence was 
reached (see refinement statistics in Table 3.2-1). 
The final models were very similar to the structure obtained for SeMet-labeled 
ε1/ζ1_K115A, but as expected from the mutation at residue 115, which restored the Walker A 
lysine of the wild-type sequence, additional electron density was observed at this position that 
allowed to unambiguously model the lysine side chain. 
In the electron density of the nucleotide-bound structure, additional density in the vicinity of 
the P-loop of this structure allowed to unambiguously model a magnesium ion and ADP into each 
heterodimer. The B-factor for ADP was refined to 51 Å2, which is comparable to the overall B-
factor for the protein atoms (50 Å2), indicating full occupancy of the nucleotide. The water 
molecules coordinating the magnesium ion were not sufficiently defined in the electron density to 
be included in the model, which resulted in a relatively low B-factor of the magnesium ion (36 Å2). 
In the UNAG binding pocket, residual density was observed, but could not be interpreted 
unambiguously. 
In contrast to the other models, a loop region in the C-terminal region of ζ1 (residues 381 
and 386) could not be build, due to a lack of well-defined electron density, indicating a high degree 
of flexibility of this loop. 
 
Phasing of native ε1/ζ1_K115A by molecular replacement 
As described above, native ε1/ζ1_K115A crystallized with unit cell parameters that differed 
from those of the other collected data sets. Therefore, phase extension was not possible. Instead, 
initial phases were obtained by molecular replacement using one heterodimer (chains G and H, 
without water molecules or ions) of the SeMet-labeled ε1/ζ1_K115A model as a search structure. 
As indicated by a Matthews coefficient of 2.73 Å3/Da and the estimated solvent content of 54.9 %, 
Phaser_for_MR [102] placed four heterodimers into the asymmetric unit (see Table 3.2-1 for 
phasing and refinement parameters). 
Inspection of the electron density revealed a different packing of those four dimers when 
compared to the non-isomorphous structures. In addition, a different positioning of the C-terminal 
region of ζ1 in two of the four dimers required manual rigid body placement of the altered region 
into the observed electron density. The initial model was then further optimized and refined till 
convergence was reached at a final Rfree of 26.2 % and a Rwork of 21.1 %. All models showed 
excellent stereochemistry as indicated by the Ramachandran statistics and by analysis with the 
MolProbity server [113]. 
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 Structure of the ε1/ζ1 complex 3.2.5
An analysis of the molecular contacts formed between the ε1/ζ1 heterodimers in the non-
isomorphous unit cells revealed that these contacts were relatively weak. They comprised a 
maximum of 2.3 % of the surface area of the heterodimer, corresponding to a solvation free energy 
gain of 5 kcal/mol, and involved a limited number of hydrogen bonding interactions or salt bridges 
as determined using the PISA server [128]. In addition, in each of the asymmetric units of the two 
non-isomorphous crystals slightly different relative dimer orientations were observed. This 
indicated that no higher-order oligomers were formed within the crystals, which was already 
suggested by light scattering experiments in solution. 
 
 
Figure 3.2-5: Crystal structure of the ε1/ζ1 heterodimer. (A) ε1/ζ1 heterodimer in ribbon 
representation. ε1 is colored green and yellow, ζ1 red, blue and gray. The N-terminal UNAG kinase 
domain is shown on the left, the C-terminal domain on the right. (B) Superposition of two ζ1 
conformations (chain F (teal) and chain H (orange)) observed in one unit cell of native 
ε1/ζ1_K115A crystals shows the movement of the C-terminal domain of ζ1 relative to the UNAG 
kinase domain. 
 
Structural flexibility of ε1/ζ1 
Each heterodimer consisted of one epsilon antitoxin bound to one zeta toxin (Figure 3.2-5A). All 
four heterodimers in the structure of SeMet-labeled ε1/ζ1_K115A were very similar with RMSD 
values around 0.2 Å for the Cα-atoms of residues 2 to 395 of ζ1_K115A and between 0.3 Å and 
0.5 Å for the Cα-atoms of residues 7 to 59 of ε1. In contrast, in the more tightly packed crystals of 
native ε1/ζ1_K115A differences between the individual ζ1_K115A polypeptide chains were 
observed. While the zeta toxins in chain B and H and chain D and F showed RMSD values for the 
Cα-atoms of 0.44 Å and 0.48 Å, respectively, superposition of chains between these two groups 
yielded RMSD values for the Cα-atoms around 1 Å. These differences were largely due to a 
movement of the C-terminal part of the protein (residues 272 to 401) relative to the remaining part 
of the dimer. From superposition of these chains it became evident that a hinge located at 
methionine 271 allowed for different relative orientations of the N- and C-terminal regions by an 
angle of at least 3 º (Figure 3.2-5B). 
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The hinge separates the two regions of ζ1 that have been suggested by sequence analysis to form an 
N-terminal UNAG kinase and a conserved C-terminal region that is present in all gonococcal zeta 
homologs. 
 
The additional C-terminal domain of ζ1 contains an OB-fold 
The C-terminal part of the ζ1 polypeptide chain folds into an independent, compact domain. It 
consists of a five-stranded Greek-key β-barrel capped by a short α-helix, resembling the so called 
oligonucleotide/oligosaccharide binding fold (OB-fold) [151], and contains an additional small, 
four-stranded, antiparallel β-sheet and an α-helix (Figure 3.2-6A). The β-barrel has an open, 
distorted conformation, similar to the one found in the OB-fold of the RNA-binding S1 domain of 
E. coli polynucleotide phosphorylase [152].  
 
 
Figure 3.2-6: The C-terminal domain of ζ1 contains an OB-fold. (A) Ribbon representation of 
the C-terminal domain of ζ1 (residues 272-401). The domain consists of a small, four-stranded, 
antiparallel β-sheet (right), a helix (middle back/top) and a so called OB-fold (right). (B) The OB-fold 
of ζ1 (residues 322-401) consists of a five-stranded, antiparallel β-barrel with a short α-helical turn 
(α34) inserted in the loop between β-strand 3 and β-strand 4. (C) Superposition of the C-terminal 
domain of ζ1 (teal, depicted as in (A)) with the C-terminal domain of Bep1 (orange, residues 230-
312, PDB ID 4NPS). 
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In a DALI search [124] for structurally similar domains in the PDB database [125], several DNA 
binding proteins were identified. Highest homology was found to the human γ-interferon-inducible 
protein 16 (PDB ID 3RNU) and the related inflammasome inducer AIM2 (PDB ID 3RN5), the 
homologous recombination proteins RecO (PBD ID 1U5K) and RecR (PDB ID 4JCV) from 
Deinococcus radiodurans and a number of other DNA and RNA binding proteins. It seems thus 
likely, that the C-terminal domain of the gonococcal zeta homologs is involved in the binding of 
polynucleotides. 
Notably, Bep1, a VirB-translocated effector protein from Bartonella clarridgeiae (PDB ID 4NPS) 
contains a similar OB-fold, of which 71 amino acids were superimposed on the OB-fold of ζ1 with 
a RMSD value for the Cα-atoms of 2.9 Å (Figure 3.2-6B). 
 
The UNAG kinase domain has a zeta-like fold but a different topology 
The N-terminal part of ζ1 folds into a separate domain that is structurally similar to the 
streptococcal zeta toxins (Figure 3.2-7A), which is reflected in a RMSD value for the Cα-atoms of 
2.6 Å (PezT) and 3.7 Å (ζspy) obtained by SSM superposition [127] in Coot [107]. Like these 
proteins, ζ1 consists of a central β-sheet surrounded by α-helices [62, 63]. The β-sheet is composed 
of five, parallel β-strands complemented by a short, antiparallel β-strand. The α-helices are 
arranged on both sides of the β-sheet to form a shallow ATP-binding cleft on one side and a cleft 
for binding a second substrate, most likely UNAG, on the opposite side of the sheet. 
 
Interestingly, aa sequence analysis of ζ1 (see section 3.2.1) revealed, that the Walker A motif is 
located further towards the C-terminus than in the streptococcal zeta toxins and the DxD and 
UNAG binding motives could not be predicted from aa sequence alignment. Nevertheless, the 
architecture of the catalytic center is conserved between ζspy and ζ1 (Figure 3.2-7B). 
Superposition of the structures of ζspy and ζ1 showed that this is due to a different order of 
secondary structure elements in the polypeptide chain; β-strand 2 of ζspy is structurally equivalent to 
β-strand 1 of ζ1 and β-strand 1 of ζspy is homologous to β-strand 2 of ζ1. To adopt the same overall 
fold, the loops connecting the β-strands in the N-terminal part of the protein are differently 
arranged, changing a 2-3-1-4-5-6 topology (ζspy) in the β-sheet to a 1-3-2-4-5-6 arrangement (ζ1). 
The corresponding change in the aa sequence results in both cases in a location of the Walker A 
motif after the third β-strand of the β-sheet (strand 1 or 2, respectively) and the magnesium 
coordinating aspartate after the first β-strand of the β-sheet (strand 2 or 1). Such a reversed order of 
catalytic residues, placing the DxD motif N-terminal to the Walker A motif, is unusual for P-loop 
kinases [153]. 
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Figure 3.2-7: The UNAG kinase domain of ζ1. (A) Superposition of the UNAG kinase domain of 
ζ1 (blue, red, light green) with ζspy (gray). All secondary structure elements surrounding the active 
site (center) possess close structural equivalents. (B) Close-up of the active site. The P-loop is 
highlighted in violet (ζ1) or purple (ζspy) and the Walker A lysine and the second aspartate of the 
DxD motif are shown as stick models. Despite the different location in the polypeptide chain, all 
active site components are located at similar positions in the three-dimensional structure. 
 
 
Substrate binding by ζ1 
Crystallization attempts with the ε1/ζ1 complex and different nucleotides were performed to 
gain insights into the influence of the structural rearrangements on substrate binding and the 
phosphoryl transfer reaction. Of these trials, co-crystallization with ADP and MgCl2 was successful 
and a well-defined electron density in the putative ATP binding pocket of ζ1 allowed to model an 
ADP nucleotide and a magnesium ion into the structure of wtε1/ζ1. 
In this ADP-bound structure, the β-phosphate of ADP replaced the sulfate ion bound to the 
P-loop in the apo-structures, as observed for other kinases [154]. This, together with the relatively 
low B-factor and the well-defined electron density, indicates correct placement of the nucleotide 
into the ATP-binding pocket. 
This nucleotide bound structure allowed to assign the ATP-binding residues in ζ1, which are 
reminiscent to the residues in other P-loop kinases [64, 153]. Except for the Walker A motif or P-
loop, which has been identified in ζ1 by sequence comparison, these motifs include a degenerate 
Walker B motif, with glutamate 133 coordinating the magnesium ion likely via a water molecule 
that could not be resolved in the electron density, and a degenerate DxD motif, with aspartate 56 
located after the first strand in the β-sheet. To initiate the phosphoryl transfer reaction, this 
aspartate probably deprotonates a hydroxyl group of the phosphate acceptor to facilitate a 
nucleophilic attack on the γ-phosphate of ATP [155]. 
Similar to other P-loop kinases [64, 153], interactions of the phosphate groups of ADP are 
mainly established by residues in the P-loop, including threonine 116, and serine 117, arginine 175 
of a putative lid module (see below) and the magnesium ion (Figure 3.2-8A). The ε-amino group of 
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the Walker A lysine is positioned approximately 4.3 Å from the β-phosphate and might thus 
interact with the transferred γ-phosphate group of ATP [64]. 
Arginine 175 protrudes into the catalytic center from an α-helix inserted between β-strand 4 
and β-strand 5 (Figure 3.2-8A). This residue and the entire α-helix are reminiscent of the so called 
lid module [153]. This lid helix is proposed to move during the phosphoryl transfer reaction to 
allow the arginine residue to stabilize the transition state [153, 156]. The 2’-hydroxy group of the 
ribose is in hydrogen bonding distance to lysine 174, which is also part of the lid helix, but further 
contacts of the ribose or the adenine base to ζ1 were not observed.  
 
 
Figure 3.2-8: Substrate binding by ζ1. (A) ATP-binding pocket of ζ1 (transparent surface 
representation with ribbon representation underneath) with bound ADP (stick model) and a 
magnesium ion (sphere). Residues of ζ1 that are in hydrogen bonding distance to ADP are shown 
as stick model. (B) UNAG (sticks) has been modeled into the UNAG binding pocket of ζ1 by 
superposition with the ε/ζspy structure in complex with UNAG (PDB ID 3Q8X). ATP enters the active 
site through the tunnel in the top center. Residues that might form interactions with the substrate 
are shown as sticks. 
 
To gain insights into how UNAG-binding is performed by ζ1, the ε1/ζ1 model was 
superimposed to the ε/ζspy structure in complex with UNAG (Figure 3.2-8B, PDB ID 3Q8X). The 
most pronounced difference in the two structures is the width of the UNAG binding cleft, which is 
significantly narrower in ζ1 when compared to ζspy, introducing a number of clashes between 
UNAG and ζ1 in this superposition. In addition, the distance between the β-phosphate of ADP and 
the 3’-hydroxyl group of the modeled UNAG is approximately 8 Å. Even when the two phosphate-
oxygen bond to the γ-phosphate of approximately 1.6 Å [157] are fully extended, this leaves a 
distance of 5 Å, which is too far for a nucleophilic attack to take place. Both observations might be 
due to a more open conformation of ζspy, which is probably induced by binding to the antitoxin εspy. 
It can be speculated that in the absence of the antitoxin and upon binding of ATP a conformational 
change takes places in ζspy, such that the two substrates approach each other at the catalytic center. 
This ‘closed’ structure might resemble the tighter active site observed in ζ1. 
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Nevertheless, residues that line the UNAG binding pocket and are likely to interact with the 
substrate can be identified. These residues include aspartate 56 and histidine 79, which are in 
hydrogen bonding distance to the 3’- and 5’-hydroxy groups, respectively. 
At the position of the glycine (Gly 118 in ζspy) of the previously identified GTXR UNAG 
binding motif [66], a conserved glycine (Gly 134) can be found. However, the consecutive 
threonine involved in phosphate binding is exchanged for a glutamine (Gln 135). The arginine 
within the same motif seems to be conserved in ζ1, although the side chain (Arg 138) adopts a 
different conformation. However, it might re-orientate towards the phosphate groups once UNAG 
is bound (Figure 3.2-8B). Interestingly, insertion of an additional amino acid between the 
glutamine and the arginine changes the GTXR motif in conventional zeta toxins to a GQXXR 
motif in ζ1. 
The most noticeable residue that might interact with the uracil base is phenylalanine 132, 
which might form a pi-stacking interaction. In addition, serine 87 and lysine 145 might form 
hydrogen bonding interactions with the uridine. 
In conclusion, although many of the residues in the UNAG binding pocket are not identical, 
homologous residues are exposed to form interactions with UNAG and position the nucleotide for 
phosphoryl transfer. 
 
ε1 binds in an elongated conformation 
ε1 was predicted to fold into three α-helices and indeed an α-helical structure is observed for 
ε1 in the crystal structure (Figure 3.2-9A). However, instead of forming a three-helix bundle like 
the streptococcal epsilon antitoxins [62, 63], ε1 consists of three α-helices that lie extended across 
the surface of ζ1. Due to this wrapping a relatively large contact area of 1730 Å2 is established as 
determined by the PISA server [128], indicating stable heterodimer formation. The binding 
interface is mainly established by hydrogen bonds and salt bridges, which is reflected by the 
complementary electrostatic surface potentials (Figure 3.2-9B), similar as it has been described for 
the PezAT complex [72]. 
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Figure 3.2-9: Binding of ε1 to ζ1. (A) ε1 forms three α-helices (dark green), which are stretched 
out over the surface of ζ1 (opaque, revealing the underlying secondary structure elements). The 
middle α-helix of ε1 lies on top of the active site (center). (B) Open book representation of the 
heterodimer interface of ε1/ζ1. The electrostatic surface potential is mapped on the surface of ε1 
(left) and ζ1 (right) and is contoured from + 2 kT/e (blue) to – 2 kT/e (red). 
 
The ε1/ζ1 complex binds ADP 
In the streptococcal epsilon/zeta complexes ε/ζspy and PezAT, binding of ATP is sterically 
blocked by residues of the antitoxin [62, 63]. In contrast, binding of ADP to the ε1/ζ1 complex was 
observed by X-ray crystallography. 
In the elongated conformation, the second helix of ε1 resides on top of the ATP-binding site 
of the kinase, similar to the position of the N-terminal helix of PezA/εspy in the complex with their 
cognate zeta toxins [62, 63]. However, the angle of this helix with respect to the zeta core is 
different and as a result the side chains of residues within this helix do not penetrate deeply into the 
ATP binding site. Instead, glutamate 36 and tyrosine 40 of ε1 are in hydrogen bonding distance to 
the 2’- and 3’-hydroxy groups of the ribose, respectively, and the methionine is in close proximity 
of the adenine base (Figure 3.2-10A). 
When comparing the apo-ε1/ζ1 structure with the ADP-bound structure, most differences 
that are observed are changes in side chain conformations of residues that interact with the 
nucleotide (Figure 3.2-10B). Movements of the main chain atoms are only minor, indicating that 
binding of ε1 to ζ1 does not interfere with binding of the adenine nucleotide. Nevertheless, no 
crystals of ε1/ζ1 bound to ATP or a non-hydrolyzable ATP analog were obtained, suggesting that 
some differences between ADP and ATP binding might exist. 
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Figure 3.2-10: Interactions of ε1 with ADP. (A) ADP bound to ε1/ζ1 is shown as stick model in 
the ATP binding cleft of ζ1 (transparent surface representation with ribbon representation 
underneath), which is covered by the middle α-helix of ε1 (green). Glutamate 36 and tyrosine 40 
are in hydrogen bonding distance to the hydroxy groups of the ribose, while methionine 25 is in 
close proximity of the adenine base. (B) Superposition of the ATP binding cleft of models obtained 
with (ε1: green, ζ1: light blue) and without (ε1: purple, ζ1: gray) bound ADP. ADP and side chains 
of ε1 that are altered upon nucleotide binding are shown as stick model. While conformational 
changes in the side chains are observed, no larger movements of the main chain are visible. 
 
 Wild-type ζ1 can be separated from its antitoxin 3.2.6
The observed difference in inhibition by ε1 compared to the streptococcal epsilon antitoxins 
raised further questions regarding the inhibition of ζ1 by ε1. In particular, inhibition by ε1 had to be 
proven experimentally and the mechanism of inhibition had to be clarified. 
Therefore, experiments were performed to determine the inhibition by ε1 by the practical 
student Annika Grimmer during an internship. To obtain quantitative data, Michaelis-Menten 
parameters were determined for ζ1 alone and in the presence of different concentrations of ε1. 
However, cloning of wild-type ζ1 (wtζ1) alone was not successful, most likely because of leakiness 
from the promoter that led to the formation of minor amounts of ζ1 and the formation of a toxic 
enzymatic reaction product. However, cloning, overexpression and purification of the ε1/ζ1 
complex was possible and it was recognized that the heterodimer can be disrupted by varying the 
sodium chloride concentration. This was used to separate wtζ1 from ε1 in order to perform in vitro 
studies. 
 
ε1/ζ1 complex obtained after nickel affinity chromatography was loaded on a cation 
exchange column and eluted by linearly increasing the salt concentration in the buffer. Dependent 
on the buffer conductivity the stoichiometry of eluted ε1 and ζ1 changed from a majority of ζ1 
which eluted at lowest salt concentration, to equimolar and free ε1 at higher conductivity 
(Figure 3.2-11A). Fractions containing mainly free wtζ1 were loaded again on a nickel affinity 
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column to remove remaining His6-tagged ε1 and the ε1/ζ1 complex. Free wtζ1 was obtained in the 
flow-through and after washing with a buffer containing 1 M NaCl. Protein purity was verified by 
SDS-PAGE and Western Blotting to exclude impurities due to residual His6-tagged ε1 
(Figure 3.2-11B/C). 
 
 
Figure 3.2-11: Isolation of free wild-type ζ1. (A) 17 % (w/v) SDS-PAGE gel of the separation of 
ε1 and ζ1 on a cation exchange column. When increasing the salt concentration, ζ1 elutes first, 
before the ε1/ζ1 complex and free ε1. Fractions containing mainly ζ1 were further purified yielding 
free wild-type ζ1 as determined by Coomassie staining (B) and a Western Blot against the His6-tag 
of ε1 (C). Data in this Figure have been contributed by Annika Grimmer. 
 
 Enzymatic activity of ζ1 3.2.7
The enzymatic activity of free wtζ1 was measured using the in vitro phosphorylation assay 
described for EzeT and a coupled ATPase assay to determine the enzymatic activity.  
For the in vitro phosphorylation assay 1 µM wtζ1 was incubated together with ATP and 
UNAG for 30 min (Figure 3.2-12A). Analysis of this reaction revealed 76 % turn-over of UNAG, 
compared to a 50 % turn-over at a three times higher concentration of wtε1/ζ1 after 3 h, hinting at 
an inhibition of the enzymatic activity by ε1. 
As observed for the ε1/ζ1 complex, a 1.8 fold excess of ADP over UNAG-3P was produced. 
What caused this non-stoichiometric relationship is unclear; especially as in the coupled ATPase 
assay no significant basal ATPase activity was detected. Therefore, ATP hydrolysis by ζ1 seems to 
be stimulated by UNAG or modified UNAG. 
In the coupled ATPase assay used [95], the ATP hydrolysis of an ATPase of interest is 
coupled to the oxidation of NADH, which can be followed spectroscopically. Steady state reaction 
velocities were determined at different concentrations of UNAG and ATP (Figure 3.2-12B/C). 
0.2 µM wtζ1 were titrated with UNAG (0.05 mM to 10 mM) or ATP (0 mM to 10 mM) while 
keeping the other substrate constant (10 mM ATP or 10 mM UNAG). These data were plotted 
according to Michaelis and Menten [158] to calculate the apparent maximal velocity (vmax) and the 
apparent Michaelis-Menten constant (Km) of wtζ1. 
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By varying the ATP concentration, a vmax of 0.2±0.005 mM/min and a Km(ATP) of 
0.2±0.03 mM was obtained at an enzyme concentration normalized to 1 μM (Figure 3.2-12D). The 
corresponding turn-over number at maximal reaction velocity is kcat=3.3 s-1. 
Varying the UNAG concentrations yielded a vmax of 0.2±0.01 mM/min and a Km(UNAG) of 
1.7±0.2 mM. In the Michaelis-Menten plot, vmax could not be reached, as UNAG concentrations 
above 10 mM caused a decrease in reaction rates. This is probably caused either by an inhibition of 
the enzymatic activity of ζ1 or the coupling enzymes by UNAG or other contaminants in the 
UNAG stock solution, or by chelation of metal ions by UNAG. Nevertheless, an excellent 
agreement of vmax determined by both titration experiments indicated that the Michaelis-Menten 
constants can be determined using UNAG concentrations up to 10 mM. 
 
 
Figure 3.2-12: Enzymatic activity of wtζ1. (A) In vitro phosphorylation assay of wtζ1 showing the 
synthesis of non-stoichiometric amounts of ADP and UNAG-3P. 76 % of UNAG were modified after 
30 min incubation. (B, C) Michaelis-Menten plots showing the initial reaction velocities determined 
at different ATP (B) or UNAG (C) concentrations. The experimental reaction rates were normalized 
to an enzyme concentration of 1 µM prior to plotting. The corresponding fits of the Michaelis-
Menten equation (black line) were used to calculate the kinetic parameters given in (D). Data in this 
Figure have been contributed by Annika Grimmer. 
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 Inhibition by ε1 3.2.8
Using the coupled ATPase assay, the inhibition of ζ1 by the putative antitoxin ε1 was 
determined. Therefore, wtζ1 was pre-incubated with different amounts of ε1 and the reaction 
velocities at different UNAG concentrations were measured to calculate apparent vmax and Km 
values for each concentration of ε1 (Figure 3.2-13A). Measurements were performed in the 
presence of an equimolar amount of ε1 (0.2 µM) or with 0.1 µM ε1 (half of the ζ1 concentration). 
In these experiments the apparent Km for UNAG nearly doubled and the vmax decreased by 
approximately one third (Figure 3.2-13B) showing that ε1 acts as an inhibitor of the UNAG kinase 
activity. Nevertheless, UNAG phosphorylation was clearly detectable with stoichiometric amounts 
of ε1 and ζ1, indicating that either ζ1 retains some activity in complex with ε1, or that the affinities 
of the two proteins are low such that at the concentrations used in the assay the ε1/ζ1 complex 
partially dissociates. 
 
 
Figure 3.2-13: Inhibition of ζ1 by ε1. (A) Michaelis-Menten plots showing the initial reaction 
velocities at different UNAG concentrations in the presence of 0 µM (blue), 0.5 µM (purple) and 
1 µM (red) ε1. The experimental reaction rates were normalized to an enzyme concentration of 
1 µM prior to plotting. The corresponding fits (colored lines) were used to calculate the kinetic 
parameters given in (B). 
 
 
 Nucleotide binding to ε1/ζ1 3.2.9
As inhibition by ε1 could be shown, further experiments were performed to gain insights into 
how this inhibition is achieved. Therefore, binding constants for ADP and ATP to ε1/ζ1 were 
determined spectroscopically.  
Equilibrium binding measurements were performed by measuring the intrinsic tryptophan 
fluorescence of a constant amount of ε1/ζ1 or free ζ1 complex, while titrating increasing amounts 
of nucleotide. However, no signal change was observed when using ζ1, indicating that the local 
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environment of the single tryptophan of ζ1, Trp305 in the C-terminal domain, is not affected by 
nucleotide binding.  
In the ε1/ζ1 complex, ε1 provides a second tryptophan, Trp54 located in the third helix, and 
the fluorescence change upon nucleotide titration to ε1/ζ1 allowed to determine binding constants 
of Kd(ADP)=3.5±0.8 μM and Kd(ATP)=7.2±1.9 μM (Figure 3.2-14A/B). 
 
In a second approach, the fluorescence of a constant amount of mant-labeled nucleotide was 
followed upon protein titration (Figure 3.2-14C). For ε1/ζ1, a Kd(mant-ADP)=6.9±0.6 μM could be 
determined, which corresponds well to a Kd(mant-ADP)=5.4±0.3 μM obtained by measuring fast 
kinetics with the stopped-flow technique (Figure 3.2-14D/E). Correspondingly, the association (kon) 
and dissociation (koff) rate constants of mant-ADP were determined as kon=0.00292±0.00001 M-1 s-1 
and koff=0.01572±.0.00003 s-1. 
The ε1/ζ1-mant-ADP complex was titrated with an excess of ADP to determine the binding 
constant of ADP, giving a Kd(ADP)=0.15±0.03 μM (Figure 3.2-14F). This value clearly deviates 
from the Kd determined by intrinsic tryptophan fluorescence, but without further information it 
cannot be decided, which binding constant is more appropriate. 
No suitable signal change was observed using a non-hydrolyzable ATP-analog (mant-
APPNHP) in titrations of the ε1/ζ1 complex. In addition, titration of free ζ1 into mant-ADP yielded 
only very weak signals that did not allow the reliable determination of a binding constant. It can be 
concluded that ε1 seems to be required to cause a sufficiently strong shift in the mant-environment 
upon nucleotide binding. This is probably caused by the hydrogen bonding interactions of 
glutamate 36 and tyrosine 40 of ε1 to the 2’- and 3’-hydroxy groups of the ribose, to which the 
mant-group is attached. 
Using fluorescence anisotropy as an alternative technique to observe protein-nucleotide 
complex formation with mant-ADP and mant-APPNHP similar results as for the fluorescence 
intensity measurements were obtained. No signal was observed for ζ1, while the increase in mant-
fluorescence for ε1/ζ1-mant-ADP complex formation was associated with a change in anisotropy. 
Moreover, fluorescence anisotropy measurements with the more rigid etheno-ADP yielded low, 
not-interpretable signal amplitudes. 
 
In conclusion, it was not possible to compare the nucleotide binding affinities of ε1/ζ1 to 
affinities of free ζ1 as none of the performed experiments allowed for the determination of binding 
rates or constants of ζ1 on its own. Binding constants of ATP and ADP to ε1/ζ1 as determined by 
tryptophan fluorescence titration were comparable, indicating that both nucleotides bind equally 
well to the ε1/ζ1 complex. 
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Figure 3.2-14: Nucleotide binding kinetics to ε1/ζ1. (A/B) Intrinsic tryptophan fluorescence of 
ε1/ζ1 was measured upon titration of ADP (A) or ATP (B). The data points were fitted with a 
quadratic equation (black line) to obtain the stated binding constants. (C) Fluorescence 
measurements of the mant-group attached to ADP upon titration of ε1/ζ1. The data points were 
fitted with a quadratic equation (black line) to obtain the stated binding constant. (D) Kinetic traces 
of direct mixing experiments using mant-ADP and different concentrations of ε1/ζ1. Fits to the 
exponential function are shown as colored lines, the resulting rate constants have been plotted 
against the protein concentration in (E). Linear regression analysis gave the stated binding 
constants. (F) Chase experiment of the mant-ADP-ε1/ζ1 complex from (C) with increasing ADP 
concentrations. The data points were fitted with a cubic equation (black line) to obtain the stated 
binding constant. 
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 ε2/ζ2 and ε3/ζ3 phosphorylate UNAG in vitro 3.2.10
After characterizing ε1/ζ1 and finding a functional zeta toxin and an inhibiting epsilon 
antitoxin, the other two putative epsilon/zeta systems were also characterized to determine their 
UNAG kinase activity and possible interactions with ε1/ζ1. 
 
To test whether all three putative zeta toxins have indeed UNAG kinase activity, in vitro 
phosphorylation assays were performed. Therefore, active zeta variants had to be expressed and 
purified. Unlike for ζ1, complex separation was not feasible, instead, the zeta homologs were 
expressed and purified together with their cognate epsilon proteins. 
The purified ε1/ζ1, ε2/ζ2 and ε3/ζ3 complexes were subjected to an in vitro chromatographic 
UNAG kinase assay as described for EzeT (see section 3.1.3). For all three epsilon/zeta systems the 
formation of a novel species from UNAG was observed (Figure 3.2-15). These species eluted at 
higher conductivity than UNAG, indicating a higher surface charge of the molecule, and showed a 
typical uridine absorption ratio of the values at 260 nm and 280 nm of 2.8:1. The modification of 
UNAG introduced by ζ2 and ζ3 is most likely the attachment of a negatively charged phosphoryl 
group, as is indicated by the hydrolysis of ATP and the conservation of aa sequence motifs typical 
for P-loop kinases. 
 
 
Figure 3.2-15: In vitro UNAG kinase assay. Separation of the phosphorylation assays of ε2/ζ2 
((A), red) and ε3/ζ3 ((B), blue) after 3 h of incubation with ATP and UNAG. The separation of 
purified UNAG-3P (gray) is shown for comparison. Formation of ADP and one or two additional 
species (*) with a retention volume similar to that of UNAG-3P is observed.  
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UNAG-3P, the product of UNAG phosphorylation by PezT, was used as a standard and 
elutes at an ionic strength of 49.7 mS. While the reaction product of ε1/ζ1 elutes at a ionic strength 
that corresponds well to UNAG-3P, slight differences in the retention volume and the 
corresponding conductivity were observed for the reaction products of ε2/ζ2 and ε3/ζ3 
(Table 3.2-3), pointing at potential differences in the surface charges of the reaction products. Most 
surprisingly, ε2/ζ2 synthesized two reaction products with nearly identical retention volumes. 
Using mass spectrometry the identity of the individual compounds could not be determined 
unambiguously. Whether the differences indicate a different site of phosphorylation or some 
additional modification and their functional implications are not known.  
 
Table 3.2-3: Products of the gonococcal zeta toxins 
 ε1/ζ1 ε2/ζ2 ε3/ζ3 UNAG-3P 
Peak position (mS) 50.0 48.9 / 50.0 50.7 49.7 
Turn-over (%) 7.8 95.9 > 99 - 
 
 
Even in complex with their cognate epsilon antitoxins, ζ2 and ζ3 achieved nearly complete 
turn-over of UNAG within 3 h (Figure 3.2-15 and Table 3.2-3), showing that the enzymes are 
either more efficient UNAG kinases than ζ1, that the epsilon/zeta complexes are less stable or that 
inhibition is less pronounced. Nevertheless, difficulties in cloning free toxin and the apparently 
positive effect of epsilon co-expression indicate inhibition by epsilon, such that all three systems 
can be considered type II epsilon/zeta TA systems. 
 
 Interactions of the gonococcal epsilon and zeta proteins 3.2.11
In a first approach to deduce the functional relevance of multiple epsilon/zeta systems on one 
plasmid, the physical interactions between the individual proteins were tested by pull-down 
experiments with the help of Florence Jungblut. Therefore, E. coli BL21(DE3)-CodonPlusRIL cells 
were co-transformed with two plasmids carrying a His6-tagged epsilon and an untagged zeta, 
respectively. As cloning of solitary wild-type toxins was not possible, the Walker A lysines of all 
three putative toxins were mutated to alanines, yielding ζ1_K115A, ζ2_K46A and ζ3_K46A, which 
were used in this assay. After protein expression was induced, cells were harvested, lysed and the 
cleared lysate was applied to nickel affinity resin to bind the His6-tagged antitoxin homologs and 
their potential binding partners. 
Recombinant expression of all proteins was successful, as can be seen in the cleared lysate 
fractions (Figure 3.2-16) and all His6-tagged epsilon homologs could be bound to nickel affinity 
resin. When ε1, ε2 and ε3, were co-expressed with their cognate zeta mutants, co-elution of both 
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proteins was observed, indicating stable complex formation, which was already observed during 
protein purification. However, binding to the non-cognate zeta homologs (e.g. ε1 to ζ2 and ε2 to ζ1 
etc.) was not detected (Figure 3.2-16). Furthermore, expression of ε1 in combination with ζ2 or ζ3 
resulted in very low protein levels and correspondingly in unspecific binding to the nickel affinity 
resin. Most likely this is caused by proteolytic degradation of free ε1, which gets stabilized in 
complex with ζ1, which was described for several other TA systems including the homologous 
ε/ζspy [71]. Interestingly, ε2 and ε3 were highly expressed even in combination with non-cognate 
zeta toxins, indicating higher proteolytic stability. 
In conclusion, this shows that the three putative epsilon/zeta systems form protein-protein 
complexes like typical type II systems, where complex formation most likely leads to inhibition of 
toxin activity. Furthermore, no interaction between non-cognate epsilon/zeta pairs could be 
detected, suggesting that the protein-protein interfaces are sufficiently different to prevent mutual 
complex formation. Therefore, the two systems on each plasmid have the potential to 
independently stabilize DNA and lead to post-segregational killing. Alternatively, one or both of 
the systems might have evolved to fulfil different tasks within the cell. 
 
 
Figure 3.2-16: Interactions of the gonococcal epsilon and zeta proteins. The gonococcal zeta 
homologs ζ1_K115A, ζ2_K46A and ζ3_K46A were co-expressed with their putative cognate and 
non-cognate epsilon antitoxins ε1, ε2 and ε3 in the indicated combinations. The cleared lysate (S) 
was applied to nickel affinity resin and bound proteins were eluted with imidazole (E). While the 
His6-tagged epsilon homologs were always bound to the resin, co-elution of each of the zeta 
mutants was only observed in combination with its cognate epsilon partner. Molecular weight 
estimates of the components of the Low Range SDS-PAGE standard (M) are given for comparison. 
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 Summary 3.2.12
The results described in this section provide a characterization of three epsilon/zeta 
TA systems in the Gram-negative bacterium N. gonorrhoeae. For ε2/ζ2 and ε3/ζ3 UNAG kinase 
activity could be confirmed and ζ2 was shown to synthesize two different reaction products, most 
likely by phosphorylation of two different hydroxyl groups in UNAG. 
The separation of the ε1/ζ1 dimer allowed to measure the enzymatic activity of free ζ1 toxin 
and to determine inhibition by ε1. ε1/ζ1 forms a heterodimeric protein-protein complex, the 
structure of which could be determined using X-ray crystallography. The ε1 antitoxin binds in an 
extended conformation and stretches out on the surface of ζ1, this suggests a different mode of 
inhibition compared to the streptococcal epsilon antitoxins. In addition, topological rewiring in the 
central β-sheet of ζ1 gave rise to a novel UNAG kinase fold in which the spatial organization is 
conserved despite re-arrangements in the primary sequence. 
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4 Discussion 
The characterization of epsilon/zeta homologs from Gram-negative bacteria - EzeT from 
E. coli and the epsilon/zeta systems from N. gonorrhoeae - described in this thesis, shows that 
these species encode for active UNAG kinases, which are inhibited by proteinaceous antitoxins. 
These results unambiguously demonstrate that UNAG kinases are found in both Gram-positive and 
Gram-negative bacteria, in contradiction of the original notion that UNAG kinases might be only 
active in Gram-positive bacteria. Specific features of chromosomal EzeT and the gonococcal 
plasmid-encoded systems will be discussed in the following two sections. 
 
4.1 Escherichia coli EzeT 
As described in chapter 3.1, a zeta homolog has been identified on the chromosome of 
numerous E. coli strains. This protein, called EzeT, phosphorylates UNAG and is expressed from 
its endogenous promoter. It is the first thoroughly characterized UNAG kinase encoded in Gram-
negative bacteria. Most remarkable is the mechanism of toxin inhibition, which is mediated by the 
N-terminal domain of EzeT. Such an autoinhibition by a covalently linked antitoxin has not been 
described for any TA system, so far. 
 
 A UNAG kinase regulated by a novel type of inhibition 4.1.1
The C-terminal domain of EzeT is homologous to the streptococcal zeta toxins, both in 
primary as well as in secondary and thus most likely also in tertiary structure. Moreover, all 
residues previously identified to be essential for the catalytic activity [61] are conserved and in the 
course of this study the protein was shown to phosphorylate UNAG in vitro. In vivo, 
overexpression of the C-terminal domain leads to the accumulation of UNAG-3P and evokes cell 
lysis, similar as it was shown for the attenuated streptococcal toxin PezT∆C242 [53]. EzeT is thus 
an active, zeta-like UNAG kinase. 
In the presence of the N-terminal domain of EzeT, this kinase activity is inhibited, most 
likely by sterically blocking ATP binding, as it was described for the streptococcal epsilon 
antitoxins [62, 63]. In conclusion, the here described results show that EzeT is expressed as a single 
polypeptide chain comprising two domains with UNAG kinase and inhibitory functions, 
respectively. While different types of inhibition by the antitoxin have been reported [21, 24], an 
antitoxin provided in cis has not been described before. Therefore, EzeT is the first member of a 
novel type of TA system. 
 
Discussion 
104 
 EzeT homologs in Gram-negative bacteria 4.1.2
When searching for homologs of EzeT in other species, related proteins were found in 
Escherichia fergusonii (93 % aa similarity) and the γ-proteobacteria Actinobacillus minor and 
Succinatimonas sp. (50 % aa similarity) (Figure 4.1-1). From sequence similarity it can be assumed 
that the E. fergusonii and A. minor proteins can phosphorylate UNAG and are inhibited by their N-
terminal domain, thus sharing the novel mechanism of inhibition by an antitoxin acting in cis. 
Notably, all of the EzeT homologs contain a degenerate DxD motif, in which only the second, 
magnesium-coordinating aspartate is conserved, which was also observed for ζ1 (see section 3.2.1). 
In contrast, the Succinatimonas homolog contains a degenerate Walker A motif and is thus 
most likely enzymatically inactive. Interestingly, the biggest differences between those proteins are 
found in the region identified as potential domain linker in EzeT, which shows a different 
arrangement in A. minor and Succinatimonas sp.. 
 
 
Figure 4.1-1: Full-length EzeT homologs. Amino acid sequence alignment of EzeT and full-
length homologs of Escherichia fergusonii ATCC 35469 (YP_002385128), Actinobacillus minor 202 
(EEV25437) and Succinatimonas sp. CAG:777 (CCX90861). Residues are colored according to 
conservation (dark green: identity to yellow: low homology). The catalytically important Walker A 
motif (red), the aspartate of the degenerate DxD (purple) motif and the UNAG binding region (gray) 
are conserved, except for two mutations in the Walker A motif of Succinatimonas (▲) that 
assumedly prevent ATP binding and hydrolysis in this protein. The blue box highlights the location 
of the interdomain linker. 
 
Additionally, homologs of EzeT lacking the N-terminal polypeptide stretch were identified 
in other host-associated Gram-negative genera (Neisseria, Haemophilus, Veillonella, 
Figure 4.1-2A). Interestingly, many of these shorter homologs, which share between 39 % to 43 % 
aa sequence identity with the C-terminal domain of EzeT, but only 27 % to 34 % identity with ζspy 
and PezT, are encoded together with a separate ORF of a putative antitoxin in a conventional 
bicistronic TA operon. These antitoxins are small, about 80 aa long, and predicted to fold into three 
helices. Moreover, all of them, including the N-terminal domain of EzeT, are conserved at their 
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N-terminus (Figure 4.1-2B). This suggested that, similar to inhibition by epsilon antitoxins in the 
streptococcal systems, these residues of the N-terminal helix of the three-helix bundle are important 
for toxin inhibition. 
 
 
Figure 4.1-2: EzeT homologs organized in bicistronic operons. Amino acid sequence 
alignment of EzeT (ECO103_4771) and bicistronic EzeT homologs, color coding as in Figure 4.1-1. 
(A) Alignment of residues 78 to 308 of EzeT with putative UNAG kinase proteins of Treponema 
succinifaciens DSM 2489 (AEB13801), Kingella kingae KKC2005004457 (EQB59621), Neisseria 
wadsworthii (WP_009115638), Veillonella parvula HSIVP1 (EQC63500) and Haemophilus 
haemolyticus (EGT79785). The catalytically important sites are conserved. (B) Alignment of 
residues 1 to 82 of EzeT with the small proteins upstream of the putative UNAG kinases shown in 
(A). The high degree of conservation at the N-terminus of these proteins is also reflected by the 
consensus logo for the first 11 amino acids created with WebLogo [123] and shown above the 
alignment. Regions predicted to be α-helical in EzeT are indicated by blue bars. Residues marked 
with diamonds () are suspected to block ATP binding similar to the streptococcal epsilon 
antitoxins and were analyzed by mutagenesis. 
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In analogy to the streptococcal epsilon antitoxins, four residues potentially located on one 
side of the N-terminal α-helix were expected to be required for the sterical blocking of ATP 
binding[62, 63]. Residues that may fulfil this function were the highly conserved methionine 5 and 
aspartate 8 and the carbamoyl-containing amino acids asparagine 12 and glutamine 16 
(Figure 4.1-2B). Truncation or mutation of these amino acids in EzeT indeed diminished inhibition.  
 
The conservation of the residues important for catalysis and inhibition in these bicistronic 
systems suggests that the individual proteins encode for a UNAG kinase and a separate antitoxin 
like conventional type II TA systems. 
It can be speculated that during the evolution of EzeT the adjacent genes in one of these 
bicistronic operons fused and gave rise to a two-domain protein. This fusion is likely the result of a 
mutation, which caused the disruption of the stop codon of the upstream gene, while placing the 
second ORF in frame with the first. Thereby, most likely a short linker was established between 
two independently folded domains. Determination of the precise fusion site in EzeT is hampered by 
the absence of a methionine in the linker region, which could otherwise resemble the start codon of 
the original toxin gene. This codon might either have been deleted during fusion or mutated 
subsequently to optimize the linker properties. 
 
 A covalent linker between toxin and antitoxin 4.1.3
In EzeT, the toxin and the antitoxin domain are translated as a single polypeptide chain, but 
can interact with each other when expressed separately, as demonstrated in the rescue experiments 
(see section 3.1.8). This indicates the presence of a specific binding interface between the two 
domains, which can be established in presence or absence of a covalent connection. However, to 
allow for the proposed epsilon-like inhibition, the domain linker between the N- and C-terminal 
domain has to be sufficiently long to enable a positioning of the N-terminal domain in the vicinity 
of the ATP-binding site. 
To estimate the required linker length the structures of PezAT and ε/ζspy were analyzed. In 
both complexes, the C-terminus of epsilon and the N-terminus of zeta are located on the same side 
of the dimer. The C-terminal α-helix of PezA and the N-terminal α-helix of PezT are 24 Å apart 
(Figure 4.1-3). This distance is slightly shorter (22 Å) in ε/ζspy as a result of a minor difference in 
the orientation of the three-helix bundle of εspy to the toxin. The minimum number of amino acids 
necessary to span this distance was calculated by assuming a distance of 3.4 Å spanned between 
the Cα-atoms of neighboring residues in an elongated β-strand conformation. In this case, at least 
6 amino acids are required to connect the two proteins. 
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Figure 4.1-3: Distance between the C-
terminus of PezA and the N-terminus of 
PezT. Model of an epsilon/zeta dimer (PDB 
ID 2P5T) showing the distance between α-
helices in the C-terminus of PezA (blue) and 
the N-terminus of PezT (red). Both termini are 
located at one side of the complex with a 
spacing of 24 Å. 
 
 
 
 
 
 
According to secondary structure predictions of EzeT, the third predicted α-helix of the N-
terminal domain and the first α-helix of the zeta toxin core are linked by a stretch of 6 to 8 amino 
acids. Thus, it is likely that this linker length is sufficient to allow EzeT to adopt an epsilon/zeta-
like conformation, but that the linker is rather a short tether than a long flexible loop. 
This covalent linkage has important consequences for the activation of these TA systems, 
when compared to separately expressed type II systems. 
 
 Activation of covalently linked TA systems 4.1.4
For bacteria carrying TA systems, the tight regulation of toxin activity is crucial for survival. 
Activation has to be restricted to situations when toxin induced cell death or stasis is evolutionary 
beneficial. In type II systems, toxin activation is achieved by complex dissociation and degradation 
of the antitoxin by cellular proteases [18]. 
In TA modules that are involved in plasmid maintenance proteolytic degradation is a 
continuous process and needs to be counteracted by constant antitoxin synthesis. Activation occurs 
when the rate of antitoxin synthesis is smaller than the degradation rate, e.g. in the case of gene 
loss [159]. In contrast, chromosomal TA systems might be induced upon exposure to stress [160-
162] or activated by small molecules [163]. 
 
In EzeT, the covalent tethering of the inhibitory domain to the UNAG kinase domain 
increases the effective local concentration of the inhibitor and, moreover, prohibits complete 
dissociation of the two domains. Activation of the UNAG kinase activity is most likely 
accomplished by cleavage of the linker, proteolytic degradation of parts of the N-terminal domain 
or the binding of factors that induce structural rearrangements or partial unfolding of the N-
terminal domain. 
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Proteolytic cleavage to activate precursor enzymes has been described for so called 
zymogens [164]. These proteins are generally toxic when occurring in the cytosol as an 
enzymatically active form, including the eukaryotic digestive and coagulation enzymes and 
secreted bacterial proteases [165]. Therefore, these proteins are translated together with an 
inactivating pro-domain, which can be also involved in correct protein folding [165]. Removal of 
the pro-domain, mostly after secretion, leads to activation of the enzyme [164]. Similarly, such an 
activation of EzeT could occur in the cytosol, once it is beneficial for the bacterium. Noteworthy, a 
similar activation strategy for artificially fused TA systems has been described recently [166, 167]. 
Here, fusion proteins of the TA system MazEF have been designed by connecting the toxin MazF 
to the antitoxin MazE using a liker that contains a protease recognition site. Activation of these 
TA fusions by protease expression was shown to be effective in vitro and led to cell killing in 
vivo [166, 167]. 
 
Although proteolytic cleavage is a convincing strategy for EzeT activation neither cleavage 
nor binding of factors, which are likely to activate EzeT, has been observed in the experiments 
described in this work. 
However, these experiments have been performed with cultures grown in rich medium at 
37 ºC, providing ideal growth conditions for E. coli. In these situations, activation of a TA system 
is most likely not beneficial to the cell. Therefore, it can be suggested that activation of EzeT is 
performed by specific factors that are only effective under certain conditions. 
Further evidence for a specific regulation is provided by the apparent inability of EzeT to 
stabilize its genetic locus, a finding that has also been reported for several other chromosomal 
TA systems [40, 146]. In contrast, in TA systems involved in plasmid maintenance the antitoxin is 
constantly degraded, which requires constant gene synthesis to keep the toxin in an inactive state. 
In these systems, activation is only influenced by the presence or absence of the genetic 
information, which is the basis for plasmid stabilization [30].  
 
A potential draw-back of EzeT activation by proteolytic cleavage is the irreversibility of this 
process. Although an inhibition of the C-terminal domain by the N-terminal domain provided in 
trans was possible, in these experiments a significantly higher expression level of the N-terminal 
compared to the C-terminal domain was reached. This would require separate high-level expression 
of the N-terminal domain, which is not feasible when both domains are encoded as a single 
polypeptide chain. Therefore, rescue after toxin activation would only be possible by toxin 
degradation. 
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 Possible functions of EzeT 4.1.5
The functions of chromosomal TA systems can be very diverse and include many stress 
adaptation strategies. To gain insights into the role of EzeT and the conditions under which it is 
activated, the knock-out strain E. coli W ezeT – was tested for its ability to induce persister cell or 
biofilm formation or phage abortive infection. No difference to the wild-type strain could be 
detected. This does not exclude a role of EzeT in these effects, as it is known from previous studies 
with TA system knock-out strains that TA systems can be highly redundant. In E. coli K-12 
MG1655 the knock-out of 10 TA modules was required to see an effect on persister cell formation 
compared to the wild-type strain [168]. 
 
Analysis of the ezeT promoter and expression levels of EzeT in E. coli W showed low-level 
expression upon incubation at 37 ºC. Furthermore, no autorepression by EzeT could be observed, a 
mechanism that is utilized by most type II TA systems to ensure constant, low-level TA complex 
synthesis [169, 170]. Instead, transcription from ezeT seems to be regulated by the cellular 
transcription machinery and might be increased under certain circumstances. Such regulation has 
been described for the MazEF TA system of Staphylococcus aureus which is transcribed by the 
alternative sigma factor σB and regulated in response to environmental and antibiotic stresses by 
additional DNA binding proteins [171]. Moreover, some type I TA systems and the E. coli type II 
system yafNO are induced by the SOS-response [41, 172, 173]. 
As no specific regulatory elements were found in the promoter region, it is likely that 
promoter recognition is not performed by the housekeeping sigma factor σ70 but the alternative 
sigma factor σ38 that is activated under stress and at high cell densities [139]. However, which kind 
of stress might induce transcription remains unknown, as no significant promoter activation was 
detected under a variety of stress conditions tested. 
 
The enzymatic activity of the C-terminal domain leads to the accumulation of UNAG-3P, 
membrane permeabilization and cell lysis when it is overexpressed alone. In addition, the 
formation of long-lived spherical cells was observed after 90 min of induction. In adherently 
growing E. coli cells, recombinantly overexpressing the attenuated streptococcal zeta toxin variant, 
PezT∆C242, similar bloated morphologies were described [53]. However, lysis upon 
overexpression of PezT∆C242 in liquid culture was observed earlier after induction [53], which 
might be a consequence of different rates of UNAG-3P formation due to different levels of active, 
folded enzyme, different kinase activity or differences in bacterial growth rate due to the different 
incubation temperatures. 
The spherical cells observed after EzeT∆N83 expression (see section 3.1.7) resemble 
spheroplasts, which form after administration of cell-wall damaging antibiotics, for example 
ampicillin [133]. Cell wall-deficient bacteria or L-forms have been studied in the laboratory, but 
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are also considered an important cause of bacterial persistence in chronic infections [132]. EzeT 
might thus induce the L-form state by down-regulation of the peptidoglycan layer as well as 
potentially lipopolysaccharides constituting the outer capsule. This down-regulation was proposed 
to reduce the amount of antigens presented on the cell surface and thereby help bacteria to evade 
the immune system [174], which would make EzeT a virulence factor that might contribute to the 
infections caused by pathogenic strains of E. coli. 
 
An interesting finding regarding the function of EzeT is the clear phylogenetic restriction to 
phylogroup B1. On the one hand, this indicates that the occurrence can be dated back to the time of 
separation of this phylogroup from the sister phylogroup A, which is estimated to have happened 
roughly 0.5 to 1.5 million years ago [175]. On the other hand, it might hint at the function of EzeT. 
With respect to the low thermal stability of EzeT, it is remarkable that B1 isolates are 
predominantly found in locations with ambient temperature e.g. soil [176], on plants [177] and in 
the gastrointestinal tract of ectotherms [178]. In addition, B1 strains show prolonged survival 
outside the host [179] and are more prone to shedding from the gastrointestinal tract than strains of 
phylogroup A [180]. It is thus possible, that EzeT has a thermosensor function, which regulates 
bacterial survival upon excretion from the host.  
The importance of such genes, which ensure survival of enteric bacteria in the environment, 
has been already proposed 30 years ago [181]. In this report the author suggested that mutations 
that increase the survival time of E. coli outside of the host will spread, because they increase the 
probability of ingestion and thus distribution to novel hosts. In addition, the author calculated that 
50 % of all E. coli cells are found in the environment, marking the importance of this habitat. 
Interestingly, E. coli W, the only laboratory strain that encodes EzeT, has been isolated from the 
soil of a cemetery [182]. 
Furthermore, another toxin with increased activity at ambient temperature, GraT of the 
GraTA TA system, was identified in the soil bacterium Pseudomonas putida[183], indicating that 
temperature-regulated TA systems might be beneficial for environmental bacteria. 
 
 A novel type of TA system? 4.1.6
Although close EzeT homologs have been identified, which are likely to be regulated in a 
similar fashion, it can only be speculated about the prevalence of autoinhibited TA systems in other 
families. Most of the published bioinformatic studies to identify proteinaceous TA systems have 
been restricted on TA systems consisting of two small neighboring genes [31, 33, 184], therefore, 
elongated homologs without an additional ORF for the antitoxin might have been overlooked. 
Indeed, homology searches that use more flexible scoring criteria regarding size, genomic context 
and domain conservation identified a plethora of putative single or unusually long toxins [32, 34].  
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The identification of covalently linked TA systems prompt further systematic bioinformatics 
studies to identify putative autoinhibited TA modules and the characterization of other solitary, 
elongated toxin homologs. These might help to identify highly-specialized and highly-regulated 
TA systems, which have been overlooked until now. 
 
 
4.2 Neisseria gonorrhoeae epsilon/zeta systems 
Three putative epsilon/zeta systems have been identified on conjugative plasmids from 
N. gonorrhoeae, denoted ε1/ζ1 and ε3/ζ3 in a variant without the tetM determinant and ε1/ζ1 and 
ε2/ζ2 in the presence of tetM. The characterization of these gonococcal epsilon/zeta systems 
revealed, that all three zeta homologs can phosphorylate UNAG, but form different reaction 
products. In addition, the three-dimensional structure of the module with the lowest sequence 
homology to zeta toxins, ε1/ζ1, was determined by X-ray crystallography. It was shown that the 
observed shift in the location of the Walker A motif by 51 amino acids is compensated by a 
different topology, such that ζ1 adopts a zeta-like three-dimensional architecture of the active site. 
Furthermore, residues important for substrate binding were identified and the structure of the C-
terminal domain, common to all gonococcal zeta toxins, was elucidated. Finally, an unusual mode 
of inhibition by ε1 was discovered. 
 
 A UNAG kinase in Gram-negative N. gonorrhoeae 4.2.1
As described in chapter 3.2, ζ1 has UNAG kinase activity and is therefore, together with 
EzeT, the second characterized UNAG kinase in Gram-negative bacteria. Surprisingly, a 1.8 fold 
higher amount of ADP than UNAG-3P was produced during the phosphorylation of UNAG by 
wtζ1 and the independently purified ε1/ζ1 complex. However, no ATPase activity was detected in 
the coupled ATPase assay when UNAG was omitted, indicating that ATP hydrolysis is stimulated 
by UNAG. In contrast, reactions performed with other zeta toxins (PezT∆C242 (not shown), EzeT, 
ε2/ζ2, ε3/ζ3) showed equimolar conversion of ATP and UNAG. 
Interestingly, a similar stimulation has also been reported for purified wild-type ζspy [185], 
which likewise does not hydrolyze ATP in the absence of UNAG, but consumes twice as much 
ATP as UNAG in a phosphorylation reaction. How and when the uncoupling of ATP hydrolysis 
and UNAG phosphorylation takes place has to be investigated further. 
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The separation of ζ1 from the ε1/ζ1 complex allowed to measure enzyme kinetics and the in 
vitro activity of a wild-type zeta toxin. Hitherto, Michaelis-Menten constants could be only 
determined for toxin mutants due to problems in cloning and expression of solitary wild-type 
toxins. Therefore, the obtained constants can only be compared to values determined for an 
attenuated version of PezT, PezT∆C242 [143]. 
The maximal reaction velocity vmax of ζ1 was found to be 0.2±0.01 mM/min at an enzyme 
concentration of 1 μM (kcat=3.3 s-1), which is 8 fold slower than the maximum rate of PezT∆C242. 
However, this maximal velocity is achieved at lower substrate concentrations as indicated by lower 
Km values when compared to the Km of PezTΔC242 for UNAG of 8 mM and for ATP of 
12 mM [143]. 
Eventually, the in vivo reaction rate depends on the intracellular substrate concentrations, 
which are 100 µM to 400 µM UNAG [186-188] and 3 mM ATP [189]. Assuming an intracellular 
concentration of 250 µM UNAG the reaction velocity of PezTΔC242 (0.04 mM/min) is only twice 
as high as the reaction velocity of wtζ1 (0.02 mM/min). It can, however, be assumed that the non-
truncated PezT has a higher enzymatic activity which makes it more toxic in vivo. The differences 
in reaction velocities might indicate functional adaptations in different species to either cause cell 
lysis or dormancy and a reduction in the UNAG-containing cell wall components like 
peptidoglycan, lipopolysaccharides or teichoic acids. 
 
 ζ1 differs from conventional zeta toxins 4.2.2
The N-terminal UNAG kinase domain of ζ1 is structurally similar to the streptococcal zeta 
toxins. However, in the primary sequence the Walker A motif of ζ1 is located further away from 
the N-terminus than in ζ2, ζ3, PezT or ζspy. This is reflected in a change in the topology of ζ1 
compared to the streptococcal proteins.  
To conserve the spatial organization of the active site and to accommodate this 
rearrangement in the overall fold, two β-strands in the central β-sheet are exchanged (Figure 4.2-1). 
This change in topology results in a different linkage of the connecting loops, while the positioning 
of the secondary structure elements is conserved. Despite the structural rearrangement, ζ1 is 
competent for ATP binding and phosphorylation, as has been shown in enzymatic activity assays. 
 
Discussion 
113 
 
Figure 4.2-1: Topology diagrams of UNAG kinases. Topology diagrams of ζ1 (A) and ζspy (B) 
based on the crystal structures (ζspy: PDB ID 1GVN; ζ1: this study). Both structures contain a 
central six-stranded β-sheet and similarly positioned α-helices. β-strand 1 and β-strand 2 (orange) 
and the successive α-helices (α1/α2, α2.1/α1.1 and α2.2/α1.2) are encoded in opposite order in the 
polypeptide chain, changing a 2-3-1-4-5-6 topology in ζspy to a 1-3-2-4-5-6 topology in ζ1. The 
required topology rewiring is shown in bold, the P-loop as red line, Walker A lysine and the 
magnesium-coordinating aspartate of the DxD motif in stick representation. α-helices lying on top of 
the β-sheet are shown in dark blue, α-helices lying behind the β-sheet in light blue, identical 
β-strands in yellow.  
 
The 2-3-1-4-5-6 topology observed in conventional zeta toxins corresponds to the common 
five-stranded, parallel β-sheet found in P-loop kinases [153, 190], with an additional sixth 
antiparallel β-strand typical for zeta toxins [62, 63]. In contrast, the 1-3-2-4-5-6 topology of ζ1 is 
rarely found in kinases [153, 190]. The conservation of the sixth β-strand suggests that the novel 
UNAG kinase fold evolved from a conventional zeta toxin by divergent evolution, although it 
cannot be fully excluded that a P-loop kinase with an uncommon topology acquired a similar 
arrangement of secondary structure elements and the ability to bind UNAG. 
The exchange of two β-strands in a β-sheet is a complex evolutionary process, especially 
when it involves catalytically important residues [191]. Direct in-frame excision and insertion of 
the nucleotides encoding for one strand and several helices within one gene is unlikely. Instead, 
topological rewiring is usually assumed to be a consequence of gene duplications and subsequent 
reductions [192]. However, such evolutionary processes have been only described in detail for 
domains consisting of a limited number of secondary structure elements [193]. In homology to 
these systems, a partial or complete duplication of ζ1 or its N-terminal domain would be required, 
that results in a functional fusion protein of two toxins. In this fusion the β-strand of one protein 
half then takes over the function of the original strand of the other half which allows deletion of 
excessive parts. How the process actually took place is not certain, but the genetic load region of 
plasmids are known for their high plasticity and frequent genomic rearrangements. 
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Figure 4.2-2: Alignment of proteins homologous to ζ1. Amino acid sequence alignment of ζ1 
(N. gonorrhoeae) and homologous proteins. Protein identifier are given in the top right, the 
numbers of residues at the N- and C-termini that have been omitted from the alignment are 
indicated. Residues are colored according to conservation (dark green: identity to yellow: low 
homology). The catalytically important Walker A motif (red) and the degenerate DxD (purple) and 
Walker B (gray) motifs are conserved. Residues that were suggested to bind the substrates are 
numbered accordingly above the alignment.  
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 Residues involved in substrate binding 4.2.1
Analysis of the X-ray crystal structure of ADP-bound ε1/ζ1 revealed several residues that 
interact with the adenine nucleotide or the magnesium ion, including the Walker A motif, 
degenerate Walker B and DxD (mutated to CAD) motifs and a putative lid helix. In addition, 
superposition with the structure of ε/ζspy in complex with UNAG [53] allowed to identify residues 
that might be important for binding of the nucleotide sugar (see section 3.2-5). However, it has to 
be kept in mind that the ε/ζspy complex seemed to be in a relatively open conformation compared to 
ζ1, such that UNAG was probably not ideally positioned. 
 
When comparing the amino acid sequence of ζ1 to the NCBI protein collection [114] using 
BLAST [115, 116], several homologous proteins were found in proteobacterial genera such as 
Burkholderia, Spingobium, Acinetobacter and Campilobacter (Figure 4.2-2).  
A depiction of the amino acid conservation of these proteins plotted onto the surface 
representation of ζ1, demonstrates a high level of conservation in the substrate binding pockets, but 
not on the remaining solvent-exposed surface (Figure 4.2-3). The conserved residues include the 
degenerate DxD motif and the adjacent β-strand 2, the Walker A motif and glutamate 133 of the 
degenerate Walker B motif. Additionally conserved residues that have been suggested for substrate 
binding are arginine 175 and arginine 181 of the lid helix, histidine 79 and lysine 145. 
Phenylalanine 132 is in several cases replaced by a tyrosine, which might still stack to the uracil 
base.  
Additionally, the side chains of the conserved residues lysine 59, asparagine 75 and 
asparagine 80 are located deep in the UNAG binding pocket and might get in hydrogen bonding 
distance to the glucosamine, once it is correctly positioned for the phosphoryl transfer reaction. 
However, the arginine of the proposed GQXXR motif is not conserved, suggesting that this 
interaction is not required for UNAG binding. 
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Figure 4.2-3: Catalytically important residues are conserved in ζ1 homologs. Amino acid 
conservation of proteins homologous to ζ1 mapped on the surface representation of ζ1 colored as 
in Figure 2. The molecule is rotated by 180 º to show the ATP binding site (left) and the UNAG 
binding pocket (right). Highest homology is found in the substrate binding pockets as depicted by 
the degree of conservation. 
 
 Inhibition by ε1 4.2.2
Inhibition of ζ1 by ε1 was proven by monitoring the decrease in enzymatic activity upon 
addition of different concentrations of ε1. Like other type II TA systems, ε1 and ζ1 form a protein-
protein complex, which is most likely required for inhibition of the enzymatic activity. This 
complex exists as a heterodimer in solution, as was determined by static and dynamic light 
scattering experiments. The apparent absence of oligomer interfaces between heterodimers was 
also confirmed by analysis of the molecular contacts in the two different crystal forms. In contrast, 
the streptococcal epsilon/zeta systems form heterotetramers, in which a central epsilon dimer is 
bound by two zeta toxins [61]. 
 
Furthermore, ε1 does not fold into a compact structure, but instead binds extended across the 
surface of ζ1. This arrangement of three α-helices looks rather similar to the RelB antitoxin of 
Pyrococcus horikoshii [194] (Figure 4.2-4A), which wraps around its cognate RelE toxin. In 
contrast, the streptococcal epsilon antitoxins form three-helix bundles with a defined hydrophobic 
core (Figure 4.2-4B). Like the RelB antitoxins and the related MazE, HigA and ParD antitoxins, ε1 
might exist unstructured in solution and adopt an ordered structure upon binding to ζ1 as described 
by the order-disorder binding model[18, 159]. According to this model, the disordered state of the 
free antitoxin is thought to present regions for the recognition by proteases, which are shielded in 
the toxin-bound form. This is corroborated by the low proteolytic stability observed during protein 
expression with non-cognate zeta toxins (see section 3.2.11). 
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Figure 4.2-4: Antitoxin folds. (A) Elongated conformation of the RelB antitoxin (green) from 
Pyrococcus horikoshii stretched out on its cognate RelE toxin (surface representation) (PDB ID 
1WMI). (B) Compactly folded εspy antitoxin (green) on top of the ATP binding site of ζspy (surface 
representation) (PDB ID 1GVN). 
 
 
The origin of the elongated ε1 fold is unknown, but it is conceivable, that either the original 
three-helix bundle antitoxin evolved to adopt a different binding mode, or that N. gonorrhoeae 
acquired a protein unrelated to the streptococcal ε1 antitoxins that evolved to inhibit ζ1. Such an 
interacting protein might be a member of another antitoxin family, like the RelE or ParD antitoxins, 
although the sequence conservation of ε1 to these proteins is low. Nevertheless, recent reports have 
shown that toxins and antitoxins of different classes can interact to form functional TA pairs [31, 
195-197]. 
 
Only minor structural rearrangements of the ε1/ζ1 complex and in particular of residues in ε1 
were observed upon ADP binding, suggesting that binding of ε1 to ζ1 does not sterically block 
ATP binding, which is in strong contrast to the mode of inhibition of the streptococcal epsilon/zeta 
systems [61]. In addition, nucleotide binding affinities for ADP and ATP were determined for the 
ε1/ζ1 complex, showing Kd values in the low micromolar range. These values are well below the 
intracellular concentrations of ATP (3 mM) and ADP (250 µM) [189], indicating that the complex 
should be able to bind these nucleotides within the cell. This suggests that the inhibition performed 
by ε1 is different from a competitive binding to the ATP site, which was observed for the 
streptococcal systems [61]. 
Instead, binding of ε1 might inhibit progression through the transition state, for example by 
inhibiting movements of the kinase domain that are required for the phosphoryl-transfer. Such 
extensive movements have been described for NMP kinases, where the lid domain approaches the 
active site during catalysis [198]. This lid is located in the loop between β-strand 4 and β-strand 5 
and contains a conserved arginine (residue 175 in ζ1) that is likely required to stabilize the 
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transition state [153]. In the ε1/ζ1 complex this part of ζ1 is located in the vicinity of the ε1 middle 
helix, which might prevent the contraction of the active site to bring arginine 175 and the 
neighboring arginine 181 closer to the transferred phosphoryl group and thereby prohibit charge 
stabilization of the transition state (Figure 4.2-5). 
 
 
Figure 4.2-5: Putative lid domain of ζ1. 
Arginine 175 and arginine 181 of α-helix 4.1 
of ζ1 (gray) are in close proximity to the 
phosphoryl groups of ADP. Tyrosine 40 of ε1 
(green) forms a hydrogen bond to the 3’-
hydroxy group of the ribose and sterically 
blocks movement of the lid helix. 
 
 
 
 
 
 
 
Alternatively, binding of ε1 might alter the kinetics of ATP and ADP binding, which could 
be fix ζ1 in a product-bound state. Unfortunately, the nucleotide binding properties of free ζ1 could 
not be characterized with the fluorescence techniques used; therefore it is impossible to directly 
compare the affinities of free and complexed ζ1 in order to determine the influence of ε1. 
Interestingly, no crystal structures of ε1/ζ1 bound to ATP, an ATP analog or UNAG could be 
obtained. 
 
From the previous considerations, it seems likely that ε1 does not compete with ATP for the 
same binding site, but regulates toxin activity by allosteric binding. Therefore, mixed inhibition 
was assumed, in which the inhibitor does not interfere with substrate binding but with the 
enzymatic conversion. In this case the type of inhibition and the underlying inhibition constants can 
be determined from the measured Michaelis-Menten kinetics for UNAG at different inhibitor 
concentrations. Nevertheless, direct competition experiments with varying ATP and ε1 levels 
would help to exclude competitive inhibition of ATP binding by ε1. 
 
The determined Michaelis-Menten kinetics showed a decrease in the apparent vmax and an 
increase in the apparent Km values for UNAG, indicating mixed inhibition, where the inhibitor 
binds to both the enzyme as well as the enzyme-substrate complex with inhibition constants Ki and 
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Ki’, respectively [199]. To confirm this assumption, a Dixon plot and a Cornish-Bowden plot were 
drawn to determine the type of inhibitor and the corresponding inhibition constants. 
According to the Dixon method the inverse of the reaction velocities at different substrate 
concentrations is plotted against the inhibitor concentration [200]. -Ki is given by the inhibitor 
concentration at the intersection of the linear regression lines through these data points. The 
Cornish-Bowden plot is drawn similarly, but instead of using the inverse of the reaction velocities 
directly, these are multiplied by the respective substrate concentrations [199]. In this plot, 
competitive inhibitors are described by a set of parallel lines, while for all other inhibitor types -Ki’ 
can be determined from the inhibitor concentration at the intersection of the linear regression lines 
through the data points. 
 
Figure 4.2-6: Inhibition of ζ1 by ε1. (A) The inverse of the reaction velocities for each set of 
UNAG concentrations was plotted against the ε1 concentration according to Dixon. The 
intersection region of the regression lines is magnified in (C) and allows to approximate the 
inhibition constant Ki. (B) The UNAG concentration divided by the reaction velocity is plotted 
against the ε1 concentration according to Cornish-Bowden. The intersection region of the 
regression lines is magnified in (D) and allows to approximate the inhibition constant Ki’. For both 
plots the experimental reaction rates were normalized to an enzyme concentration of 1 µM prior to 
plotting. The legend shown on the top right gives the different UNAG concentrations in mM. 
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Using these graphical methods, a mixed inhibition by ε1 could be confirmed, as in both plots 
the regression lines form an intersection (Figure 4.2-6). The intersections are not well defined, due 
to the limited number of inhibitor and substrate concentrations used, but nevertheless a rough 
estimate of the inhibition constants can be made. Ki, describing the inhibitor binding to the enzyme, 
i.e. the Kd, is given by the inhibitor concentration at the intersection in the Dixon plot 
(Figure 4.2-6A/C), which is approximately 0.7 μM. Ki’, describing the inhibitor binding to the 
enzyme-substrate complex, is given in a similar fashion by the inhibitor concentration at the 
intersection in the Cornish-Bowden plot (Figure 4.2-6B/D). This value is slightly higher, between 
2 µM to 3 µM, indicating that ε1 binding to the ζ1-substrate complex is only mildly impaired by 
UNAG binding. 
 
The obtained Kd for binding of ε1 to ζ1 is in good agreement with the Kd of the plasmidic 
ε/ζspy system of 1 µM [70]. It can be assumed that a Kd around 1 µM is a an optimal affinity 
ensuring reliable toxin inhibition when toxin and antitoxin genes are present and transcribed, while 
allowing activation by epsilon release and degradation in case of plasmid loss. In order to 
determine the Kd for ε1/ζ1 more precisely additional inhibitor concentrations have to be used to 
calculate the Ki. A direct determination of binding constants was attempted using isothermal 
titration calorimetry, but was not possible due to the apparent interference of other effects caused 
by dilution of ε1 (data not shown). 
 
 The C-terminal domain might bind to DNA 4.2.3
All three gonococcal zeta toxins contain an additional C-terminal domain with high sequence 
similarity in all three proteins. This domain has been structurally characterized in ζ1 and was found 
to fold into an OB-fold, a small, additional β-sheet and an α-helix. OB-folds are known for 
interactions with other molecules, in particular oligonucleotides and oligosaccharides, but also 
proteins and small metabolites [201]. In addition, OB-folds can establish catalytic sites as is 
demonstrated in inorganic pyrophosphatases [202]. 
The OB-fold of ζ1 is structurally related to the family of nucleotide-binding OB-folds, like those 
found in transcriptional regulators, DNA-repair proteins or tRNA synthetases. The primary 
sequence shares highest homology with the conjugal transfer proteins KfrB (44.2 % amino acid 
sequence similarity), which is located on the same plasmid, and TraB from Citrobacter freundii 
(43.6 % similarity). Structures of these proteins have not been determined, but it seems conceivable 
that they also adopt an OB-fold that might be involved in DNA binding.  
 
The DNA-binding activity of the OB-fold could theoretically be involved in transcriptional 
regulation of ε1/ζ1 expression, especially as no ω-like repressor [68] could be identified on the 
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plasmid and ε1 does not contain a separate DNA-binding domain, which is responsible for 
transcriptional regulation in PezAT [62]. However, these assumptions and the nucleotide binding 
region have to be tested experimentally. Theoretically, the promoter could be either located directly 
upstream of the ε1/ζ1 bicistron, or - as has been proposed by Pachulec et al. [81] - ε2/ζ2 or ε3/ζ3, 
ε1/ζ1 and a transcriptional regulator marR could constitute a single operon. The promoter of the 
operon might than be either regulated by MarR or by one or both of the OB-fold containing zeta 
toxins. 
 
 ε2/ζ2 and ε3/ζ3 are functional epsilon/zeta systems 4.2.4
The gonococcal conjugative plasmids carry two adjacent epsilon/zeta systems, ε1/ζ1 and 
either ε2/ζ2 or ε3/ζ3 [81], which were shown to not physically interact with each other (see 
section 3.2.11). This suggests that these epsilon/zeta systems function independently and mutation 
or removal of one of these systems would not disturb the functioning of the other. It is thus possible 
that one or both of the systems have evolved to fulfil different tasks within the cell. 
 
Bioinformatic analysis indicated that ε2/ζ2 or ε3/ζ3 contain an N-terminal domain high 
sequence similarity to PezT and ζspy. In addition, conservation of the predicted secondary structure 
elements suggests a typical zeta-like fold. Furthermore, the epsilon antitoxins likely have a higher 
proteolytic stability than ε1 (see section 3.2.11) and are slightly longer, suggesting that ε2 and ε3 
might fold into a three-helix bundle like the streptococcal zeta toxins [62, 63]. Structural 
information for these systems is not available, as crystallization trials with ε2/ζ2 and ε3/ζ3 did not 
yield conditions that were deemed suitable for optimization. 
As inferred from the homology to ζspy and PezT, ζ2 and ζ3 phosphorylate UNAG. The 
reaction product of the enzymatic reaction with ζ3 seems to resemble UNAG-3P, whereas two 
different phosphorylated UNAG species are formed by ζ2. One of these reaction products is most 
likely UNAG-3P, while the second product possesses minor chemical differences, which leads to 
weaker interaction with the resin of the anion exchange column used for separation. This difference 
might be caused by additional modifications or an alternative phosphorylation site, e.g. the 
4’-hydroxy group of the N-acetyl glucosamine moiety. Further experiments using, for example, 
nuclear magnetic resonance spectroscopy could help to deduce the structure of the products. 
In kinases, the site of phosphorylation is determined by the orientation of the substrate in the 
binding pocket, which positions the phosphoryl acceptor group in proximity of the γ-phosphate of 
ATP. Thus, synthesis of two different reaction products indicates some degree of flexibility in 
substrate recognition, which might be an evolutionary pathway towards a change in substrate 
specificity and could ultimately lead to emergence of a new enzyme class. 
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 Why do plasmids contain two epsilon/zeta systems? 4.2.5
The gonococcal epsilon/zeta systems are located in the genetic load region of a conjugative 
plasmid, pLE2451. These load regions are known to acquire novel genes and rapidly exchange 
genetic material, leading to a flexible genetic content [203]. The associated higher mutation rates 
are thought to be important factors in the evolution of novel protein families [204]. 
It is possible that such evolutionary processes are observable in pLE2451. On the one hand, 
gene duplications and deletions are a likely cause for the topological rewiring observed in ζ1, on 
the other hand, ζ2 and ζ3 seem to have diverged from a common ancestor that was present at the 
time of tetM integration [81]. The observed flexibility in the enzymatic reaction performed by ζ2 
indicates a lack of evolutionary pressure to preserve the UNAG kinase activity, which might be due 
to ε1/ζ1, located on the same plasmid, performing an identical enzymatic reaction. 
In conclusion, the presence of two epsilon/zeta systems on the conjugative plasmids might 
be rather a sign of genetic load regions being evolutionary playgrounds than a functional 
requirement. 
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4.3 Conclusions and Outlook 
The data presented in this thesis provide the first characterization of active UNAG kinases 
encoded in the genomes of Gram-negative bacteria, demonstrating the extensive spread of 
epsilon/zeta systems in bacteria. 
Overexpression of a toxic form of EzeT led to accumulation of intracellular UNAG-3P and 
cell lysis, similar to overexpression of PezT∆C242 [53], indicating that under these conditions the 
peptidoglycan layer is severely disturbed. However, under physiological concentrations, toxin 
activation might rather lead to dormancy, as has been proposed for ζspy [135]. The result of toxin 
activation as either dormancy or cell death is an ongoing debate in the toxin-antitoxin field [19, 
205, 206]. 
When inducing dormancy, zeta expression in Gram-negative bacteria might not only 
decrease the level of peptidoglycan, but could also disturb the synthesis of other carbohydrates 
dependent on UNAG. Such structures include lipopolysaccharides [56] and several capsular 
polysaccharides [207], which are exposed on the outer surface of Gram-negative bacteria. The 
formation of lipopolysaccharides depends on the addition of fatty acid chains to the 3’-hydroxy 
group of UNAG and is, therefore, likely disturbed by UNAG-3P synthesis. A reduction in the 
amount of lipopolysaccharides could enhance bacterial interactions, like described for hyaluronic 
acid down-regulation [208, 209], and therefore contribute to cellular clumping and biofilm 
formation. 
The implication different cellular targets of UNAG-3P formation does encourage further 
studies on the functionality of zeta homologs in other species, including archaea, which encode zeta 
homologs[31]. Archaea do not form a peptidoglycan layer in their cell wall [210], but utilize 
UNAG for example in the formation of sialic acid [211], which can serve as nutrient, or as surface 
coating [212]. 
In conclusion, the results of this thesis demonstrate that epsilon/zeta modules are a versatile, 
highly abundant TA system family, which can be utilized by bacteria in multiple ways.  
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7 Appendix 
7.1 Primer sequences 
primer name sequence1 
EzeT 
T7_for TAATACGACTCACTATAGGG 
EzeT_3’NotI_His_r GCATCGCGGCCGCTTGTGTATTCCCGCTG 
pET_bone_for ATGCGTCCGGCGTAGAGGATC 
EzeT_3’HindIII_r CAGCATAAGCTTCTTTGTTAGCAGCCGGATCTCAG 
EzeT_83stop_HindIII_r GCATAAGCTTACGTAGTATTGTTG 
EzeT_5’NcoI_start82_f GCATCCATGGATTCAGAAAATAAAG 
EzeT_5’NcoI_start62_f CATGCCATGGGTAAGATTCTCCTTCAGC 
EzeT_5’NcoI_start36_f CATGCCATGGGCGATGCTCTCAAGCG 
EzeT_3’SalI_r CGTCGACCGGATCTCAGTGGTGGTGGTGGTG 
EzeT_K121A_f GGGCAACCCGGAGCAGGTGCATCATCTCTGATTG 
EzeT_K121A_r CAATCAGAGATGATGCACCTGCTCCGGGTTGCCC 
EzeT_M5A_D8A_f CCATGGCTACTTTAGCGGAAAAAGCTGCACTTTTAGCC 
EzeT_M5A_D8A_r GGCTAAAAGTGCAGCTTTTTCCGCTAAAGTAGCCATGG 
EzeT_N12A_Q16A_f GATGCACTTTTAGCCGGAGCCAGTGCGTGCATCACG 
EzeT_N12A_Q16A_r CGTGATGCACGCACTGGCTCCGGCTAAAAGTGCATC 
ε1/ζ1 
E1_5’NdeI_f GGCCATATGAATAAAGTTGAGCCCCAAGAAAGTAA 
Z1_3’HindIII_r TTTTAAGCTTGATAATCAGCGAAATTTCCGTGATC 
Z1_EcoRI_K115A_f GGGAATTCCGGGTTCGGGAGCAACTTCGACAG 
E1_3’HindIII_r GCCAAGCTTATTGCTCCTTATTTGCCGCCCACAAC 
Z1_5’NcoI_f CCGCCATGGTAAAACTGTCTAGCGATATTAATTTG 
Z1_3’XhoI_His_r GGCCCTCGAGTCTGCTGATGGATTTTTTGGCGG 
T7_rev TATGCTAGTTATTGCTCAGCG 
Z1_A115K_f GGAATTCCGGGTTCGGGAAAAACTTCGACAGTAAAAACAATG 
Z1_A115K_r CATTGTTTTTACTGTCGAAGTTTTTCCCGAACCCGGAATTCC 
ε2/ζ2 
E2_5’NdeI_f AGCCCATATGCAAATGCAAGAAACTATTCC 
Z2_K46S_r GACTGGATCCCGCTCCGGGTTGTGC 
Z2_K46S_f AGCGGGATCCAGTAAGGCAGCTTCTTTAGC 
Z2_3’XhoI_r GCTACTCGAGCTCATCATCGCTTCATCG 
E2_3’HindIII_r CGTAAAGCTTCATTTTACACGTCCAACTG 
Z2_5’NcoI_f TGTACCATGGTTGAGTACACCCC 
Z2_S46K_f CCCGGAGCGGGTAAGAGTAAGGCAGC 
Z2_S46K_r GCTGCCTTACTCTTACCCGCTCCGGG 
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ε3/ζ3 
Z3_K46A_f TCAACCGGGAGCGGGAGCAAGTAAGACCGCCGACATC 
Z3_K46A_r GATGTCGGCGGTCTTACTTGCTCCCGCTCCCGGTTG 
E3_5’NdeI_f CCGGAGATATCATATGGGCATGAAAG 
E3_3’HindIII_r GGCCTTGAAGCTTACTCATACAGAACCCCCAAC 
Z3_5’NcoI_f TGGGGGTTCTCCATGGGTGATTACCAAAAG 
Z3_404stop_HindIII_r TGGTGCTCGAGTAAGCTTCATCGCTTCATC 
ezeT promoter 
EzeT_5’NdeI_His_f CATTTAACAGGAGTGTTAATGCATATGCACCATCACCATCACCCC 
EzeT_5’NdeI_His_r GGGGTGATGGTGATGGTGCATATGCATTAACACTCCTGTTAAATG 
GFP_3’EcoRI_r GACTGAATTCGGTTATGCTAGTTATTGCTC 
GFP_delSD_f CGAAAAATATCATTTAACGTACGTGTTAATGCATATGAGC 
GFP_delSD_r GCTCATATGCATTAACACGTACGTTAAATGATATTTTTCG 
GFP_delPSdown_f CCTGTAGAACAGTATTATAATTGTTGAAAAATATCATTTAACAGG 
GFP_delPSdown_r CCTGTTAAATGATATTTTTCAACAATTATAATACTGTTCTACAGG 
GFP_delPS_f CTCCTGTAGAACAGTATAGGTCGCACCGAAAAATATC 
GFP_delPS_r GATATTTTTCGGTGCGACCTATACTGTTCTACAGGAG 
GFP_s70_f GATTAAATAATATCTGAAAAGCTTGACAACTCCTGTAGAACAG 
GFP_s70_f CTGTTCTACAGGAGTTGTCAAGCTTTTCAGATATTATTTAATC 
GFP_del35_f GATTAAATAATATCTGAAAAGCAGCTAGACTCCTGTAGAACAG 
GFP_del35_r CTGTTCTACAGGAGTCTAGCTGCTTTTCAGATATTATTTAATC 
GFP_delUPE_1_f CCATTCGCCATTCAGGCAAGCTTGCCATGATTTGTTACG 
GFP_delUPE_1_r CGTAACAAATCATGGCAAGCTTGCCTGAATGGCGAATGG 
GFP_delUPE_2_f CATAGATTAAATAAAAGCTTAAAAGCAAAATCACTCC 
GFP_delUPE_2_r GGAGTGATTTTGCTTTTAAGCTTTTATTTAATCTATG 
GFP_delprom_f CACTCCTGTAGAACAAGCTTATAATCACCGAAAAATATC 
GFP_delprom_r GATATTTTTCGGTGATTATAAGCTTGTTCTACAGGAGTG 
Integration 
HA-tag_1_f GGAATACACAAGCGGCCTACCCATACGATGTTCACCACCACCAC
TGAG 
HA-tag_1_r CTCAGTGGTGGTGGTGAACATCGTATGGGTAGGCCGCTTGTGTA
TTCC 
HA-tag_2_f CCTACCCATACGATGTTCCAGATTACGCTTGAGATCCGGCTGC 
HA-tag_2_r GCAGCCGGATCTCAAGCGTAATCTGGAACATCGTATGGGTAGG 
EzeT_5’NdeI_f CTAGCATATGGCTACTTTAATGG 
HA-tag_3’BamHI_r GACTGGATCCTCAAGCGTAATCTGGAAC 
Neo_5’MfeI_f CATGCAATTGAATTAACCCTCACTAAAGGGCG 
Neo_3’MfeI_r CATGCAATTGTAATACGACTCACTATAGGGCTC 
Int_f GAGCAGGTGGTGCAGAAGCTGC 
M13_rev CAGGAAACAGCTATGAC 
Int_control_f CGTTGATTGGCAATGACCTGTC 
Int_control_r GCAGAGAAGGGGACGTTAAGG 
1 Restriction sites are underlined, mutated codons/promoter regions are in bold. 
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7.2 Amino acid sequence alignment of EzeT proteins from 
different Escherichia coli strains 
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Figure 7.2-1: Amino acid sequence alignment of EzeT proteins from different E. coli strains. 
37 groups of identical EzeT sequences with an overall amino acid sequence identity of 88 % and 
pairwise sequence identities above 96 %  have been identified in 364 different E. coli strains. Most 
residues are either identical (green) or highly conserved (orange) between the different proteins. 
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7.3 Abbreviations 
(v/v)   Volume per volume 
(w/v)   Weight per volume 
Å   Ångström 
aa   Amino acid 
a.u.    Arbitrary units 
APS   Ammonium persulfate 
AppNHp   Adenosine-5’-[(β,γ)-imido]triphosphate 
ATPγS   Adenosine-5’-(γ-thiol)-triphosphate 
bp   Base pairs 
C-terminus  Carboxy terminus 
CD   Circular dichroism 
CFU   Colony forming unit 
CV   Column volume 
DTE   Dithioerythritol 
EDTA   Ethylenediaminetetraacetic acid 
GFP   Green fluorescent protein 
HEPES   2-[4-(2-Hydroxyethyl)piperazin-1-yl]ethanesulfonic acid 
His6    Hexahistidine 
IPTG   Isopropyl β-D-1-thiogalactopyranoside 
kb   Kilobase 
Kd   Binding constant 
kDa   Kilodalton 
Ki   Inhibitory constant 
Km    Michaelis-Menten constant 
koff   Dissociation rate constant 
kon   Association rate constant 
LB   Lysogeny broth medium 
LMW   Low molecular weight marker 
MALDI-TOF  Matrix-assisted laser desorption/ionization time-of-flight 
Mant   2'-/3'-O-(N'-Methylanthraniloyl) 
MES   2-(N-Morpholino)ethanesulfonic acid 
mS   Millisiemens  
MW   Molecular weight 
MWCO  Molecular weight cut-off 
N-terminus  Amino terminus 
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NADH/NAD  Nicotinamide adenine dinucleotide, reduced/oxidized form 
OD600   Optical density at a wavelength of 600 nm 
ORF   Open reading frame 
PCD   Programmed cell death 
PCR   Polymerase chain reaction 
PDB   Protein data bank 
PEP   Phosphoenol pyruvate 
PMF   Peptide mass fingerprinting 
RMSD    Root mean square deviation 
Rpm   Revolutions per minute 
PSK   Postsegregational killing 
SAD   Single wavelength anomalous diffraction 
SDS   Sodium dodecyl sulfate  
SDS-PAGE  Sodium dodecyl sulphate polyacrylamide gel electrophoresis 
SeMet   Selenomethionine  
T   Temperature 
TA   Toxin-antitoxin 
TEMED  N,N,N′,N′-Tetramethylethane-1,2-diamine 
TEV   Tobacco etch virus 
Tm   Melting temperature 
Tris   Tris(hydroxymethyl)-aminomethan 
U   Unit 
UNAG   Uridine diphosphate-N-acetylglucosamine 
UNAG-3P  Uridine diphosphate-N-acetylglucosamine-3’-phosphate 
UV   Ultraviolet light 
vmax   Maximal velocity 
wt   Wild-type 
 
Amino acids in one and three letter code 
A Ala Alanine    M Met Methionine 
C Cys Cysteine    N Asn Asparagine 
D Asp Aspartic acid    P Pro Proline 
E Glu Glutamic acid    Q Gln Glutamine 
F Phe Phenylalanine    R Arg Arginine 
G Gly Glycine    S Ser Serine 
H His Histidine    T Thr Threonine 
I Ile Isoleucine    V   Val Valine 
K Lys Lysine     W Trp Tryptophan 
L Leu Leucine    Y Tyr Tyrosine 
